% Exported from Psilocybin Research Publication Tracker
% Tracker site: https://psilocybin-research.com
% Publication tracker: https://psilocybin-research.com/
\documentclass[11pt]{article}
\usepackage[T1]{fontenc}
\usepackage[utf8]{inputenc}
\usepackage{enumitem}
\usepackage[hidelinks]{hyperref}
\usepackage[margin=1in]{geometry}
\title{Psilocybin and Psilocin Research Export}
\author{Psilocybin Research Publication Tracker}
\date{2026-07-13}
\begin{document}
\maketitle
\noindent Exported from \href{https://psilocybin-research.com}{psilocybin-research.com}. Records: 1419.

\begin{enumerate}[leftmargin=*]
\item Ibi Daisuke, Takaba Rika, Yoshida Keisuke, Kawase Ririna, Kitagawa Hiroko, Matsushita Momoko, Ito Kana, Uno Shoya, Nishimura Fumiya, Kitagaki Shinji, Hiramatsu Masayuki (2026). \textit{Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress}. Neuropsychopharmacology Reports. [published; Crossref]. \href{https://doi.org/10.1002/npr2.70152}{doi:10.1002/npr2.70152}.
\item Lin C, Wang X. (2026). \textit{Epigenetic landscapes of classical psychedelics and ketamine: molecular mechanisms of long-lasting neuromodulation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03744-8}{doi:10.1038/s41380-026-03744-8}.
\item Thomas CW, LaMalfa KS, Whelan TP, Blackmore T, Golden CT, Pizzagalli DA, Bergman J, Gilmour G, Kangas BD. (2026). \textit{Psychedelics produce enduring enhancement of reward responsiveness in male rats.}. Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-026-02475-2}{doi:10.1038/s41386-026-02475-2}.
\item Bruyère Health Research Institute. (2026). \textit{PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07063862}{source link}.
\item Ottawa Hospital Research Institute (2026). \textit{PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04754061}{source link}.
\item Liu, C.; Ho, E. M.; Enos, A. S.; Baublyte, U. B.; Luna, I. M.; Kosche, A. R.; Sohal, V. S. (2026). \textit{Psilocybin selectively rescues cognitive flexibility impairments caused by aberrant prefrontal error signaling}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.07.05.736652}{doi:10.64898/2026.07.05.736652}.
\item Raul Edison Luna Lazo, Nicole Milagritos Cardoso Azorza, Jatziri Yanina Vilca Yanac, Ahmad Kassem El Zein, Omar Abraham Ramírez Paucar, Luana Mota Ferreira, Roberto Pontarolo (2026). \textit{Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.}. Open MIND. [published; OpenAlex]. \href{https://doi.org/10.17605/osf.io/guqxr}{doi:10.17605/osf.io/guqxr}.
\item Baker, J. J.; Kogan, E.; Ma, S.; Lu, J.; Zuo, Y. (2026). \textit{Dissociating the Hallucinogenic and Neuroplastic Effects of Psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.06.716778}{doi:10.64898/2026.04.06.716778}.
\item Rosado AF, Yu AL, Yang JH, Rondeau J, Floris G, Basu A, Staszko S, Dibbs M, Feng J, Li Y, Warner-Schmidt J, Kelmendi B, Krystal JH, Pittenger C, Kwan AC, Kaye AP. (2026). \textit{α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice.}. Molecular Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03713-1}{doi:10.1038/s41380-026-03713-1}.
\item Omar Azuara-Antonio, Erika Rubí De La Cruz-Elizaldeb, José Eduardo Carmona-Rodriguez, Lesly Idaliht Hernandez-Martinez (2026). \textit{Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case Review}. Mexican Journal of Medical Research ICSA. [published; OpenAlex]. \href{https://doi.org/10.29057/mjmr.v14i28.16493}{doi:10.29057/mjmr.v14i28.16493}.
\item Koning E, Richard J, Keshen A. (2026). \textit{Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.}. International Journal of Eating Disorders. [published; Europe PMC]. \href{https://doi.org/10.1002/eat.70164}{doi:10.1002/eat.70164}.
\item Askari M, Surapaneni V. (2026). \textit{Convergent biosynthesis of psilocybin in an ectomycorrhizal lineage: is the psychoactive end-product the selected trait?}. EcoEvoRxiv. [preprint; Europe PMC]. \href{https://doi.org/10.32942/x2fd49}{doi:10.32942/x2fd49}.
\item Pasquini L, Vohryzek J, Escrichs A, Perl YS, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G. (2026). \textit{Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/hbm.70596}{doi:10.1002/hbm.70596}.
\item Akbar RJ, Stringer AD, Wiah S, Dachepalli M, Daws SE, Inan S, Rawls SM. (2026). \textit{Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/fbp.0000000000000879}{doi:10.1097/fbp.0000000000000879}.
\item Junior WSC, Bezerra KS, Matias EGC, Oliveira JIN, Fulco UL. (2026). \textit{MFCC-DFT mapping of ligand recognition at the 5-HT2A receptor: energetic analysis of the interactions between serotonin, psychedelics, and antipsychotics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1039/d6cp00943c}{doi:10.1039/d6cp00943c}.
\item Gumpper RH, Nichols DE (2026). \textit{Chemistry/structural biology of psychedelic drugs and their receptor(s).}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17361}{doi:10.1111/bph.17361}.
\item Askey T, Lasrado R, Maiarú M, Stephens GJ (2026). \textit{Psilocybin as a novel treatment for chronic pain.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.17420}{doi:10.1111/bph.17420}.
\item Sharp T, Ippolito A (2026). \textit{Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT receptor agonists.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70050}{doi:10.1111/bph.70050}.
\item Hoyer D (2026). \textit{Psychedelics, entactogens and psychoplastogens for depression and related disorders.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70088}{doi:10.1111/bph.70088}.
\item Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T (2026). \textit{Evidence that 5-HT receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70109}{doi:10.1111/bph.70109}.
\item Qureshi O, Cowley J, Pegg A, Cooper AJ, Gordon J, Brady CA, Belli A, Butterworth S, Upthegrove R, Andrews N, Barnes NM (2026). \textit{Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?}. British journal of pharmacology. [published; PubMed]. \href{https://doi.org/10.1111/bph.70138}{doi:10.1111/bph.70138}.
\item Fleury S, Nautiyal KM. (2026). \textit{Correction: The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-026-03488-5}{doi:10.1038/s41380-026-03488-5}.
\item Ascone F, Buzzelli V, Mottarlini F, Di Trapano M, Miglioranza P, Rava A, Feo A, Spano F, Hausman M, Sugaya K, Caffino L, Fumagalli F, Trezza V (2026). \textit{Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.}. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. [published; PubMed]. \href{https://doi.org/10.1038/s41386-026-02361-x}{doi:10.1038/s41386-026-02361-x}.
\item Escobar-Cornejo Guillermo, Corredor-Gamba Julián, Rodriguez-Rojas Yoly, Cárdenas F. P. (2026). \textit{The relevance of the 5HT2A-mGlu2 heterodimer in explaining the clinical ambivalence of psilocybin}. Revista de Neuro-Psiquiatría. [published; Crossref]. \href{https://doi.org/10.20453/rnp.v89i2.7539}{doi:10.20453/rnp.v89i2.7539}.
\item Ladislavová L, Kútná V, Mazochová K, Šíchová K, Danda H, Lhotková E, Uttl L, Brejtr V, Syrová K, Mazoch V, Horsley R, Páleníček T. (2026). \textit{Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2026.174231}{doi:10.1016/j.pbb.2026.174231}.
\item Wang Y, Wang H, Lin C, Wang X (2026). \textit{Chemical ecology and convergent evolution of natural hallucinogens: From ecological defense to conserved neural targets.}. Proceedings of the National Academy of Sciences of the United States of America. [published; PubMed]. \href{https://doi.org/10.1073/pnas.2535785123}{doi:10.1073/pnas.2535785123}.
\item Estela-Fernandez CA, Mohamed Yousif Elsheikh R, Beatrice DB, A Alhendal A, Irene Ewe C, Montesinos SY, Wensel J, Mishra AP, Yousif AA, Ali HT. (2026). \textit{Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40211-026-00584-4}{doi:10.1007/s40211-026-00584-4}.
\item Johns Hopkins University (2026). \textit{5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05452772}{source link}.
\item Özaydın Y, Canlan Özaydın B. (2026). \textit{Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811261456196}{doi:10.1177/02698811261456196}.
\item University Hospital, Basel, Switzerland (2026). \textit{Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06884514}{source link}.
\item Johns Hopkins University (2026). \textit{Psilocybin Administration With 5-HT1a Blockade}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07565493}{source link}.
\item Mauro Pettorruso, Giacomo d’Andrea, Antonio Inserra, Clara Cavallotto, Stefano Censi, Étienne Billard, Antonio Di Stefano, Luisa De Risio, Maria Giulia Tullo, Claudio D’Addario, Giorgio Di Lorenzo, Richard G. Wise, Stefano L. Sensi, Francesca Zoratto, Giovanni Martinotti (2026). \textit{Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-026-04203-2}{doi:10.1038/s41398-026-04203-2}.
\item M.D. Anderson Cancer Center (2026). \textit{TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06200155}{source link}.
\item M.D. Anderson Cancer Center (2026). \textit{TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06801041}{source link}.
\item Júlio César Claudino dos Santos, Sofia Januário Bolan, Guilherme Lodetti da Silva, Germano Lapa Viana, Eduardo Pacheco Rico, Cinara Ludvig Gonçalves (2026). \textit{Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges}. Journal of Psychiatric Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpsychires.2026.06.035}{doi:10.1016/j.jpsychires.2026.06.035}.
\item Lenka Seillier, Alexandre Seillier, Morgan A. Zvolska, Romana Šlamberová (2026). \textit{Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim test}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261458349}{doi:10.1177/02698811261458349}.
\item Johns Hopkins University (2026). \textit{Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and Efficacy}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06407635}{source link}.
\item Eric P. Rubenstein (2026). \textit{Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive Use}. Journal of Advances in Developmental Research. [published; OpenAlex]. \href{https://doi.org/10.71097/ijaidr.v17.i1.1997}{doi:10.71097/ijaidr.v17.i1.1997}.
\item Astrit Sabani, Adnan Khatak (2026). \textit{Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence}. Annals of Medicine and Surgery. [published; OpenAlex]. \href{https://doi.org/10.1097/ms9.0000000000005244}{doi:10.1097/ms9.0000000000005244}.
\item Bhat A, Zolali E, Sakib MA, Rahimian M, McMahon LR, German N, Obeng S (2026). \textit{Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.6c00202}{doi:10.1021/acschemneuro.6c00202}.
\item Julia Osipowska, Marlena Kwolek, Alicja Judzińska, Bartosz Piech, Kamila Sobczyńska, Justyna Ignarska, Magda Terbosh, Sabina Kubicz `Mzabi, Emilia Trojanowska, Magdalena Dubaj (2026). \textit{THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.2(50).2026.5605}{doi:10.31435/ijitss.2(50).2026.5605}.
\item Akemini J Udoro, Yadanar Yukyi, Ali Z Ansari, Hiram A Gandara, Fizza Ahmed, Derek Hunt (2026). \textit{Acute Hallucinogen Intoxication Following Ingestion of a Commercially Available Mushroom Extract Product: A Case Report}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.110791}{doi:10.7759/cureus.110791}.
\item J. Mingardi, R. Molteni, F. Bifari (2026). \textit{Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depression}. Pharmacological Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.phrs.2026.108290}{doi:10.1016/j.phrs.2026.108290}.
\item Johns Hopkins University (2026). \textit{PRISMatic: A Phase 1b Randomized, Double-Armed, Parallel-Group, Placebo-Controlled Trial of Psilocybin Efficacy With or Without Pimavanserin Pretreatment}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07610135}{source link}.
\item Adam R. Pines, Xue Zhang, John Kochalka, Sam Vesuna, Isaac Kauvar, Divya Rajasekharan, T. Rick Reneau, Teddy J. Akiki, Laura M. Hack, Joshua S. Siegel, Leanne M. Williams (2026). \textit{Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice}. Proceedings of the National Academy of Sciences. [published; OpenAlex]. \href{https://doi.org/10.1073/pnas.2522000123}{doi:10.1073/pnas.2522000123}.
\item Kevin F. Boehnke, Niloufar Pouyan, Jacob S. Aday (2026). \textit{Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians}. Drugs. [published; OpenAlex]. \href{https://doi.org/10.1007/s40265-026-02339-5}{doi:10.1007/s40265-026-02339-5}.
\item Shuhan Lu, Zhixin Zhang, Xinmiao Xue, Yuke Jiang, Chi Zhang, Peng Liu (120506), Dongdong He, Shen Weidong, Shiming Yang, Fangyuan Wang (2026). \textit{Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus}. Hearing Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.heares.2026.109701}{doi:10.1016/j.heares.2026.109701}.
\item Centre for Addiction and Mental Health (2026). \textit{Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06512220}{source link}.
\item Jenna Houff, Andrew Williams, Obie Allen, Barbara Gisabella, Harry Pantazopoulos, Alberto Del Arco (2026). \textit{Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex}. European Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1111/ejn.70574}{doi:10.1111/ejn.70574}.
\item Josh Allen, Bianca Jupp, Tamara L. Baker, Mohammad B. Haskali, Robert Brkljača, Zoe Plummer, Mujun Sun, Justin Brand, Brian R. Christie, Chantel T. Debert, Stuart J. McDonald, Terence J. O’Brien, Pablo M. Casillas-Espinosa, Sandy R. Shultz (2026). \textit{Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats}. Cell Reports Medicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.xcrm.2026.102867}{doi:10.1016/j.xcrm.2026.102867}.
\item Anna Beatriz Vicentini, Caio Cesar de Paula, José Augusto Silva Reis, José Carlos Bouso, Jaime E. C. Hallak, Rafael G. dos Santos (2026). \textit{Classic psychedelics and personality: An updated systematic review}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261449386}{doi:10.1177/02698811261449386}.
\item Egger K, Bozsak R, Aicher HD, Sari H, Poetzsch SN, Rominger A, Martin-Soelch C, Smallridge JW, Dornbierer D, Quednow BB, Scheidegger M, Cumming P. (2026). \textit{Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [18F]FDG-PET study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0271678x261454172}{doi:10.1177/0271678x261454172}.
\item Kervadec E, Bezo A, Serreau R, Strika-Bruneau L, Fauvel B, Amirouche A, Benyamina A, Romeo B. (2026). \textit{Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/jcp.0000000000002197}{doi:10.1097/jcp.0000000000002197}.
\item Unknown authors (2026). \textit{Single-dose psilocybin with CBT more effective than nicotine patch for smoking cessation}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31467}{doi:10.1002/pu.31467}.
\item Alex Hood, Gary ELKINS (2026). \textit{Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2026.00507}{doi:10.1556/2054.2026.00507}.
\item Kristoffer Brendstrup-Brix, Brice Ozenne, Patrick M. Fisher, Dea S. Stenbæk, Anja S. Petersen, Sophia Armand, Drummond E-Wen. McCulloch, Maja Rou Marstrand-Joergensen, Sara M. Ulv Larsen, Annette Johansen, R O B V Jensen, Gitte M. Knudsen, M.K. Madsen (2026). \textit{Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261449380}{doi:10.1177/02698811261449380}.
\item Gang Pei (2026). \textit{A spatiotemporal gating hypothesis for psilocybin plasticity: reconciling the 5-HT₂A-TrkB mechanistic paradox}. Cell Discovery. [published; OpenAlex]. \href{https://doi.org/10.1038/s41421-026-00906-4}{doi:10.1038/s41421-026-00906-4}.
\item David A Barajas, Heather C Noda Carter, Michael R Tomedi, Hiu Yu Lam, Tiffany N Deloatch, Gregory D Reynolds, Marisol S. Castaneto, Pucheng Ke (2026). \textit{Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometry}. Journal of Analytical Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1093/jat/bkag030}{doi:10.1093/jat/bkag030}.
\item Zhang T, Lin C, Wang X. (2026). \textit{Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.6c00146}{doi:10.1021/acsptsci.6c00146}.
\item Unknown authors (2026). \textit{Serotonergic Psychedelics as a Potential Therapeutic Strategy for Anxiety, A Systematic Review}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/gf7bq\_v1}{source link}.
\item Dallas T Mason (2026). \textit{Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6}{source link}.
\item Rachel N Clark (2026). \textit{The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach}. Digital Showcase Research, Scholarship, \& Creative Works (University of Lynchburg). [published; OpenAlex]. \href{https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694\&context=dmscjournal}{source link}.
\item Noah Cavallaro, Priya Rai, David Akins, Sima Soltanpour, Md Taufiq Nasseef, Richard J. Ortiz, Rachel Utama, Caitlyn R. Cody, Anoushka Mistry, Heather C. Brenhouse, Praveen Kulkarni, Craig F. Ferris (2026). \textit{Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats}. Neuroscience Bulletin. [published; OpenAlex]. \href{https://doi.org/10.1007/s12264-026-01632-3}{doi:10.1007/s12264-026-01632-3}.
\item Centre for Addiction and Mental Health (2026). \textit{Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06299319}{source link}.
\item Conn K, Wong N, Sunnetci S, Al Siyabi A, McCoy K, Huang K, Greaves E, Milton LK, Kuhlmann L, Maguire S, Foldi CJ. (2026). \textit{Appetite for change: How psilocybin reshapes food reward learning through striatal dopamine function}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.05.14.725265}{doi:10.64898/2026.05.14.725265}.
\item Kevin H. Yang, Miranda Rasmussen, Kush Bhatt, Nora Satybaldiyeva, Wayne Kepner, Alison A. Moore, Jaclyn Bergstrom (2026). \textit{Association Between Lifetime Hallucinogen Use and Valvular Heart Disease: Findings from the All of Us Research Program}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2026.2673845}{doi:10.1080/02791072.2026.2673845}.
\item Bartłomiej Kosiarski, Anna Skrzypek, Patrycja Markowicz, Mikołaj Zbrożek, Krzysztof Biłyk, Maciej Hutkowski, Zuzanna Chwostek, Hanna Maruchniak, Wiktoria Marzec, Paulina Biedroń (2026). \textit{Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybin}. Journal of Pre-Clinical and Clinical Research. [published; OpenAlex]. \href{https://doi.org/10.26444/jpccr/221219}{doi:10.26444/jpccr/221219}.
\item Jessie Kim, Liam Lochhead, Cory R. Weissman (2026). \textit{From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70262}{doi:10.1002/prp2.70262}.
\item Centre for Addiction and Mental Health (2026). \textit{Does Psilocybin Require Psychedelic Effects to Treat Depression? A4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05710237}{source link}.
\item Bart A. Ellenbroek, Gernot Riedel (2026). \textit{Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000878}{doi:10.1097/fbp.0000000000000878}.
\item James J. Peters Veterans Affairs Medical Center (2026). \textit{Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07251491}{source link}.
\item Kayleigh LaMalfa, Diego A. Pizzagalli, Jack Bergman, Christopher W. Thomas, Brian Kangas (2026). \textit{Prohedonic Effects of Psilocybin (COMP360) in a Touchscreen-Based Rodent Probabilistic Reward Task (Abstract ID: 227883)}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpet.2026.104267}{doi:10.1016/j.jpet.2026.104267}.
\item Sean Hayduk, Amy Stringer, Satoria Zagorski, Sara Jane Ward (2026). \textit{PDE4B Inhibition and Psilocybin as Promising Approaches for Treating Methamphetamine Use Disorder: Preclinical Evidence From Rat Models (Abstract ID: 232554)}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpet.2026.104282}{doi:10.1016/j.jpet.2026.104282}.
\item Unknown authors (2026). \textit{Pure psilocybin reduces reward-associated preference while mushroom extract shows transient exploratory effects in rats}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; OpenAlex]. \href{https://doi.org/10.51126/revsalus.v8isupii.46826}{doi:10.51126/revsalus.v8isupii.46826}.
\item Joseph Hennessey, John Mantsch, John McCorvy (2026). \textit{Effects of Psilocybin on Attentional Set-Shifting Following Chronic Unpredictable Stress in Rats (Abstract ID: 231339)}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpet.2026.104291}{doi:10.1016/j.jpet.2026.104291}.
\item Anna Signor, Martina Colognesi, Giovanna Finzi, Daniela Gabbia, Andrea Mattarei, Stefano Comai, Gianfranco Pasut, Franco Folli, Paolo Manfredi, Sara De Martin (2026). \textit{SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH models}. Journal of Hepatology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0168-8278(26)01861-1}{doi:10.1016/s0168-8278(26)01861-1}.
\item Gyandev Gupta, Ravina Yadav (2026). \textit{Role of Psychological support in sustaining Antidepressants effects in Psilocybin - Assisted Clinical}. JOURNAL OF ADVANCE AND FUTURE RESEARCH. [published; OpenAlex]. \href{https://doi.org/10.56975/jaafr.v4i5.509087}{doi:10.56975/jaafr.v4i5.509087}.
\item O'Mahony B, Harrington C, Harkin A, Lally N (2026). \textit{Trip killers: Addressing a critical knowledge gap in psychedelic research.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/02698811261431056}{doi:10.1177/02698811261431056}.
\item Marilyn H. Silva (2026). \textit{New Approach Methodologies and Open Access Tools Help Characterize Risks for DART, DNT, or Endocrine Effects From Exposure to Hallucinogens With Potential Pesticide Contaminants}. Birth Defects Research. [published; OpenAlex]. \href{https://doi.org/10.1002/bdr2.70048}{doi:10.1002/bdr2.70048}.
\item Hajivalizadeh S, Farahmand K, Kazemzadeh K, Hajivalizadeh G, Shamabadi A. (2026). \textit{Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cnr2.70587}{doi:10.1002/cnr2.70587}.
\item Kwiatos N, Ossel S, Mutti FG. (2026). \textit{Synthesis of Amines for Active Pharmaceutical Ingredients Using the Whole-Cell Factory Saccharomyces Cerevisae.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cbic.202500898}{doi:10.1002/cbic.202500898}.
\item Marini S, De Berardis D. (2026). \textit{The Ecstasy of Gold in Neurodiversity: Focus on the Use of Psychedelics in Autism Spectrum Disorder}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1998.v1}{doi:10.20944/preprints202604.1998.v1}.
\item Wang H, Li X, Yu F, Wang X (2026). \textit{The Harmonious Dance: A Narrative Review on Psychedelics and Music in Therapeutic Settings.}. Current neuropharmacology. [published; PubMed]. \href{https://doi.org/10.2174/011570159x442471260422110855}{doi:10.2174/011570159x442471260422110855}.
\item Neil K. Savalia, Lingxiao Shao, Cory Knox, A. Gilbert, Quan Jiang, Alex Kwan (2026). \textit{157. Opposing 5-HT Receptors Modulate Psilocybin's Action on Dendritic Calcium Dynamics}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.391}{doi:10.1016/j.biopsych.2026.03.391}.
\item Heike Schuler, Delong Zhou, Chloé Savignac, Vedrana Cvetkovska, Yiu-Chung Tse, Juliet Meccia, Danilo Bzdok, Rosemary C. Bagot (2026). \textit{Profiling the Cell-Type Specific Effects of Psilocybin in Medial Prefrontal Cortexh}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.054}{doi:10.1016/j.biopsych.2026.03.054}.
\item Joshua Poulin, Nic Viulet, Ashley Liu, Bradley J. MacIntosh, Sean M. Nestor (2026). \textit{483. Acute Functional Brain Changes Associated With Psilocybin in Depression and Healthy Adults: A Systematic Review and Coordinate-Based Meta-Analysis}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.03.717}{doi:10.1016/j.biopsych.2026.03.717}.
\item Askey T, Allen-Ross D, Luzyanin D, Lasrado R, Gilmour G, Hunt SP, Tamagnini F, Ahmed M, Stephens GJ, Maiarú M. (2026). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s42003-026-10065-7}{doi:10.1038/s42003-026-10065-7}.
\item Low ZXB. (2026). \textit{Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2026.111717}{doi:10.1016/j.pnpbp.2026.111717}.
\item Hinchcliffe JK, Bartlett J, Thomas CW, Golden CT, Gilmour G, Bortolotto ZA, Robinson ES. (2026). \textit{Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant Effects}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.20.719483}{doi:10.64898/2026.04.20.719483}.
\item Yacoub J, Bray E, Bayyat J, Glatfelter GC, Leake A, Buitrago EM, Maitland AD, Partilla J, Cavalco NG, Schalk SS, Lammers JC, Baumann MH, McCorvy J, Leahy JW, Gulick D, Witowski CG, von Salm JL. (2026). \textit{Serotonergic Polypharmacology of 2-Halogenated Tryptamines}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.16.718915}{doi:10.64898/2026.04.16.718915}.
\item Agnieszka Bysiek, Izabela Szpręgiel, Adam Wojtas, Marzena Maćkowiak, Agnieszka Wawrzczak-Bargieła, Monika Leśkiewicz, Ewa Trojan, Katarzyna Kamińska, Weronika Kumorek, Wiktor Bilecki, K Golembiowska (2026). \textit{Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2026.111710}{doi:10.1016/j.pnpbp.2026.111710}.
\item Christopher S. Gondi, Manu Gnanamony, Tarun P. Gondi, Lilyt Nersesyan, Lusine Demirkhanyan (2026). \textit{Psychedelics and Autism Therapy: A Review of Current Research and Future Directions}. Current Issues in Molecular Biology. [published; OpenAlex]. \href{https://doi.org/10.3390/cimb48040417}{doi:10.3390/cimb48040417}.
\item Davoudian PA, Jiang Q, Knox CA, Savalia NK, Shao L, Wilson J, Weiner AM, Chong CW, Liao C, Nothnagel JD, Sakurai T, Kwan AC. (2026). \textit{Psilocybin reshapes cortical inhibition through selective interneuron recruitment}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.04.16.718963}{doi:10.64898/2026.04.16.718963}.
\item Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E. (2026). \textit{Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202604.1125.v1}{doi:10.20944/preprints202604.1125.v1}.
\item D. P. Effinger, J. L. Hoffman, Sema G. Quadir, C. S. Rollison, D. Toedt, M. Echeveste Sanchez, M. W. High, C. W. Hodge, Melissa A. Herman (2026). \textit{Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-026-71481-1}{doi:10.1038/s41467-026-71481-1}.
\item Saif S. Ali, Robin L. Carhart-Harris, Karl G. Sieg (2026). \textit{Classic psychedelics in obsessive-compulsive disorder: a circuit-based framework}. Nature Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1038/s44220-026-00626-4}{doi:10.1038/s44220-026-00626-4}.
\item Jordana Kazdan, Karim S. Ladha, M. Ishrat Husain (2026). \textit{Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70238}{doi:10.1002/prp2.70238}.
\item Manesh Girn, Manoj K. Doss, Leor Roseman, Katrin H. Preller, Fernanda Palhano-Fontes, Lorenzo Pasquini, Frederick S. Barrett, Pablo Mallaroni, Natasha L. Mason, Christopher Timmermann, Drummond E-Wen McCulloch, Patrick M. Fisher, Brian Winston, Flora Moujaes, Felix Muller, Matthias E. Liechti, Franz X. Vollenweider, Johannes G. Ramaekers, Kim Kuypers, Dráulio B. Araújo, Olaf Sporns, Joshua S. Siegel, Nico U.F. Dosenbach, David J. Nutt, Robin L. Carhart-Harris, Emmanuel A. Stamatakis, Danilo Bzdok (2026). \textit{An international mega-analysis of psychedelic drug effects on brain circuit function}. Nature Medicine. [published; OpenAlex]. \href{https://doi.org/10.1038/s41591-026-04287-9}{doi:10.1038/s41591-026-04287-9}.
\item Yong-Xing Qiao, Wei Dai, Yishan Yao, Qian-qian Wei, Chen-xing Yue, Yong-Yu Yin, Yun-feng Li, Liming Zhang (2026). \textit{The astrocytes in the prefrontal cortex contribute to the rapid antidepressant-like effects of psilocybin in the chronic restraint stress mouse model}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2026.111698}{doi:10.1016/j.pnpbp.2026.111698}.
\item Sebastian Schober, Lisa Dorfmann, Karl Walther, Felix Blei, A.R. Chadeayne, Markus Gressler, Stefan Bartram, Sarah E. O’Connor, Dirk Hoffmeister (2026). \textit{Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome}. ChemBioChem. [published; OpenAlex]. \href{https://doi.org/10.1002/cbic.70318}{doi:10.1002/cbic.70318}.
\item J. Geraci, Erik Viirre, Bessi Qorri, Luca Pani (2026). \textit{Psychedelics and the quantum brain: a falsifiable hypothesis on Posner molecules and spin-dependent pharmacology}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2026.1777613}{doi:10.3389/fphar.2026.1777613}.
\item Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin (2026). \textit{Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders}. Psychiatry and Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.65801/pcp.3512}{doi:10.65801/pcp.3512}.
\item Maltman JL, González-Maeso J. (2026). \textit{Reshaping human neurons.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7554/elife.110981}{doi:10.7554/elife.110981}.
\item Schmidt M, Hoffrichter A, Davoudi M, Horschitz S, Lau T, Meinhardt MW, Spanagel R, Ladewig J, Köhr G, Koch P. (2026). \textit{Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7554/elife.104006}{doi:10.7554/elife.104006}.
\item Veronica Mäki-Marttunen (2026). \textit{Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors}. Communications Biology. [published; OpenAlex]. \href{https://doi.org/10.1038/s42003-026-09912-4}{doi:10.1038/s42003-026-09912-4}.
\item Medical University of Vienna (2026). \textit{Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07490353}{source link}.
\item Shivaputra A. Patil, Holly C. Hunsberger (2026). \textit{Psilocybin: Chemical Foundations and Emerging Therapeutic Potential}. Mini-Reviews in Medicinal Chemistry. [published; OpenAlex]. \href{https://doi.org/10.2174/0113895575429775260119043318}{doi:10.2174/0113895575429775260119043318}.
\item Gillet A, Geron C, Vitello MM, Lejeune N. (2026). \textit{Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-026-01274-z}{doi:10.1007/s40263-026-01274-z}.
\item Taddei-Tardón M, Medina-Rodríguez L, Maltman JL, Hudson S, Potukanuma S, Jiménez JH, Martín-Guerrero SM, González-Maeso J, López-Giménez JF. (2026). \textit{Integrated 5-HT2A -TrkB and G protein signaling in serotonergic psychedelic responses}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.19.712961}{doi:10.64898/2026.03.19.712961}.
\item J K Aronson (2026). \textit{When I use a word... The psychedelic mind’s eye}. BMJ. [published; OpenAlex]. \href{https://doi.org/10.1136/bmj.s548}{doi:10.1136/bmj.s548}.
\item Anna Komarczewska, Michał Kociński, Patryk Iglewski, Michał Pietrasz, Jakub Idziński, Anna Lubomska (2026). \textit{PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.5034}{doi:10.31435/ijitss.1(49).2026.5034}.
\item Anchesi I, Raffaele I, Astorino MF, Lui M, Calabrò M, Cipriano GL. (2026). \textit{Beyond the Genomic Storm: Evaluating Tabernanthalog as a Potential Scaffold for Silent Neuroplasticity and Broad-Spectrum Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms27062811}{doi:10.3390/ijms27062811}.
\item Alessandra Linardi, Ariadiny Lima Caetano, Rodrigo Portes Ureshino (2026). \textit{Editorial: Psychedelic substances and neurological diseases: from basics to clinical application}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2026.1816812}{doi:10.3389/fphar.2026.1816812}.
\item Johns Hopkins University (2026). \textit{Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04123314}{source link}.
\item Akey Sungheetha, R. Rajesh Sharma, Oluwasegun Julius Aroba, Sheila Mahapatra, P. D. Mahendhiran (2026). \textit{Explainable AI framework for psilocybin depression treatment optimization}. Frontiers in Computer Science. [published; OpenAlex]. \href{https://doi.org/10.3389/fcomp.2025.1652190}{doi:10.3389/fcomp.2025.1652190}.
\item Marc-Antoine Crocq, Philippe Auby (2026). \textit{The renaissance of research on psychedelics in child and adolescent psychopharmacology}. Child and Adolescent Psychiatry and Mental Health. [published; OpenAlex]. \href{https://doi.org/10.1186/s13034-026-01069-6}{doi:10.1186/s13034-026-01069-6}.
\item Francisco A. Moreno, Katja Ehrmann Allen, Christopher B. Wiegand, Rajan Dunne, James I. Prickett, Brian Bayze, John J. B. Allen (2026). \textit{A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811261424214}{doi:10.1177/02698811261424214}.
\item Michel Sabé, Paul Grof, Nathan Sackett, Sara Tai, Pamela Kryskow, Anya K. Bershad, Douglas Turkington, Matteo Buonarroti, Marco De Pieri, Pantelis Baniotopoulos, Mickael Eskinazi, Kerem Böge, Stefan Leucht, Federico Seragnoli, Leonice Furtado, Tatiana Aboulafia Brakha, Logos Curtis, Matthias Kirschner, Stefan Kaiser, Louise Penzenstadler, Daniele Zullino, Mikkel Højlund, Jade Gallo, Marco Solmi, Jacopo Sapienza, Marta Bosia, Joseph La Torre (2026). \textit{Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review}. Schizophrenia Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.schres.2026.03.003}{doi:10.1016/j.schres.2026.03.003}.
\item Yale University (2026). \textit{Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06442423}{source link}.
\item Shikha Baghel Chauhan, Naziya Akhtar, chirag Jain, Indu Singh (2026). \textit{Strategic Neurodelivery of Psychedelic Compounds: Bridging MolecularPharmacology with Therapeutic Innovation in CNS Disorders}. CNS \& Neurological Disorders - Drug Targets. [published; OpenAlex]. \href{https://doi.org/10.2174/0118715273434237251212095005}{doi:10.2174/0118715273434237251212095005}.
\item Floris G, Jefferson SJ, Rondeau J, Yu AL, Menniti FS, Kwan AC, De Aquino JP, Krystal JH, Pittenger C, Kaye AP. (2026). \textit{Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.06.710108}{doi:10.64898/2026.03.06.710108}.
\item Fabiano N, Stubbs B, Lawrence DW, Rosenblat JD, Teixeira PJ, Wong S, Zhou C, Carhart-Harris R (2026). \textit{The combination of exercise and psychedelics for the treatment of major depressive disorder.}. Discover mental health. [published; PubMed]. \href{https://doi.org/10.1007/s44192-026-00408-5}{doi:10.1007/s44192-026-00408-5}.
\item Region Skane (2026). \textit{The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07169747}{source link}.
\item Claydon MDB, Hinchcliffe JK, Bartlett J, Golden CT, Thomas CW, Gilmour G, Mellor JR, Bortolotto ZA, Robinson ESJ. (2026). \textit{Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2026.03.02.709133}{doi:10.64898/2026.03.02.709133}.
\item Griškova-Bulanova I, Vejmola Č, Páleníček T. (2026). \textit{Serotonergic modulation of cortical gamma synchronization: right-lateralized psilocin effects on 40 Hz auditory steady-state responses in rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1152/jn.00519.2025}{doi:10.1152/jn.00519.2025}.
\item Bo Jarrett Wood, M. Frances Vest, Catharine Carfagno, Kyla Rose Bartley, Papori Sharma, Adam L. Halberstadt, Bruce E. Blough, Kevin S. Murnane (2026). \textit{Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00484}{doi:10.1021/acsptsci.5c00484}.
\item Samuel E. Williamson, Elise K. Burkhartzmeyer, Michael T. Faley, Rachel Friedman Ohana, Ilia A. Guzei, Mike Valley, James J. Cali, Alexander M. Sherwood (2026). \textit{Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.5c00879}{doi:10.1021/acschemneuro.5c00879}.
\item Stanley Kisourin (2026). \textit{Nicotinoyl-Tryptamine Derivatives as Potential Dual-Action Prodrugs for NAD⁺ Enhancement and Neuroprotection}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18825289}{doi:10.5281/zenodo.18825289}.
\item Isis Koutrouli, Vojtěch Brejtr, Marek Schwendt, Kacper Witek, Chrysostomos Charalambous, K. Aleksič, N. Miniariková, Eva Lhotková, Martin Toman, M. Nikolič, Radek Jurok, Petra Cihlářová, Vladimír Mazoch, Pavel Ryšánek, Martin Kuchař, Klára Šíchová, Tomáš Páleníček (2026). \textit{Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse Prevention}. Addiction Biology. [published; OpenAlex]. \href{https://doi.org/10.1111/adb.70111}{doi:10.1111/adb.70111}.
\item Zhang J, Lin C, Lv X, Zhao H, Wang X. (2026). \textit{Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2026.02.011}{doi:10.1016/j.biopsych.2026.02.011}.
\item Girault N, Quiroga L, Jedrecy S, Bertin S, Djonouma N, Fossati P. (2026). \textit{[Perspectives opened up by the physiopathological understanding of psychiatric disorders].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/41878960}{source link}.
\item Shokr MM, Fawzy MN, Abdelaziz AM. (2026). \textit{Pharmacological regulation of adult brain neuroplasticity: Synergistic roles of neuropeptide signaling, psychedelics, and synaptic modulators.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mcn.2026.104076}{doi:10.1016/j.mcn.2026.104076}.
\item Gabriella Gobbi (2026). \textit{The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07433452}{source link}.
\item Albert Garcia-Romeu, Gideon P. Naudé, Alison W. Rebman, Sara So, Abigail Yaffe, Ian Geithner, Erica A. Kozero, Ting Yang, Mark J. Soloski, John N. Aucott (2026). \textit{Pilot study of psilocybin in patients with post-treatment lyme disease}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-026-38091-9}{doi:10.1038/s41598-026-38091-9}.
\item Momoko Ishii, Mark Zervas (2026). \textit{SSRIs, Psilocybin, MDMA, and Disease Modeling: Strategies to Advance PTSD Treatment}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.14293/pr2199.003034.v1}{doi:10.14293/pr2199.003034.v1}.
\item Jordan McDowell, Jada Middleton, Alanna Bluett, Alisa Kozachenko, Bayan Attar, Yuvraj Singh Saini, Jennifer Burke, Cayden McPhee, Mutahera Mutahera, Talya Ahmed, Nabila Ibrahim, Gilbert Atukwatsibwe, Sulabha Adhikari, Mohammad Esmaili, Jean-Vital Yambayamba (2026). \textit{Effects of Psilocybin and Select Pharmaceutical Interactions}. MacEwan University Student eJournal. [published; OpenAlex]. \href{https://doi.org/10.31542/bcek6t76}{doi:10.31542/bcek6t76}.
\item Itishree Sahoo, Sairam Masadi, Ashwath Maheswari, Rachel Utama, Muhammad Abeer, Sima Soltanpour, Md Taufiq Nasseef, Tochi Chukwuemeka, Nandini Sinhal, Jyot Pandit, Richard J. Ortiz, Noah Cavallaro, Eric Brengel, Praveen Kulkarni, Michael A. Gitcho, Craig F. Ferris (2026). \textit{Sex-dependent developmental changes in behavior, brain structure, functional connectivity, and sensory perception following exposure to psilocybin during adolescence}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-026-02356-8}{doi:10.1038/s41386-026-02356-8}.
\item Minauro-Sanmiguel F, Vargas-Perez H. (2026). \textit{Hallucinogenic Therapy in Alzheimer's Disease targeting Mitochondria-Associated Membranes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroscience.2026.02.028}{doi:10.1016/j.neuroscience.2026.02.028}.
\item Zurika Murray, Angélique Lewies, Johannes F. Wentzel, Marietjie Schutte-Smith, Elizabeth Erasmus, Anwar E.M. Noreljaleel, Hendrik G. Visser, Anke Wilhelm, Abdul Rashid Issahaku (2026). \textit{Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brain}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-026-39483-7}{doi:10.1038/s41598-026-39483-7}.
\item Habelt B. (2026). \textit{The potential of event-related beta oscillations as biomarkers for neuromodulatory treatment efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2026.1779055}{doi:10.3389/fpsyg.2026.1779055}.
\item Hadassah Medical Organization (2026). \textit{Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07079930}{source link}.
\item Tianyi Xu, Sabrina Wong, Gia Han Le, Christine E. Dri, Kayla M. Teopiz, Andy Lu, Serene M. L. Lee, Taeho Greg Rhee, Liyang Yin, Stavroula I. Bargiota, Roger Ho, Roger S. McIntyre (2026). \textit{Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2794-6487}{doi:10.1055/a-2794-6487}.
\item Junhong Liu, Y. Lynn Wang, Ke Xia, Jia-Bin Wu, Danhao Zheng, Aoling Cai, Haitao Yan, Ruibin Su (2026). \textit{Acute psilocin increased cortical activity in rat}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2026.1593703}{doi:10.3389/fnins.2026.1593703}.
\item Sheida Shadani, Erika Greaves, Zane B. Andrews, Claire J. Foldi (2026). \textit{Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp026a.0003}{doi:10.61373/pp026a.0003}.
\item Pablo Mallaroni, S. Parker Singleton, Natasha L. Mason, Theodore D. Satterthwaite, Johannes G. Ramaekers (2026). \textit{Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-026-03447-0}{doi:10.1038/s41380-026-03447-0}.
\item Homon A, Laramie J, Hayward JJ, Trant JF (2026). \textit{We Licked the Toads so You Don't Have to: A Comprehensive Analysis of the Chemical Syntheses of the Classical Psychedelics Bufotenin(e) and 5-Methoxy-N,N-Dimethyltryptamine.}. ChemMedChem. [published; PubMed]. \href{https://doi.org/10.1002/cmdc.202500525}{doi:10.1002/cmdc.202500525}.
\item Mehmet Bostancıklıoğlu, Davut Sinan Kaplan, Ramazan Bal, Elif Yiğit, Hasan Ulusal, Ebru Temiz (2026). \textit{MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of Fear}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2026.01.016}{doi:10.1016/j.biopsych.2026.01.016}.
\item Anna Maria Komarczewska, Filip Matusiak, Klaudia Brzoza, Michał Kociński, Patryk Iglewski, Michał Pietrasz (2026). \textit{Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects}. Quality in Sport. [published; OpenAlex]. \href{https://doi.org/10.12775/qs.2026.51.68216}{doi:10.12775/qs.2026.51.68216}.
\item Jesper L. Kristensen (2026). \textit{Regarding “The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses”}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-026-03844-7}{doi:10.1038/s41398-026-03844-7}.
\item Lukasz Siwek, Marta Nowocien, Barbara Balajewicz, Angelika Samborska, Sara Szukalska, Marta Karczewska, Karolina Lichwala, Kamil Wroblewski, Paulina Wróblewska (2026). \textit{The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative Review}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.102694}{doi:10.7759/cureus.102694}.
\item Roser P. (2026). \textit{[Pharmacological post-acute treatment of alcohol use disorder: Established strategies and innovative approaches].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.23785/tu.2026.01.006}{doi:10.23785/tu.2026.01.006}.
\item Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska (2026). \textit{PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4711}{doi:10.31435/ijitss.1(49).2026.4711}.
\item Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero (2026). \textit{The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence}. Zenodo (CERN European Organization for Nuclear Research). [published; OpenAlex]. \href{https://doi.org/10.5281/zenodo.18375715}{doi:10.5281/zenodo.18375715}.
\item Marco Banzato, Martina Colognesi, Lorena Lucatello, Stefano Comai, Gianfranco Pasut, Francesca Capolongo, Laura Orian, Lucia Biasutto, Anna Signor, Daniela Gabbia, Paolo L. Manfredi, Sara De Martin, Andrea Mattarei (2026). \textit{Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure}. Journal of Medicinal Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1021/acs.jmedchem.5c01797}{doi:10.1021/acs.jmedchem.5c01797}.
\item Rishika Scott, James Smith (2026). \textit{The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression}. Emerging Minds Journal for Student Research. [published; OpenAlex]. \href{https://doi.org/10.59973/emjsr.317}{doi:10.59973/emjsr.317}.
\item Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska (2026). \textit{THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS}. International Journal of Innovative Technologies in Social Science. [published; OpenAlex]. \href{https://doi.org/10.31435/ijitss.1(49).2026.4582}{doi:10.31435/ijitss.1(49).2026.4582}.
\item Ana Domi, Erika Lucente, Davide Cadeddu, Niklas Bengtsson, Erik Smedler, Louise Adermark (2026). \textit{Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2026.110854}{doi:10.1016/j.neuropharm.2026.110854}.
\item Martina Colognesi, Daniela Gabbia, Anna Signor, Miles Sarill, Lucia Centofanti, Andrea Rinaldi, Luciano Cascione, Sara Nunziata, Marco Banzato, Andrea Mattarei, Giovanna Finzi, Sonia Sonda, Diana Pendin, Ilaria Zanotto, Stefano Comai, Gianfranco Pasut, Abdullah Alajati, Miriam Saponaro, Loredana Bucciarelli, Maria Elena Lunati, Andrea Alimonti, et al. (2026). \textit{Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms}. Repository for Publications and Research Data (ETH Zurich). [published; OpenAlex]. \href{https://doi.org/10.3929/ethz-c-000793359}{doi:10.3929/ethz-c-000793359}.
\item Piotr Olejnik, Katarzyna Kamińska, Krystyna Gołembiowska, Kaja Kasarełło (2026). \textit{Effects of psilocybin and chronic mild stress on microglial activation in rat spinal cord: an ex vivo analysis}. Pharmacological Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s43440-026-00824-y}{doi:10.1007/s43440-026-00824-y}.
\item Rached G, Campana A, Fiani D, Nguyen C, Van den Eynde V, Gillman PK, Barnett BS. (2026). \textit{Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-025-01256-7}{doi:10.1007/s40263-025-01256-7}.
\item Anna C. Renner, Robert B. Kargbo (2026). \textit{Chemical Design and Pharmacokinetics Enable Precision Psychedelic Therapeutics}. ACS Medicinal Chemistry Letters. [published; OpenAlex]. \href{https://doi.org/10.1021/acsmedchemlett.5c00780}{doi:10.1021/acsmedchemlett.5c00780}.
\item Koch P, Schmidt M, Hoffrichter A, Davoudi M, Horschitz S, Lau T, Meinhardt M, Spanagel R, Ladewig J, Köhr G. (2026). \textit{Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4242829/v3}{doi:10.21203/rs.3.rs-4242829/v3}.
\item Charalampos L. Kandilakis, Costas Papatheodoropoulos (2026). \textit{Psychedelic Modulation of Excitation/Inhibition Balance: A Dual-Phase Neurodevelopmental Model}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.5c00892}{doi:10.1021/acschemneuro.5c00892}.
\item Zuzanna Kościuk, Izabela Szpręgiel, Agnieszka Bysiek, K. Gołembiowska (2026). \textit{The effect of psilocin on neurotransmitters release in the claustrum and on rat behavior}. Pharmacological Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s43440-025-00817-3}{doi:10.1007/s43440-025-00817-3}.
\item Frederick D. Sancilio, Maghsoud Dariani, Purvi Chavda, Harsha Mysore Rajagopal, Lyl Tomlinson (2026). \textit{Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2607726}{doi:10.1080/02791072.2025.2607726}.
\item Kunal Kumar Sharma (2025). \textit{Psychedelics and neuroanesthesia: A narrative review of converging mechanisms}. Journal of Scientific Innovations in Anesthesiology. [published; OpenAlex]. \href{https://doi.org/10.65929/jsia.2026.1.2.002}{doi:10.65929/jsia.2026.1.2.002}.
\item Mahvash Khan, Muhammad Omar Malik, Sara Sajjad, Muhammad Uzair, Inayat Shah, Muhammad Ismail Bhatti (2025). \textit{COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER}. Genetics and Molecular Research. [published; OpenAlex]. \href{https://doi.org/10.4238/e91xh631}{doi:10.4238/e91xh631}.
\item Belle Buzzi (2025). \textit{Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal Studies}. VCU Scholars Compass (Virginia Commonwealth University). [published; OpenAlex]. \href{https://scholarscompass.vcu.edu/etd/8246}{source link}.
\item Aneta Petrušková (2025). \textit{Effects of Serotonergic Psychedelics on Synaptic Function and Neuroplasticity}. OPUS FAU - Online publication system of Friedrich-Alexander-Universität Erlangen-Nürnberg. [published; OpenAlex]. \href{https://doi.org/10.25593/open-fau-2619}{doi:10.25593/open-fau-2619}.
\item Maurice Lam, C. Khor, S. Hultin, J. J. Cheung, N. A. Shah (2025). \textit{‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injury}. Internal Medicine Journal. [published; OpenAlex]. \href{https://doi.org/10.1111/imj.70313}{doi:10.1111/imj.70313}.
\item I.R.A. Koutrouli, K. Šíchová, W. Kacper, V. Brejtr, K. Aleksič, N. Miniariková, E. Lhotková, M. Nikolič, T. Páleníček (2025). \textit{Psilocybin and ibogaine as therapeutic candidates for cocaine addiction: Insights from a rat self-administration model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106393}{doi:10.1016/j.nsa.2025.106393}.
\item K. Aleksič (2025). \textit{The role of 5-HT2A receptors in sleep architecture and memory consolidation in the animal model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106729}{doi:10.1016/j.nsa.2025.106729}.
\item M. Benes, D. Gregus, P. Adamek, T. Páleníček, J. Horacek (2025). \textit{Psilocybin increases connectivity between unimodal and transmodal networks in healthy volunteers listening to music}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.106823}{doi:10.1016/j.nsa.2025.106823}.
\item Holze F, Liechti ME, Müller F. (2025). \textit{Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2024\_510}{doi:10.1007/7854\_2024\_510}.
\item Philip Kamilar-Britt, Alyssa B. Oliva, Mitch Earleywine (2025). \textit{Perceptions of Psilocybin-Assisted Psychotherapy and Standard Interventions for Nicotine Cessation}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2607724}{doi:10.1080/02791072.2025.2607724}.
\item Connor J. Maltby, Adam K. Klein, Enya Paschen, Jessica Pinto, Dino Dvořák, Joseph R. Hedde, Ashley N. Hanks, Massimiliano Bianchi, Zoe Hughes (2025). \textit{An exploration of the relationships between the effects of psilocybin on behavior, 5-HT2A receptor occupancy, and neuroplastic effects in mice}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251395386}{doi:10.1177/02698811251395386}.
\item Hediye Moghadam, Parisa Akbari, Elmira Beirami, Samaneh Nabavifard, Akram Ameli, Neda Valian (2025). \textit{The Effect of Magic Mushroom ( Psilocybe azurescens ) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors}. Journal of Neuroscience Research. [published; OpenAlex]. \href{https://doi.org/10.1002/jnr.70107}{doi:10.1002/jnr.70107}.
\item Ziran Huang, Xiaoyan Wei, Yihui Wang, Jin Tian, Jihui Dong, Bo Liang, Lin Lu, Wen Zhang (2025). \textit{Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex}. Neurotherapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neurot.2026.e00841}{doi:10.1016/j.neurot.2026.e00841}.
\item Spiti A, Caldirola D, Perna G. (2025). \textit{New Antidepressant Development in the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-981-95-6872-7\_23}{doi:10.1007/978-981-95-6872-7\_23}.
\item Xia K, Gao T. (2025). \textit{[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.12122/j.issn.1673-4254.2026.01.01}{doi:10.12122/j.issn.1673-4254.2026.01.01}.
\item de la Fuente Revenga M, González-Maeso J. (2025). \textit{Snapshot IP1 Detection Following 5-HT2A Receptor Stimulation in the Mouse Brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00932}{doi:10.1021/acschemneuro.5c00932}.
\item Ashkan Veysi, Daniela Atanasovski, Maryam Ardalan, Nasrin Motamed, Elias Eriksson (2025). \textit{Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat}. Acta Neuropsychiatrica. [published; OpenAlex]. \href{https://doi.org/10.1017/neu.2026.10075}{doi:10.1017/neu.2026.10075}.
\item Miguel Benjamín Cervera-Sánchez, Daniel San-Juan, Roberto Díaz-Peregrino, Evelin Zulema Camacho-Castillo, Sthefany Anahi Bringas-Ortiz, Christian Padilla-Cabezutd (2025). \textit{Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure Risks}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.22541/au.176701186.65064859/v1}{doi:10.22541/au.176701186.65064859/v1}.
\item Houff J, Williams A, Allen O, Gisabella B, Pantazopoulos H, Del Arco A. (2025). \textit{Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.22.696123}{doi:10.64898/2025.12.22.696123}.
\item Paweł Liszka, Agata Ogórek, Klaudia M Olejnik-Chlewicka, Konrad Puchalski, Marta Zasiadła, Klaudia M Patrzykąt, Jakub Perediatkiewicz, Wojciech Urbański, Paweł M Łuczak, Jakub Brodowski (2025). \textit{Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.99942}{doi:10.7759/cureus.99942}.
\item Shadani S, McCoy K, Ong L, Greaves E, Conn K, Andrews ZB, Foldi CJ. (2025). \textit{Psilocybin modulates social behaviour in male and female mice in a time-dependent manner}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.18.695064}{doi:10.64898/2025.12.18.695064}.
\item M. Haseeb Ul Rasool, Taha Hannan, Muhammad Imam (2025). \textit{Magic mushrooms and mood: exploring Psilocybin as a depression treatment}. Journal of the Pakistan Medical Association. [published; OpenAlex]. \href{https://doi.org/10.47391/jpma.30858}{doi:10.47391/jpma.30858}.
\item Qinqing Chen, Peiyuan Chen, Tao Wei, Sunita Chamyuang, Bai-Xiong Chen (2025). \textit{From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applications}. Creative Science. [published; OpenAlex]. \href{https://doi.org/10.55674/cs.v18i1.264689}{doi:10.55674/cs.v18i1.264689}.
\item Matthews Nicholass K, Flis I, Hanley M, Knight M, Lane S, Littlejohn G, Thom M, Billington R, Boden R, Cummins R, Green B, Griffin C, Jones S, Salmon D, Sleep I, Smirnoff N, Ellis J. (2025). \textit{Wherefore the magic? The evolutionary role of psilocybin in nature}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.64898/2025.12.17.694186}{doi:10.64898/2025.12.17.694186}.
\item Sophie Woodruff, Meghan Hibicke, Charles D. Nichols (2025). \textit{Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1177/28314425251393186}{doi:10.1177/28314425251393186}.
\item M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya (2025). \textit{Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment}. The journal of desk research review and analysis.. [published; OpenAlex]. \href{https://doi.org/10.4038/jdrra.v3i2.87}{doi:10.4038/jdrra.v3i2.87}.
\item Yvan Beaussant, MD, MSci (2025). \textit{Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06001749}{source link}.
\item Anna C. Renner, Robert B. Kargbo (2025). \textit{Advances in Psychedelic Therapeutics: Multimodal Iboga Analogs, EEG-Guided Psilocybin Dosing, and Optimized Harmine-DMT Formulations}. ACS Medicinal Chemistry Letters. [published; OpenAlex]. \href{https://doi.org/10.1021/acsmedchemlett.5c00714}{doi:10.1021/acsmedchemlett.5c00714}.
\item Vollebregt R, Storm AEM, Lucassen PJ, Somers M. (2025). \textit{Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2025.106529}{doi:10.1016/j.neubiorev.2025.106529}.
\item Nicole Ledwos, Jenna Baer, Muhammad Ishrat Husain, Daniel M. Blumberger, Rachel Patterson, Elizabeth Hollingdrake, Ezmond S.L. Cheung, Colin Hawco, Christoph Zrenner, Brigitte Zrenner, Jamie D. Feusner, Susan L. Rossell, David Castle, Gwyneth Zai (2025). \textit{Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2025.10895}{doi:10.1192/bjo.2025.10895}.
\item Teopiz KM, Le GH, Wong S, McIntyre RS. (2025). \textit{The effect of dextromethorphan on reward-related behaviors: A systematic review of preclinical and clinical evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jad.2025.120836}{doi:10.1016/j.jad.2025.120836}.
\item Taslim Uddin, Suma Akter, Kanak Yadab Ghosh (2025). \textit{Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges}. Advanced Neurology. [published; OpenAlex]. \href{https://doi.org/10.36922/an025410095}{doi:10.36922/an025410095}.
\item Unknown authors (2025). \textit{Defining ‘psychedelic’}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/5ybhk\_v1}{source link}.
\item Morris Lintong Barimbing, Dian Pritasari Jeger, Made Edwin Sridana (2025). \textit{Efficacy of psilocybin on death anxiety in terminal patients: a narrative review}. Progress in Palliative Care. [published; OpenAlex]. \href{https://doi.org/10.1080/09699260.2026.2657096}{doi:10.1080/09699260.2026.2657096}.
\item Amin Reihani, Fatemeh Shaki (2025). \textit{Unexpected Detection of Psilocybin in a 100 mg Tramadol Tablet: A Forensic Case Report}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doi.org/10.22038/apjmt.2025.89401.1525}{doi:10.22038/apjmt.2025.89401.1525}.
\item S. Fereydouni (2025). \textit{Psilocybin and Neuroplasticity: Mechanisms, Therapeutic Potential, and Future Directions}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2025.100215}{doi:10.1016/j.etdah.2025.100215}.
\item Nina Kleditzsch, James J Gattuso, Anthony J. Hannan, Thibault Renoir (2025). \textit{Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin}. European Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1111/ejn.70351}{doi:10.1111/ejn.70351}.
\item Małgorzata Domżalska, Joanna Kwiatkowska, Iwona Cichoń, Ewa Sokołowska (2025). \textit{A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress model}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-025-29642-7}{doi:10.1038/s41598-025-29642-7}.
\item Jorge Ferreira (2025). \textit{Psilocybin reduces comorbid chronic pain and depression in mice}. Lab Animal. [published; OpenAlex]. \href{https://doi.org/10.1038/s41684-025-01663-9}{doi:10.1038/s41684-025-01663-9}.
\item Van Ameringen M, Patel V, Patterson B, Hopkinson P, Rahat M. (2025). \textit{New treatments for OCD? Evidence for cannabinoids and psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jpsychires.2025.11.021}{doi:10.1016/j.jpsychires.2025.11.021}.
\item Sana Rasheed, Rida Arif, Ahmed Asad Raza, Abedin Samadi (2025). \textit{Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder}. Annals of Medicine and Surgery. [published; OpenAlex]. \href{https://doi.org/10.1097/ms9.0000000000004349}{doi:10.1097/ms9.0000000000004349}.
\item Alaina M. Jaster, Thomas M Hadlock, Belle Buzzi, Jessica L. Maltman, Gabriella Silva, Somdatta Saha, Eda Köşeli, Abby M Pondelick, Nikita Thakur, Xin Zhang, Gaoshan Li, Sandra Ledesma-Corvi, K. Moore, Hannah R. Peterson, Barbara Fujita, Alexia L. Zylko, Melissa J. Lewis, Justin L. Poklis, Matthew S. Halquist, Jennifer T. Wolstenholme, Dana E. Selley, Peter J. Hamilton, Chang Lu, M. Imad Damaj, Javier González-Maeso (2025). \textit{Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid reward}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-025-64887-w}{doi:10.1038/s41467-025-64887-w}.
\item Silvia Natoli, Arturo Cuomo, Maurizio Marchesini, Livio Luongo, Giuliano Lo Bianco, Vittorio Guardamagna, Shigeki Yamaguchi (2025). \textit{Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?}. Medical Sciences. [published; OpenAlex]. \href{https://doi.org/10.3390/medsci13040277}{doi:10.3390/medsci13040277}.
\item University of Zurich (2025). \textit{Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06081179}{source link}.
\item Beersheva Mental Health Center (2025). \textit{Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04882839}{source link}.
\item Zhang W, Hwang SY, Luther J. (2025). \textit{Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11894-025-01026-x}{doi:10.1007/s11894-025-01026-x}.
\item Tony R. Montgomery, DeMond M. Grant (2025). \textit{Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological Restoration}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.31124/advance.175630073.36585408/v2}{doi:10.31124/advance.175630073.36585408/v2}.
\item Meghan DellaCrosse, Shoval Gilead, Rafael Lancelotta, Ana María Ortiz Bernal, Christopher Timmermann, Alan K. Davis (2025). \textit{Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents}. Psychedelics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psyche.2025.100004}{doi:10.1016/j.psyche.2025.100004}.
\item Hannah M. Kramer, Meghan Hibicke, Jason W. Middleton, Alaina M. Jaster, Jesper L. Kristensen, Charles D. Nichols (2025). \textit{Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-025-02272-3}{doi:10.1038/s41386-025-02272-3}.
\item Sarah N. Magee, Allison C. Sereno, Maria Echeveste-Sanchez, Elizabeth G. Shannon, Abir Mohsin, Sarah E. Mott, Sara Faccidomo, Clyde W. Hodge, Melissa A. Herman (2025). \textit{The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female Mice}. Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1523/jneurosci.0652-25.2025}{doi:10.1523/jneurosci.0652-25.2025}.
\item Renner AC, Kargbo RB. (2025). \textit{Engineering the Next Generation of Psychedelic Therapeutics through Serotonergic Precision and Pharmacokinetic Control.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00661}{doi:10.1021/acsmedchemlett.5c00661}.
\item Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S, Sabé M, Fiedorowicz J, Saraf G, Zein J, Berk M, Husain MI, Rosenblat JD, Rubaiyat R, Corace K, Wong S, Hatcher S, Kaluzienski M, Yatham LN, Cipriani A, Gosling CJ, Carhart-Harris R, Tanuseputro P, Myran DT, Fabiano N, Moher D, Mayo LM, Nicholls SG, White T, Prisco M, Radua J, Vieta E, Ladha KS, Katz J, Veroniki AA, Solmi M. (2025). \textit{Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2025.09.011}{doi:10.1016/j.euroneuro.2025.09.011}.
\item Milad Soltanzadeh, Zheng Wang, Shona G. Allohverdi, Colleen E. Charlton, André Schmidt, Franz Xaver Vollenweider, Andreea O. Diaconescu (2025). \textit{Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm}. Universität Zürich, ZORA. [published; OpenAlex]. \href{https://doi.org/10.5167/uzh-292276}{doi:10.5167/uzh-292276}.
\item University of Washington (2025). \textit{A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05847686}{source link}.
\item Josh Allen, Mujun Sun, Tamara L. Baker, Shannon Dames, Pamela Kryskow, Brian R. Christie, Stuart J. McDonald, Sandy R. Shultz (2025). \textit{Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-025-03329-x}{doi:10.1038/s41380-025-03329-x}.
\item Faith Ekoh, Shanice Rerrie, James Angud, Ersilia Mirabelli (2025). \textit{Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4040039}{doi:10.3390/psychoactives4040039}.
\item Richard Drexler, Belgin Yalçın, Rebecca Mancusi, Abigail Rogers, Kiarash Shamardani, Pamelyn J. Woo, Alexandre Ravel, Yahaya A Yabo, Carlos Alberto Oliveira de Biagi-Junior, Costanza Lo Cascio, Robert C. Malenka, Boris D. Heifets, Mariella G. Filbin, Dieter Henrik Heiland, Karl Deisseroth, Michelle Monje (2025). \textit{CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYS}. Neuro-Oncology. [published; OpenAlex]. \href{https://doi.org/10.1093/neuonc/noaf201.0244}{doi:10.1093/neuonc/noaf201.0244}.
\item Thomas Zandonai, Sofia Venturini, Ornella Corazza (2025). \textit{Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?}. Performance Enhancement \& Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.peh.2025.100386}{doi:10.1016/j.peh.2025.100386}.
\item André Leão Dantas, Lara Moreira Jalles Milani, Saulo Gabriel Moreira Falci, João Américo da Silveira, Cristina Pereira Isolan, Lia Dietrich (2025). \textit{Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications}. Caderno Pedagógico. [published; OpenAlex]. \href{https://doi.org/10.54033/cadpedv22n12-345}{doi:10.54033/cadpedv22n12-345}.
\item Washington University School of Medicine (2025). \textit{Precision Functional Brain Mapping to Understand the Mechanisms of Psilocybin}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04501653}{source link}.
\item d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM, Di Battista D, Mosca A, Miuli A, Di Carlo F, Russo M, Di Petta G, Fornaro M, Pettorruso M, Sensi SL, Martinotti G. (2025). \textit{Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-025-03654-3}{doi:10.1038/s41398-025-03654-3}.
\item Rubén García-Cabrerizo, Itziar Beruete-Fresnillo, Pedro Bergas-Cladera, M. Julia García-Fuster (2025). \textit{Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity}. Biomedicine \& Pharmacotherapy. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopha.2025.118720}{doi:10.1016/j.biopha.2025.118720}.
\item Anna Rose Childress, Ph.D. (2025). \textit{A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06786325}{source link}.
\item special to C EN Mara Johnson-Groh (2025). \textit{Is there more to magic mushrooms than psilocybin?}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10322-feature2}{doi:10.1021/cen-10322-feature2}.
\item Martin HM, Cofre R, Destexhe A. (2025). \textit{Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic states}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.10.20.683366}{doi:10.1101/2025.10.20.683366}.
\item Gabriele M. König, Li-Ming Hsu, Yi-Ting Chiu, Gavin P. Schmitz, Martin MacKinnon, Yen-Yu I. Shih, Bryan L. Roth, Sarah N. Magee, Evi Kostenis, Melissa A. Herman, Mia L. Foglesong (2025). \textit{Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/ce6e-4888}{doi:10.17615/ce6e-4888}.
\item David J. Heal, Jane Gosden, Sharon L. Smith (2025). \textit{Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251382147}{doi:10.1177/02698811251382147}.
\item Gerard J. Marek, Soma Makai-Bölöni, Daniel Umbricht, Edward P. Christian, Jason Winters, Dino Dvořák, Shane Raines, Zoë A. Hughes, Eric W. Austin, Adam K. Klein, William Leong, Fas J. Krol, Anne J. van der Graaf, Maria J. Juachon, Marije E. Otto, Laura Borghans, Gabriël E. Jacobs, Andrew C. Kruegel, Jonathan Sporn (2025). \textit{A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251378512}{doi:10.1177/02698811251378512}.
\item Rongyan Li (11403789), Haohan Yan (22432650), Yujin Chen (1412254), Yangyang Liu (807797), Lingjie Tang (9276407), Jing Yu (81085), Junjun Liu (674159), Huan Wang (109286), Sheng Wang (339979), Jianjun Cheng (646595) (2025). \textit{Structure-GuidedDesign of Novel 5-HT2A Partial Agonists as PsychedelicAnalogues with Antidepressant Effects}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acs.jmedchem.5c02045.s001}{doi:10.1021/acs.jmedchem.5c02045.s001}.
\item Douglas B. Craig (2025). \textit{Analysis of Serotonin in Caenorhabditis Elegans Subjected to Micro-Dosing with Psilocybin| Iris Publishers}. Insights in Chemistry and Biochemistry. [published; OpenAlex]. \href{https://doi.org/10.33552/icbc.2025.03.000562}{doi:10.33552/icbc.2025.03.000562}.
\item Sha Jin, H.Y. Wang, Xiaohui Wang (2025). \textit{Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatment}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025v.0038}{doi:10.61373/pp025v.0038}.
\item University of Washington (2025). \textit{A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic Cancer}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06644170}{source link}.
\item Rongyan Li, Haohan Yan, Yujin Chen, Yangyang Liu, Lingjie Tang, Jing Yu, Junjun Liu, Huan Wang, Sheng Wang, Jianjun Cheng (2025). \textit{Structure-Guided Design of Novel 5-HT2A Partial Agonists as Psychedelic Analogues with Antidepressant Effects}. Journal of Medicinal Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1021/acs.jmedchem.5c02045}{doi:10.1021/acs.jmedchem.5c02045}.
\item Padawer-Curry JA, Krentzman OJ, Kuo CC, Wang X, Bice AR, Nicol GE, Snyder AZ, Siegel JS, McCall JG, Bauer AQ. (2025). \textit{Psychedelic 5-HT2A receptor agonism alters neurovascular coupling and differentially affects neuronal and hemodynamic measures of brain function.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41593-025-02069-z}{doi:10.1038/s41593-025-02069-z}.
\item Rajiv Agrawal, Daniel J. Gillie, Alison E. Mungenast, Milan Chytil, Sharon Engel, Michael C. Wu, Kurt Rasmussen, Eliseo Salinas, David E. Olson (2025). \textit{Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.5c00667}{doi:10.1021/acschemneuro.5c00667}.
\item Renee Ireland (2025). \textit{Psychedelics in Practice: Science, Safety, and the Future of Healing}. The proceedings of sliit international conference on advancements in science and humanities. [published; OpenAlex]. \href{https://doi.org/10.54389/epsd8792}{doi:10.54389/epsd8792}.
\item Unknown authors (2025). \textit{Control group improvement lower in psilocybin trials for depression}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31371}{doi:10.1002/pu.31371}.
\item Renner AC, Kargbo RB. (2025). \textit{Stabilizing Psilocybin Pharmacology and Tuning Safety with Atypical Antipsychotic Cotherapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00595}{doi:10.1021/acsmedchemlett.5c00595}.
\item Centre Hospitalier St Anne (2025). \textit{Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07210112}{source link}.
\item Domzalska M, Kwiatkowska J, Cichon I, Sokolowska E. (2025). \textit{Towards Novel Antidepressant Strategies: A Comparative Study of Ketamine, Psilocybin, and Fluoxetine in a Chronic Stress Model}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7269356/v1}{doi:10.21203/rs.3.rs-7269356/v1}.
\item M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana, Mohamed Safir Ali (2025). \textit{Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders}. Journal of Pharma Insights and Research.. [published; OpenAlex]. \href{https://doi.org/10.69613/thv1dn30}{doi:10.69613/thv1dn30}.
\item Ahmad Hammo, Stephen Wisser, Joseph Cichon (2025). \textit{Single-dose psilocybin rapidly and sustainably relieves allodynia and anxiodepressive-like behaviors in mouse models of chronic pain}. Nature Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1038/s41593-025-02068-0}{doi:10.1038/s41593-025-02068-0}.
\item Anneliese McConnell, Wei He, Harry McConnell, Sandro Sprendei, Paul F. Sowman (2025). \textit{3642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperception}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1136/bmjno-2025-anzan.170}{doi:10.1136/bmjno-2025-anzan.170}.
\item Courtney Y, Anderson JM, Lagares-Linares C, Wenthur CJ, Lehtinen MK. (2025). \textit{Gestational LSD exposure in mouse rapidly reaches embryonic CSF and is associated with altered choroid plexus signaling, cerebral cortical development, and offspring behavior}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.30.677638}{doi:10.1101/2025.09.30.677638}.
\item Shao LX, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C, Tan D, Nothnagel JD, Liu RJ, Woodburn SC, Bilash OM, Kim H, Che A, Kwan AC (2025). \textit{Publisher Correction: Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors.}. Nature. [published; PubMed]. \href{https://doi.org/10.1038/s41586-025-09671-y}{doi:10.1038/s41586-025-09671-y}.
\item Brandon Richardson, Antonio Inserra, Michael Pileggi, Thomas Prudhomme, Vítor Bruno, Derek Wan-Yan-Chan, Ilia Shareghi-Ghahreman, Sofia Nasini, Tadhg Strand, Marco Leyton, Nahum Sonenberg, Danilo De Gregorio, Jeffrey Sprouse, Francis Rodriguez Bambico, Gabriella Gobbi (2025). \textit{Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2025.111522}{doi:10.1016/j.pnpbp.2025.111522}.
\item Cassandra J. Hatzipantelis, Min Liu, A. H. G. Love, Sadie J. Leventhal, Hero Maera, Srinidhi Viswanathan, Emily Avetisyan, Liana Belinsky, McKenna M. Rangel, Nina J. Jain, Max Kelly, C. Copeland, Yara A. Khatib, Oliver Fiehn, David E. Olson, Danielle S. Stolzenberg (2025). \textit{Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-025-64371-5}{doi:10.1038/s41467-025-64371-5}.
\item Saadet Inan, Paige E. Morris, Scott M. Rawls, Stephanie E. Daws (2025). \textit{Psilocybin inhibits formalin-induced nociception through 5-hydroxytryptamine 2A receptor in rats}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000856}{doi:10.1097/fbp.0000000000000856}.
\item Hunt T. (2025). \textit{Electrodynamics of the Psychedelic Experience}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202509.1813.v1}{doi:10.20944/preprints202509.1813.v1}.
\item Alhaj HA, Samara J, Alnamous A, Karima R, Saber-Ayad M. (2025). \textit{Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2025.1651898}{doi:10.3389/fphar.2025.1651898}.
\item Askey T, Allen-Ross D, Luzyanin D, Lasrado R, Gilmour G, Hunt SP, Tamagnini F, Ahmed M, Stephens GJ, Maiarú M. (2025). \textit{Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.09.15.676273}{doi:10.1101/2025.09.15.676273}.
\item Kermanshah A, Stapleton M, Mauriello CM, Cobas M, Cordoba Torres IT. (2025). \textit{Severe Rhabdomyolysis With Stage 3 Acute Kidney Injury After Ayahuasca Use Managed Without Renal Replacement Therapy: A Case Report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.92568}{doi:10.7759/cureus.92568}.
\item Ophir Netzer, Noa Magal, Yonatan Stern, Tzuk Polinsky, Raz Gross, Roee Admon, Roy Salomon (2025). \textit{Trauma under psychedelics: how psychoactive substances impact trauma processing}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.21363}{doi:10.1002/wps.21363}.
\item Sonda S, Pendin D, Comai S, De Martin S, Manfredi P, Mattarei A. (2025). \textit{Emerging mechanisms of psilocybin-induced neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2025.08.012}{doi:10.1016/j.tips.2025.08.012}.
\item Emma M. Bonniwell (14267047), Rana Alabdali (22241286), Joseph J. Hennessey (22241289), John L. McKee (22179170), Natalie G. Cavalco (20388684), Josie C. Lammers (22241292), Ethan J. Moore (22241295), Luca Franchini (10578054), Cesare Orlandi (204175), John D. McCorvy (1416910) (2025). \textit{Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased Agonism}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.5c00647.s001}{doi:10.1021/acschemneuro.5c00647.s001}.
\item Bonniwell EM, Alabdali R, Hennessey JJ, McKee JL, Cavalco NG, Lammers JC, Moore EJ, Franchini L, Orlandi C, McCorvy JD. (2025). \textit{Serotonin 5-HT2C Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00647}{doi:10.1021/acschemneuro.5c00647}.
\item Tap SC, Thomas K, Páleníček T, Stenbæk DS, Oliveira-Maia AJ, van Dalfsen JH, Schoevers RA. (2025). \textit{Concomitant use of antidepressants and classic psychedelics: A scoping review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251368360}{doi:10.1177/02698811251368360}.
\item Jakub Vohryzek, Andrea I. Luppi, Selen Atasoy, Gustavo Deco, Robin Carhart-Harris, Christopher Timmermann, Morten L. Kringelbach (2025). \textit{N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-025-02190-4}{doi:10.1038/s41386-025-02190-4}.
\item John A. Razidlo, Noelle Cataldo, Cody J. Wenthur (2025). \textit{Psilocybin Enhances Cued Fear Extinction and Extinction Recall in Stress-Naïve, Acutely Stressed, and Chronically Stressed Mice}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00462}{doi:10.1021/acsptsci.5c00462}.
\item King's College London (2025). \textit{Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT07164755}{source link}.
\item Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM. (2025). \textit{Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/neu.2025.10039}{doi:10.1017/neu.2025.10039}.
\item Georgios Mikellides, Marios Kyriazis (2025). \textit{Psychedelics and mental health: reimagining care through science, insight, and compassion}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2025.1649929}{doi:10.3389/fphar.2025.1649929}.
\item Kaylee Reid, Daniel Kot, Argel Aguilar-Valles (2025). \textit{Therapeutic Effects of Psychedelics and their Non-Hallucinogenic Analogs on Depressive-Like Behaviour}. Carleton undergraduate journal of science.. [published; OpenAlex]. \href{https://doi.org/10.22215/cujs.v5i1.5286}{doi:10.22215/cujs.v5i1.5286}.
\item Kerem Kemal Soylemez, Emma Marie de Boo, Aysil Susuzlu, Joanne Lusher (2025). \textit{Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030031}{doi:10.3390/psychoactives4030031}.
\item McCoy K, Reed F, Conn K, Foldi CJ. (2025). \textit{Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/AGR/IND609297819}{source link}.
\item Anton L.V. Avanceña, Linh N. Vuong, James G. Kahn, Elliot Marseille (2025). \textit{Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03556-4}{doi:10.1038/s41398-025-03556-4}.
\item Tony Montgomery, DeMond M. Grant (2025). \textit{Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological Rejuvenation}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.31124/advance.175630073.36585408/v1}{doi:10.31124/advance.175630073.36585408/v1}.
\item Guy A. Higgins, Cam MacMillan, Inés de Lannoy, Carolyn M. Tyler, Malik Slassi (2025). \textit{Pharmacological characterisation of psilocybin and 5-MeO-DMT discriminative cues in the rat and their translational value for identifying novel psychedelics}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251361453}{doi:10.1177/02698811251361453}.
\item Ross J. Purple, Rahul Gupta, Christopher W. Thomas, Caroline T. Golden, Nicola Palomero-Gallagher, Robin Carhartt-Harris, Seán Froudist-Walsh, Matthew W. Jones (2025). \textit{Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-025-03182-y}{doi:10.1038/s41380-025-03182-y}.
\item Drewko AJ, Habets RLP, Brunt TM. (2025). \textit{Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03169-9}{doi:10.1038/s41380-025-03169-9}.
\item Bilenker D, Avena NM. (2025). \textit{Psychedelics and the Serotonin Hypothesis of Eating Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15080893}{doi:10.3390/brainsci15080893}.
\item James J Gattuso, Geraldine Kong, Bilgenur Bezcioglu, Da Lu, Millicent N. Ekwudo, Carey Wilson, Carolina Gubert, Anthony J. Hannan, Thibault Renoir (2025). \textit{Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder}. Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuropharm.2025.110648}{doi:10.1016/j.neuropharm.2025.110648}.
\item Centre Hospitalier Universitaire de Nīmes (2025). \textit{Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06650800}{source link}.
\item Maxwell B. Madden, Chloe Schaefgen, Binita Vedak, Jian Kwon, Kiara S. Dresp Pedra, Samuel H. Sheats, Adam C. Puché, Steffen B. E. Wolff, Brian N. Mathur (2025). \textit{Serotonin and psilocybin activate 5-HT1B receptors to suppress cortical signaling through the claustrum}. Nature Communications. [published; OpenAlex]. \href{https://doi.org/10.1038/s41467-025-62980-8}{doi:10.1038/s41467-025-62980-8}.
\item Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N, Tailor C, Khan R, Pemminati S. (2025). \textit{Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.90425}{doi:10.7759/cureus.90425}.
\item Kargbo RB. (2025). \textit{Therapeutic Divergence in 5-HT2A Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00475}{doi:10.1021/acsmedchemlett.5c00475}.
\item Rosa I, Padula LP, Semeraro F, Marrangone C, Inserra A, De Risio L, Boffa M, Zoratto F, Borgi M, Guidotti R, Lorenzo GD, D'Addario C, Pettorruso M, Martinotti G. (2025). \textit{Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.psychres.2025.116697}{doi:10.1016/j.psychres.2025.116697}.
\item Nadav Liam Modlin, Jessica L. Maples-Keller, Maria Sarang, Lucie Siebenaler, Carolina Maggio, Susannah Pick, Victoria Williamson, Anthony J. Cleare, James Rucker (2025). \textit{Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms}. Psychiatry and Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.5152/pcp.2025.24934}{doi:10.5152/pcp.2025.24934}.
\item Harsha S. Krishna (2025). \textit{Intersecting Psychedelic Pharmacology and Gut-Brain Axis Signaling in Neurodegenerative Disorders}. JUNIOR RESEARCHERS. [published; OpenAlex]. \href{https://doi.org/10.52340/jr.2025.03.03.09}{doi:10.52340/jr.2025.03.03.09}.
\item Wang X, Jun F, Lin C, Wang X (2025). \textit{Psychedelics and the Gut Microbiome: Unraveling the Interplay and Therapeutic Implications.}. ACS chemical neuroscience. [published; PubMed]. \href{https://doi.org/10.1021/acschemneuro.5c00418}{doi:10.1021/acschemneuro.5c00418}.
\item Unknown authors (2025). \textit{Response to emotional stimuli weaker in SSRI users compared with psilocybin}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31349}{doi:10.1002/pu.31349}.
\item Meredith C. Meacham, Maha N. Mian, Ralph C. Wang, Allison R. Coker, B. Anderson, Juan Carlos C. Montoy (2025). \textit{Latent Classes of Lifetime Use of Seven Hallucinogens in the United States}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2537040}{doi:10.1080/02791072.2025.2537040}.
\item Małgorzata Wierzbicka, Renata Kopczyk, Aleksandra Gerlach, Joanna Rymaszewska (2025). \textit{Therapeutic and legal aspects of psilocybin in cancer-related depression}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1591864}{doi:10.3389/fpsyt.2025.1591864}.
\item Bernard Lerer, Peretz Golding, Michal Brownstien, Adam Kozikowski, Tzuri Lifschytz (2025). \textit{204. A NOVEL, NON-HALLUCINOGENIC PSYCHEDELIC FOR THE TREATMENT OF OCD AND TIC DISORDER}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.019}{doi:10.1093/ijnp/pyaf052.019}.
\item Hiroe Tani (2025). \textit{577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.377}{doi:10.1093/ijnp/pyaf052.377}.
\item Argel Aguilar-Valles, Dhiral Kot, Victor Lewis, Gianfilippo Coppola (2025). \textit{544. MOLECULAR AND CELLULAR MECHANISMS OF THE LONG-LASTING EFFECTS OF PSYCHEDELICS AND THEIR NON-HALLUCINOGENIC DERIVATIVES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.363}{doi:10.1093/ijnp/pyaf052.363}.
\item Bernard Lerer, Michal Brownstien, Mitchell A. Lazar, Peter A. Goldstein, Alexander Botvinnik, Alan P. Kozikowski, Tzuri Lifschytz (2025). \textit{551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHES}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf052.368}{doi:10.1093/ijnp/pyaf052.368}.
\item Mickaël Naassïla (2025). \textit{Psychedelics as treatment of alcohol use disorders: insights from preclinical models and comparison of the different psychedelics psilocybin, LSD and ketamine}. Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroscience.2025.05.064}{doi:10.1016/j.neuroscience.2025.05.064}.
\item Unknown authors (2025). \textit{363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIOR}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC12359530}{source link}.
\item Adebo M, Bonnet M, Laouej O, Defaix C, McGowan JC, Butlen-Ducuing F, David DJ, Poupon E, Tritschler L, Gardier AM. (2025). \textit{Psilocybin as Transformative Fast-Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/fcp.70038}{doi:10.1111/fcp.70038}.
\item Zirkel RT, Isaacson M, Liao C, Yi M, Yamaguchi K, Rivera D, Kuceyeski A, Nishimura N, Kwan AC, Schaffer CB. (2025). \textit{Psilocybin Prolongs the Neurovascular Coupling Response in Mouse Visual Cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.25.666803}{doi:10.1101/2025.07.25.666803}.
\item Heidi Allen, B. Stott (2025). \textit{Preparing Social Work for Psychedelic-Assisted Therapy}. Social Work. [published; OpenAlex]. \href{https://doi.org/10.1093/sw/swaf031}{doi:10.1093/sw/swaf031}.
\item Barbara Anna Zapalska, Antonina Teresa Witkowska, Anna Cukrowska, Artur Galus (2025). \textit{Psilocybin-assisted treatment of depression}. Medical Science. [published; OpenAlex]. \href{https://doi.org/10.54905/disssi.v29i161.e110ms3657}{doi:10.54905/disssi.v29i161.e110ms3657}.
\item King's College London (2025). \textit{Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05651126}{source link}.
\item Egger K, Bozsak R, Aicher H, Sari H, Poetzsch S, Rominger A, Martin-Soelch C, Dornbierer D, Quednow B, Scheidegger M, Cumming P. (2025). \textit{Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-7099164/v1}{doi:10.21203/rs.3.rs-7099164/v1}.
\item Rudy LM, Godlewski MM. (2025). \textit{Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms26157233}{doi:10.3390/ijms26157233}.
\item Askariyan K, Joghataei MT, Dehghan S, Nohesara S, Riahi Pour L, Mohammadi MH, Ahmadirad N. (2025). \textit{An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111461}{doi:10.1016/j.pnpbp.2025.111461}.
\item A. T. Yang, Xiangqian Lv, Hongshuang Wang, Xiaohui Wang (2025). \textit{Psychedelics, Spirituality, and Fundamentalism: A Brain Network Approach to Cognitive Flexibility and Rigidity}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.5c00509}{doi:10.1021/acschemneuro.5c00509}.
\item Nicholas P. Cherup, Patrick H. Finan (2025). \textit{Psilocybin as a psychophysical adaptogen in chronic pain rehabilitation}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2025.105507}{doi:10.1016/j.jpain.2025.105507}.
\item Jain MK, Gumpper RH, Slocum ST, Schmitz GP, Madsen JS, Tummino TA, Suomivuori CM, Huang XP, Shub L, DiBerto JF, Kim K, DeLeon C, Krumm BE, Fay JF, Keiser M, Hauser AS, Dror RO, Shoichet B, Gloriam DE, Nichols DE, Roth BL. (2025). \textit{The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2025.06.012}{doi:10.1016/j.neuron.2025.06.012}.
\item Tobías Fernández-Borkel, Lucas F. Borkel, Jaime Rojas-Hernández, Elisa Hernández-Álvarez, Domingo Jesús Quintana Hernández, Ludovica G. Ponti, Luis Alberto Henríquez-Hernández (2025). \textit{The Causal Role of Consciousness in Psychedelic Therapy for Treatment-Resistant Depression: Hypothesis and Proposal}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00445}{doi:10.1021/acsptsci.5c00445}.
\item Michael-Paul Schallmo, Sophia Jungers, Ranji Varghese, Kathryn R. Cullen, Michael D. Evans, Jessica L. Nielson, Link Swanson (2025). \textit{Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot study}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/jov.25.9.2091}{doi:10.1167/jov.25.9.2091}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v3}{doi:10.31234/osf.io/7x8q4\_v3}.
\item Unknown authors (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/7x8q4\_v3}{source link}.
\item Plummer Z, Allen J, Brand J, Mayo LM, Shultz SR, Christie BR. (2025). \textit{Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111448}{doi:10.1016/j.pnpbp.2025.111448}.
\item Cohen ZZ, Blest-Hopley G (2025). \textit{Females in Psychedelic Research: A Perspective for Advancing Research and Practice.}. ACS pharmacology \& translational science. [published; PubMed]. \href{https://doi.org/10.1021/acsptsci.5c00255}{doi:10.1021/acsptsci.5c00255}.
\item Glenn DL, Choi SH, Zimmerman RS. (2025). \textit{A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811251353251}{doi:10.1177/02698811251353251}.
\item Miyuan Zhang (21677016), Haojiang Zhai (21677019), Longwei Yang (21677022), Haohong Li (5164970), Xiaohui Wang (19899) (2025). \textit{The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of Psilocin}. Figshare. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00324.s001}{doi:10.1021/acsptsci.5c00324.s001}.
\item Khaleel Rajwani, Melanie Almonte, F. Feroz, Jamila Hokanson, Edward Jacobs, Julian Savulescu, Ilina Singh, David B. Yaden, Brian D. Earp (2025). \textit{Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention Studies}. Wellcome Open Research. [published; OpenAlex]. \href{https://doi.org/10.12688/wellcomeopenres.24181.1}{doi:10.12688/wellcomeopenres.24181.1}.
\item Kosuke Kato, Jennifer Kleinhenz, Yoon-Joo Shin, Cristian Coarfa, Ali John Zarrabi, Louise Hecker (2025). \textit{Psilocybin treatment extends cellular lifespan and improves survival of aged mice}. npj Aging. [published; OpenAlex]. \href{https://doi.org/10.1038/s41514-025-00244-x}{doi:10.1038/s41514-025-00244-x}.
\item Miyuan Zhang, Haiyan Zhai, Longwei Yang, Haohong Li, Xiaohui Wang (2025). \textit{The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00324}{doi:10.1021/acsptsci.5c00324}.
\item Park D, Lee G, Lee WG, Kim B, Lee Y, Kim JW. (2025). \textit{The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-025-03100-2}{doi:10.1038/s41380-025-03100-2}.
\item Pauline Braekow, Joachim Neumann, Uwe Kirchhefer, Ulrich Gergs (2025). \textit{Effects of Psilocin and Psilocybin on Human 5-HT4 Serotonin and H2 Histamine Receptors in Perfused Hearts of Transgenic Mice}. Pharmaceuticals. [published; OpenAlex]. \href{https://doi.org/10.3390/ph18071009}{doi:10.3390/ph18071009}.
\item Tolle HM, Luppi AI, Lawn T, Roseman L, Nutt D, Carhart-Harris RL, Mediano PAM. (2025). \textit{Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.07.02.662710}{doi:10.1101/2025.07.02.662710}.
\item Luca Pellegrini, Naomi Fineberg, Sorcha O'Connor, Ana Maria Frota Lisbôa Pereira de Souza, Kate Godfrey, Sara Reed, Joseph Peill, Mairead Healy, Cyrus Rohani-Shukla, Hakjun Lee, Robin Carhart-Harris, Trevor W. Robbins, David Nutt, David Erritzøe (2025). \textit{Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study}. Comprehensive Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.comppsych.2025.152619}{doi:10.1016/j.comppsych.2025.152619}.
\item David W. Lawrence, Alex P. Di Battista, Michael G. Hutchison (2025). \textit{Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case Report}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030022}{doi:10.3390/psychoactives4030022}.
\item Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS (2025). \textit{Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-024-06599-5}{doi:10.1007/s00213-024-06599-5}.
\item Judith Stirn, Christian D. Klein (2025). \textit{Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic-Assisted Therapy}. Archiv der Pharmazie. [published; OpenAlex]. \href{https://doi.org/10.1002/ardp.70022}{doi:10.1002/ardp.70022}.
\item Hieronymus F, López E, Werin Sjögren H, Lundberg J. (2025). \textit{Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jamanetworkopen.2025.24119}{doi:10.1001/jamanetworkopen.2025.24119}.
\item Hynek Danda, Kristýna Mazochová, Klára Šíchová, Vladimír Mazoch, Lucie Olejníková Ladislavová, Kateřina Syrová, Bronislav Jurásek, Petra Cihlářová, Radek Jurok, Tomáš Páleníček, Martin Kuchař (2025). \textit{Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar rats}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2025.111439}{doi:10.1016/j.pnpbp.2025.111439}.
\item Ciszowski K, Ziaja A, Niedzielska-Andres E, Pomierny-Chamioło L. (2025). \textit{Natural hallucinogens of fungal and animal origin: action and potentialapplications - a narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24425/fmc.2025.156119}{doi:10.24425/fmc.2025.156119}.
\item Wu Y, Ran J, Mo J, Wang J. (2025). \textit{4-HIAA Blocks Methamphetamine-Induced Conditioned Place Preference in Mice Through Modulation of the 5-HT Pathway in the Nucleus Accumbens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/adb.70063}{doi:10.1111/adb.70063}.
\item Mathieu Fradet (2025). \textit{Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4030021}{doi:10.3390/psychoactives4030021}.
\item Nayiri Barton (2025). \textit{Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease}. Global Journal of Medical Research. [published; OpenAlex]. \href{https://doi.org/10.34257/gjmravol25is1pg1}{doi:10.34257/gjmravol25is1pg1}.
\item Rita De Gasperi, Georgina Pérez Garcia, Miguel A. Gama Sosa, Gissel M. Perez, Rania Abutarboush, Usmah Kawoos, Patrick R. Hof, Carolyn W. Zhu, Stephen T. Ahlers, Gregory A. Elder (2025). \textit{Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure}. Frontiers in Neurology. [published; OpenAlex]. \href{https://doi.org/10.3389/fneur.2025.1594335}{doi:10.3389/fneur.2025.1594335}.
\item Vinarcsik L, Smoller C, Grossberg G. (2025). \textit{Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40266-025-01221-5}{doi:10.1007/s40266-025-01221-5}.
\item McCulloch DE, Larsen K, Johansen A, Reveles Jensen KH, Nykjaer CH, Holze F, Falck N, Neufeld VAB, Steenstrup E, Skov-Andersen PM, Spangaard A, Geisler M, Randrup PP, Jensen PS, Shulganov V, Johansen SS, Nielsen MKK, Andersen TL, Stenbaek DS, Svarer C, Fisher PM, Knudsen GM. (2025). \textit{Molecular, haemodynamic and functional effects of LSD in the human brain}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2025.06.17.25329677}{doi:10.1101/2025.06.17.25329677}.
\item Ying Zhang, Lei Yang, Qiuyu Zhang, Chao Li, Fuqiang Mao, Chuanjun Zhuo (2025). \textit{The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03410-7}{doi:10.1038/s41398-025-03410-7}.
\item Ines Erkizia-Santamaría, Igor Horrillo, Nerea Martínez-Álvarez, Daniel Pérez-Martínez, Guadalupe Rivero, Amaia M. Erdozain, J. Javier Meana, Jorge E. Ortega (2025). \textit{Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03421-4}{doi:10.1038/s41398-025-03421-4}.
\item Liu Yi-Fei, Lien-Chung Wei (2025). \textit{Advancing the Anthropology of Psychedelics: Integrating Clinical Evidence, Sociocultural Insights, and Ethical Frameworks}. Anthropology of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1111/anoc.70004}{doi:10.1111/anoc.70004}.
\item Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A. (2025). \textit{Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.5c00152}{doi:10.1021/acschemneuro.5c00152}.
\item Subha Subramanian, Travis Rick Reneau, Demetrius Perry, Ravi V. Chacko, Timothy O. Laumann, Karin Flavin, Christine Horan, Julia Schweiger, Nicholas V. Metcalf, Eric J. Lenze, Abraham Z. Snyder, Nico U.F. Dosenbach, Ginger E. Nicol, Joshua S. Siegel (2025). \textit{Psilocybin’s acute and persistent brain effects: a precision imaging drug trial}. Scientific Data. [published; OpenAlex]. \href{https://doi.org/10.1038/s41597-025-05189-0}{doi:10.1038/s41597-025-05189-0}.
\item Lashgari NA, Khalaji M, Rana P, Badrabadi F, Rahnama M, Nasoori H, Momeni Roudsari N, Khosravi Nia MM, Shafaroodi H. (2025). \textit{Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12035-025-05097-9}{doi:10.1007/s12035-025-05097-9}.
\item Judith Stirn, Raphael Berger, Harald Hübner, Peter Gmeiner, Christian D. Klein (2025). \textit{Towards "unmakable" psychedelics: SAR exploration of psilocin analogs obtained by a HATU-mediated amide coupling strategy}. European Journal of Medicinal Chemistry Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ejmcr.2025.100278}{doi:10.1016/j.ejmcr.2025.100278}.
\item Weleff J, Pulido-Saavedra A, Aghaei AM, Ing K, Arakelian M, Fontenele R, Nero N, Barnett BS, Anand A, Bassir Nia A, Angarita GA (2025). \textit{The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.}. Psychiatry research. [published; PubMed]. \href{https://doi.org/10.1016/j.psychres.2025.116446}{doi:10.1016/j.psychres.2025.116446}.
\item Jason C. Slot, Dirk Hoffmeister (2025). \textit{Psychedelic fungi}. Current Biology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cub.2025.02.026}{doi:10.1016/j.cub.2025.02.026}.
\item Joseph K, Collins J, Genovese T, Maxwell M, Lieberman JA, Osten P. (2025). \textit{Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.05.26.655791}{doi:10.1101/2025.05.26.655791}.
\item Araam Abboud, Clay M. Schiebrel, Ramzi W. Nahhas, Sam Durkin, Kyle Hua, Hannah Redding, Danielle Gainer (2025). \textit{Patients’ Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health Treatment}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2511752}{doi:10.1080/02791072.2025.2511752}.
\item Anders A. Jensen, Cláudia R. Cecchi, Meghan Hibicke, Astrid H. Bach, Erik Kaadt, Emil Märcher-Rørsted, Charles D. Nichols, Betina Elfving, Jesper L. Kristensen (2025). \textit{The Selective Serotonin 5-HT2A Receptor Agonist (S)-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00208}{doi:10.1021/acsptsci.5c00208}.
\item University Hospital, Basel, Switzerland (2025). \textit{Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness (PDR-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06796361}{source link}.
\item Salma Laabi, Claire LeMmon, Callie Vogel, M. Chacón, Víctor M. Jiménez (2025). \textit{Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling}. International Immunopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.intimp.2025.114940}{doi:10.1016/j.intimp.2025.114940}.
\item Ines Erkizia-Santamaría, Nerea Martínez-Álvarez, Leyre Salinas-Novoa, J. Javier Meana, Jorge E. Ortega (2025). \textit{Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyaf035}{doi:10.1093/ijnp/pyaf035}.
\item Vogt SB, Liechti ME. (2025). \textit{Clinical pharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.02.003}{doi:10.1016/bs.irn.2025.02.003}.
\item Han C, Baek H, Lim JY, Kim E, Tran CK, Freeman E, Chen Z, Yoo SH, Burish MJ. (2025). \textit{Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s10194-025-02008-0}{doi:10.1186/s10194-025-02008-0}.
\item Dumenil M, Cordova G, El-Hage W. (2025). \textit{[Psilocybin in the setting of treatment-resistant unipolar depression: A case report].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.encep.2025.02.007}{doi:10.1016/j.encep.2025.02.007}.
\item McCoy K, Reed F, Conn K, Foldi CJ. (2025). \textit{Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.physbeh.2025.114957}{doi:10.1016/j.physbeh.2025.114957}.
\item Shelby A. McGriff, Jacquelin C Hecker, Alexander D. Maitland, John S. Partilla, Michael H. Baumann, Grant C. Glatfelter (2025). \textit{Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-025-06795-x}{doi:10.1007/s00213-025-06795-x}.
\item Haojiang Zhai, Hongshuang Wang, Haohong Li, Xiaohui Wang (2025). \textit{The Intersection of Psychedelics and Sleep: Exploring the Impacts on Sleep Architecture, Dream States, and Therapeutic Implications}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00234}{doi:10.1021/acsptsci.5c00234}.
\item Icahn School of Medicine at Mount Sinai (2025). \textit{Investigating the Role of Serotonin in the Mechanism of Action of Psilocybin in Patients With Major Depressive Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06592833}{source link}.
\item Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D. (2025). \textit{Serotonergic psychedelics for depression: A comprehensive overview.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.irn.2025.04.009}{doi:10.1016/bs.irn.2025.04.009}.
\item Grant Jones (2025). \textit{Race/ethnicity moderates the associations between lifetime psilocybin use and opioid use disorder}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0321461}{doi:10.1371/journal.pone.0321461}.
\item Michael A. Wheeler (2025). \textit{Michael A. Wheeler: Psychedelics and neuroimmune circuits-what a strange trip, indeed}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp025k.0011}{doi:10.61373/pp025k.0011}.
\item Wang Z, Robbins B, Zhuang R, Bruggen Rv, Sandini T, Li X, Zhang Y. (2025). \textit{Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto Rats}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-5493661/v1}{doi:10.21203/rs.3.rs-5493661/v1}.
\item Martina Colognesi, Daniela Gabbia, Anna Signor, Stefano Comai, Andrea Mattarei, Gianfranco Pasut, Lucia Centofanti, Stefano La Rosa, Giovanna Finzi, Franco Folli, M. Pappagallo, Paolo L. Manfredi, Sara De Martin (2025). \textit{FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLD}. Journal of Hepatology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0168-8278(25)01632-0}{doi:10.1016/s0168-8278(25)01632-0}.
\item Jonathan A. Leighton, Carmen Lau, Aisha Savdo, L Granata (2025). \textit{Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series}. Cephalalgia Reports. [published; OpenAlex]. \href{https://doi.org/10.1177/25158163251345472}{doi:10.1177/25158163251345472}.
\item Saara Susan Sevander, Marja-Liisa Rissanen (2025). \textit{The benefits and harm of psychedelics in the treatment of patients with mental health and substance abuse disorders: an integrative literature review}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.59476/hesdia.v0i1.700}{doi:10.59476/hesdia.v0i1.700}.
\item Unknown authors (2025). \textit{Psilocybin-assisted therapy shows range of benefits in cancer patients}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31316}{doi:10.1002/pu.31316}.
\item Rebecca Harding, Neomi Singer, Matthew B. Wall, Talma Hendler, David Erritzøe, David Nutt, Robin Carhart-Harris, Leor Roseman (2025). \textit{Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-025-03035-8}{doi:10.1038/s41380-025-03035-8}.
\item Jérémie Richard, Jeremy Scott, Sandeep M. Nayak, Nathan D. Sepeda, Matthew X. Lowe, Heather Jackson, Albert Garcia-Romeu (2025). \textit{Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-025-01489-z}{doi:10.1007/s11469-025-01489-z}.
\item McClure, Taylor, Krzywicki, AJ, Nathan, Jude, Kane, Jackson (2025). \textit{Undergraduate Students' Perceptions and Understanding of Psychedelic-Assisted Therapy}. Exhibit - A Showcase of Scholarship, Creativity and Preservation Provided by Xavier University Library (Xavier University). [published; OpenAlex]. \href{https://www.exhibit.xavier.edu/curca/2025/schedule/48}{source link}.
\item Louise Penzenstadler, Sandra Baudois, Alma Lingenberg, Sabina Catalano Chiuvé, Emilie Tomkova, Vanessa Fleury (2025). \textit{[Treatment with psychedelics: potential benefits in Parkinson's disease].}. PubMed. [published; OpenAlex]. \href{https://doi.org/10.53738/revmed.2025.21.915.47180}{doi:10.53738/revmed.2025.21.915.47180}.
\item Cummins BR, Billac GB, Nichols DE, Nichols CD. (2025). \textit{5-HT2A receptors: Pharmacology and functional selectivity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmr.2025.100059}{doi:10.1016/j.pharmr.2025.100059}.
\item Kerem Kemal Soylemez, Emma Marie de Boo, Joanne Lusher (2025). \textit{Regulatory Challenges of Integrating Psychedelics into Mental Health Sector}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives4020011}{doi:10.3390/psychoactives4020011}.
\item Artur Pałasz, Marta Pukowiec, Katarzyna Bogus, Aleksandra Suszka-Świtek, Łukasz Filipczyk, Kinga Mordecka-Chamera, John J. Worthington, Maria Sygidus, Adam Wojtas, Agnieszka Bysiek, Krystyna Gołembiowska (2025). \textit{Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251330783}{doi:10.1177/02698811251330783}.
\item Damian Świeczkowski, Aleksander Kwaśny, Michał Pruc, Zuzanna Gaca, Łukasz Szarpak, Wiesław Jerzy Cubała (2025). \textit{Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2529-7029}{doi:10.1055/a-2529-7029}.
\item Arya Afrooghe, Elham Ahmadi, Ali Lesani, Mahya Soleymani Mehranjani, Mohammad Elahi, Mohammadreza Babaei, Maryam Shayan, Hamed Shafaroodi, Razieh Mohammad Jafari, Alireza Foroumadi, Mohammad Amin Manavi, Ahmad Reza Dehpour (2025). \textit{Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathway}. Naunyn-Schmiedeberg s Archives of Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00210-025-04152-5}{doi:10.1007/s00210-025-04152-5}.
\item Effinger DP, Schalk SS, King JL, Strong JR, O’Connell CK, Calderon JR, McCorvy JD, Thompson SM. (2025). \textit{Assessing the potential cardiovascular risk of microdosing the psychedelic LSD in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.04.08.647757}{doi:10.1101/2025.04.08.647757}.
\item Umbacia MA, Leon MX, Quintero JM, Castro LM, Paez V, Dodd S, Bustos RH. (2025). \textit{Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14728214.2025.2488786}{doi:10.1080/14728214.2025.2488786}.
\item Danielle Bukovsky, Aron Amaev, Jianmeng Song, Edgardo Torres Carmona, S. Lauren Kyte, Fumihiko Ueno, Vincenzo De Luca, Christopher R. Bowie, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen (2025). \textit{13. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging Study}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2025.02.250}{doi:10.1016/j.biopsych.2025.02.250}.
\item Ellen Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, Balázs Szigeti, Connie Ludwig, Jill L. Ostrem, Caroline M. Tanner, Meredith Bock, Katiah Llerena, Patrick R. Finley, Aoife O’Donovan, José Rafael P. Zuzuárregui, Zachary Busby, Amber McKernan, Andrew Penn, Aliss C.C. Wang, Raymond C. Rosen, Joshua Woolley (2025). \textit{Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-025-02097-0}{doi:10.1038/s41386-025-02097-0}.
\item Jennifer Jones (2025). \textit{Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2025.1565852}{doi:10.3389/fpsyt.2025.1565852}.
\item Unknown authors (2025). \textit{The neurons that mediate a psychedelic’s long-term antidepressive effects}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/d41586-025-00979-3}{doi:10.1038/d41586-025-00979-3}.
\item Ling-Xiao Shao, Clara Liao, Pasha A. Davoudian, Neil K. Savalia, Quan Jiang, Cassandra Wojtasiewicz, Diran Tan, Jack D. Nothnagel, Rongjian Liu, Samuel C. Woodburn, Olesia M. Bilash, Hail Kim, Alicia Che, Alex C. Kwan (2025). \textit{Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/s41586-025-08813-6}{doi:10.1038/s41586-025-08813-6}.
\item Nicholas Gregory, Tyler E. Girard, Akila Ram, Austen B. Casey, Robert C. Malenka, Vivianne L. Tawfik, Boris D. Heifets (2025). \textit{Psilocybin Has No Analgesic Properties in Multiple Mouse Models of Acute and Chronic Pain}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2025.104862}{doi:10.1016/j.jpain.2025.104862}.
\item Lenka Seillier, Barbora Čechová, Alexandre Seillier, Romana Šlamberová (2025). \textit{Psilocybin has a narrow therapeutic window as an antidepressant treatment}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2025.111368}{doi:10.1016/j.pnpbp.2025.111368}.
\item Unknown authors (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.1093/schbul/sbaf068}{doi:10.1093/schbul/sbaf068}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v2}{doi:10.31234/osf.io/7x8q4\_v2}.
\item Agnieszka Bysiek, Adam Wojtas, Izabela Szpręgiel, Agnieszka Wawrzczak-Bargieła, Marzena Maćkowiak, Krystyna Gołembiowska (2025). \textit{The effect of low-dose psilocybin on brain neurotransmission and rat behavior}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2025.111347}{doi:10.1016/j.pnpbp.2025.111347}.
\item University Hospital, Basel, Switzerland (2025). \textit{Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in a Randomized, Placebo-controlled, Cross-over Trial in Healthy Participants (LPD-Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06899334}{source link}.
\item Brian H. Silverstein, Nicholas Kolbman, Amanda Nelson, Tiecheng Liu, Peter R. Guzzo, Jim Gilligan, UnCheol Lee, George A. Mashour, Giancarlo Vanini, Dinesh Pal (2025). \textit{Intravenous psilocybin induces dose-dependent changes in functional network organization in rat cortex}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-025-03308-4}{doi:10.1038/s41398-025-03308-4}.
\item Serretti A. (2025). \textit{Anhedonia: Current and future treatments.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/pcn5.70088}{doi:10.1002/pcn5.70088}.
\item Gregory Ian Robinson, Marta Gerasymchuk, Timur Zanikov, Esmaeel Ghasemi Gojani, Shima Asghari, Alyssa Groves, Lucie Haselhorst, Sanjana Nandakumar, Cora Stahl, Ceejay Cruz, Mackenzie Cameron, Yeva Zahoruiko, Dongping Li, Rocio Rodriguez-Juarez, Alex Snelling, Darryl Hudson, Anna Fiselier, Olga Kovalchuk, Igor Kovalchuk (2025). \textit{LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice}. Pharmaceuticals. [published; OpenAlex]. \href{https://doi.org/10.3390/ph18040451}{doi:10.3390/ph18040451}.
\item Rockhill KM, Black JC, Iwanicki J, Abraham A. (2025). \textit{Polysubstance Use Profiles Among the General Adult Population, United States, 2022.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2105/ajph.2024.307979}{doi:10.2105/ajph.2024.307979}.
\item Ram Harari, Dmitriy Getselter, Evan Elliott (2025). \textit{The psychedelic psilocybin and light exposure have similar and synergistic effects on gene expression patterns in the visual cortex}. Molecular Brain. [published; OpenAlex]. \href{https://doi.org/10.1186/s13041-025-01191-0}{doi:10.1186/s13041-025-01191-0}.
\item Eda Köşeli, Belle Buzzi, Torin Honaker, Yogesh Rakholia, Melissa J. Lewis, Maya Gaines-Smith, Alaina M. Jaster, Javier González-Maeso, M. Imad Damaj (2025). \textit{IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT2A receptors in mouse models of chronic pain}. Pharmacological Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.phrs.2025.107699}{doi:10.1016/j.phrs.2025.107699}.
\item Zusanna Bjurenfalk, Alva Cosmo, Otto Simonsson, Caroline Ran (2025). \textit{Lifetime classic psychedelic use and headaches: A cross-sectional study}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811251324372}{doi:10.1177/02698811251324372}.
\item Dr Hafiz Shafique Ahmad, Muhammad Waqar Ali, Usman Ul Haq (2025). \textit{PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERS}. Journal of medical \& health sciences review.. [published; OpenAlex]. \href{https://doi.org/10.62019/r713mw08}{doi:10.62019/r713mw08}.
\item Repple J, Bayas M, Möser C, Kobayashi NF, Reif A. (2025). \textit{Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2025.02.903}{doi:10.1016/j.biopsych.2025.02.903}.
\item Lauren Wilseck, Preet Chatha, Lawrence Canale, Dhvanit Raval, Jeremy Weleff (2025). \textit{Psychedelics for Substance Use Disorders: Updates for the Psychiatric Trainee}. American Journal of Psychiatry Residents Journal. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp-rj.2025.200301}{doi:10.1176/appi.ajp-rj.2025.200301}.
\item University Hospital, Basel, Switzerland (2025). \textit{Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05523401}{source link}.
\item Josephine Yalovitser, jonah levine, Cole Zweber, Lauren Tien, Mallory Stultz, Henry Mitchell, Elizabeth Cote, Charles D. MacLean (2025). \textit{Vermont Primary Care Provider Perspectives on Psychedelics - A Cross-Sectional Study}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2025.2474246}{doi:10.1080/02791072.2025.2474246}.
\item Craig, Danny R, Blalock, Eric M. (2025). \textit{Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?}. UKnowledge (University of Kentucky). [published; OpenAlex]. \href{https://uknowledge.uky.edu/jpns/vol2/iss1/1}{source link}.
\item Elmira Zolali, Mahfuz Sakib, Jenny L. Wilkerson, Lance Richard McMahon, Samuel Obeng (2025). \textit{Evaluating the Influence of CYP450 Enzyme Inducers on the Efficacy of Psilocybin as a Treatment for Neuropsychiatric Disorders (Abstract ID: 167358)}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpet.2024.100843}{doi:10.1016/j.jpet.2024.100843}.
\item Aneta Petrušková, Debarpan Guhathakurta, Enes Yağız Akdaş, Bartomeu Perelló-Amorós, Renato Frischknecht, Eva-Maria Weiss, Tomáš Páleníček, Anna Fejtová (2025). \textit{Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons}. Journal of Neurochemistry. [published; OpenAlex]. \href{https://doi.org/10.1111/jnc.70020}{doi:10.1111/jnc.70020}.
\item Yaden DB, Graziosi M, Owen AM, Agin-Liebes G, Aaronson ST, Allen KE, Barrett FS, Bogenschutz MP, Carhart-Harris R, Ching THW, Cosimano MP, Danforth A, Davis AK, Garcia-Romeu A, Griffiths R, Grob CS, Gründer G, Gukasyan N, Heinzerling KG, Hendricks PS, Holze F, Horton DM, Johnson MW, Kelmendi B, Knatz Peck S, Koslowski M, Liechti ME, Mertens LJ, Moreno FA, Nayak SM, Nicholas CR, Preller KH, Rieser NM, Ross S, Sergi K, Sloshower J, Smigielski L, Stenbæk DS, Vollenweider FX, Weiss B, Wolff M, Yaden ME. (2025). \textit{A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1089/psymed.2024.0019}{doi:10.1089/psymed.2024.0019}.
\item Becker AM, Humbert-Droz M, Mueller L, Jelušić A, Tolev A, Straumann I, Avedisian I, Erne L, Thomann J, Luethi D, Grünblatt E, Meyer Zu Schwabedissen H, Liechti ME. (2025). \textit{Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.3618}{doi:10.1002/cpt.3618}.
\item Mohammad Balabandian, Mohammad Amin Manavi, Ali Lesani, Razieh Mohammad Jafari, Hamed Shafaroodi, Neda Heidari, Javad Mirnajafi-Zadeh, Alireza Foroumadi, Arya Afrooghe, Ahmad Reza Dehpour (2025). \textit{Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways}. Pharmacology Research \& Perspectives. [published; OpenAlex]. \href{https://doi.org/10.1002/prp2.70079}{doi:10.1002/prp2.70079}.
\item Dave M, Shore R, Cupido T, Haley C, Clinkard D. (2025). \textit{Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/eja.0000000000002138}{doi:10.1097/eja.0000000000002138}.
\item Heller NH, Barrett FS, Buchborn T, Collerton D, Dupuis D, Halberstadt AL, Jardri R, Noorani TN, Preller KH, Taylor J, Waters F, Winston B, Leptourgos P. (2025). \textit{Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/7x8q4\_v1}{doi:10.31234/osf.io/7x8q4\_v1}.
\item Xue Wang, Cong Lin, Xiaohui Wang (2025). \textit{Psychedelics and Pro-Social Behaviors: A Perspective on Autism Spectrum Disorders}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.5c00034}{doi:10.1021/acsptsci.5c00034}.
\item Lucido MJ, Dunlop BW. (2025). \textit{Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/brainsci15020161}{doi:10.3390/brainsci15020161}.
\item Brengel EK, Axe B, Maheswari A, Abeer MI, Ortiz RJ, Woodward TJ, Walhof R, Utama R, Sawada C, Balaji S, Kulkarni PP, Bradshaw HB, Gitcho MA, Ferris CF. (2025). \textit{Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular Biology}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.02.03.636248}{doi:10.1101/2025.02.03.636248}.
\item Shannon Hughes, Lucia Terpak, Reilly Capps, Pam Peters, Nicole Lilly, Dylan Rivard (2025). \textit{Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2025.00375}{doi:10.1556/2054.2025.00375}.
\item Vanessa Fleury, Emilie Tomkova, Sabina Catalano Chiuvé, Louise Penzenstadler (2025). \textit{Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report}. Journal of Parkinson s Disease. [published; OpenAlex]. \href{https://doi.org/10.1177/1877718x241312604}{doi:10.1177/1877718x241312604}.
\item A. Signor, Martina Colognesi, Daniela Gabbia, Ilaria Zanotto, Y. Frion-Herrera, Stefano Comai, Andrea Mattarei, Gianfranco Pasut, Franco Folli, M. Pappagallo, Paolo Manfredi, S. De Martin (2025). \textit{Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytes}. Digestive and Liver Disease. [published; OpenAlex]. \href{https://doi.org/10.1016/j.dld.2025.01.134}{doi:10.1016/j.dld.2025.01.134}.
\item Daisuke Ibi, Rika Takaba, Keisuke Yoshida, Takayoshi Mamiya, Shinji Kitagaki, Masayuki Hiramatsu (2025). \textit{BEHAVIORAL ANALYSES OF ANTIDEPRESSANT-LIKE EFFECT OF SEROTONERGIC PSYCHEDELICS IN MICE}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyae059.584}{doi:10.1093/ijnp/pyae059.584}.
\item Myfanwy Graham, Wayne Hall, Rosalie Liccardo Pacula, David Hammond (2025). \textit{International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMA}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112089}{doi:10.1016/j.drugalcdep.2024.112089}.
\item Destiny Carbello, Tomáš Páleníček (2025). \textit{Source Localized Auditory Erp Sensory and Preattentive Correlates of Psilocybin-Induced Ego-Dissolution Related Effects}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.112090}{doi:10.1016/j.drugalcdep.2024.112090}.
\item Amanda L. Elmore, Marina Bolser, Matt Richey (2025). \textit{Lifetime Psilocybin Use and Opioid Use Disorder in Pregnant and Non-Pregnant Women of Reproductive Age}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2024.111723}{doi:10.1016/j.drugalcdep.2024.111723}.
\item Marazziti D, Weiss F, Gurrieri R, Russomanno G, Gambini M, Magnesa A, Coccoglioniti A, Perugi G (2025). \textit{Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective.}. Expert review of neurotherapeutics. [published; PubMed]. \href{https://doi.org/10.1080/14737175.2024.2445016}{doi:10.1080/14737175.2024.2445016}.
\item Noback M, Kenton JA, Klein AK, Hughes ZA, Kruegel AC, Schmid Y, Halberstadt AL, Young JW. (2025). \textit{Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2025.110334}{doi:10.1016/j.neuropharm.2025.110334}.
\item de Deus JL, Maia JM, Soriano RN, Amorim MR, Branco LGS. (2025). \textit{Psychedelics in neuroinflammation: Mechanisms and therapeutic potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111278}{doi:10.1016/j.pnpbp.2025.111278}.
\item O'Connor S, Godfrey K, Reed S, Peill J, Rohani-Shukla C, Healy M, Robbins T, Frota Lisboa Pereira de Souza A, Tyacke R, Papasyrou M, Stenbæk D, Castro-Rodrigues P, Chiera M, Lee H, Martell J, Carhart-Harris R, Pellegrini L, Fineberg NA, Nutt D, Erritzoe D. (2025). \textit{Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.c209}{doi:10.7759/cureus.c209}.
\item Sorcha O'Connor, Kate Godfrey, Sara Reed, Joseph Peill, Cyrus Rohani-Shukla, Mairead Healy, Trevor W. Robbins, Ana Frota Lisboa Pereira de Souza, Robin J. Tyacke, Maria Papasyrou, Dea Siggaard Stenbæk, Pedro Castro-Rodrigues, Martina Chiera, Hakjun Lee, Jonny Martell, Robin Carhart-Harris, Luca Pellegrini, Naomi Fineberg, David Nutt, David Erritzøe (2025). \textit{Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.78171}{doi:10.7759/cureus.78171}.
\item Kinderlehrer DA. (2025). \textit{Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2147/ndt.s500337}{doi:10.2147/ndt.s500337}.
\item Kargbo RB. (2025). \textit{Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.5c00031}{doi:10.1021/acsmedchemlett.5c00031}.
\item James J Gattuso, Carey Wilson, Shanshan Li, Anthony J. Hannan, Thibault Renoir (2025). \textit{Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybin}. European Journal of Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ejphar.2025.177304}{doi:10.1016/j.ejphar.2025.177304}.
\item Niklas Viohl, Ali Asghar Hakami Zanjani, Himanshu Khandelia (2025). \textit{Molecular insights into the modulation of the 5 HT2 A receptor by serotonin, psilocin, and the G protein subunit Gqα}. FEBS Letters. [published; OpenAlex]. \href{https://doi.org/10.1002/1873-3468.15099}{doi:10.1002/1873-3468.15099}.
\item Zylko A, Rakoczy R, Roberts B, Wilson M, Powell A, Page A, Heitkamp M, Fiest D, Jones J, McMurray M. (2025). \textit{Age- and estrous-dependent effects of psilocybin in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.10.632408}{doi:10.1101/2025.01.10.632408}.
\item Eduardo d’Avila Lins Lacerda, Bianca Medeiros Ferraz da Nóbrega, Yasmin Mesquita Dias Franca Gadelha, Liliane Reis Teixeira, Manolo Altieri Espinar, Bruna Trigueiro Carlini, Gabriel Santa Cruz Lins, Anthonielly Leinat Lima, Isabel Azevedo, Paulo Heinrich Soares Bomtempo (2025). \textit{PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERS}. Health and Society. [published; OpenAlex]. \href{https://doi.org/10.51249/hs.v5i01.2377}{doi:10.51249/hs.v5i01.2377}.
\item Schuler H, Zhou D, Savignac C, Cvetkovska V, Tse Y, Meccia J, Lopez J, Harutyunyan AS, Ragoussis J, Bzdok D, Bagot RC. (2025). \textit{Cell-type specific transcriptional modulation by psilocybin induces sustained plasticity in mouse medial prefrontal cortex}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.08.631940}{doi:10.1101/2025.01.08.631940}.
\item Constantino JL, van Dalfsen JH, Massetti S, Kamphuis J, Schoevers RA. (2025). \textit{Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111251}{doi:10.1016/j.pnpbp.2025.111251}.
\item Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE. (2025). \textit{Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2025.111249}{doi:10.1016/j.pnpbp.2025.111249}.
\item Liao C, O’Farrell E, Weiner AM, Qalieh Y, Savalia NK, Girgenti MJ, Kwan KY, Kwan AC. (2025). \textit{Single-nucleus transcriptomics reveals cell type-specific and time-dependent effects of psilocybin and ketamine on gene expression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2025.01.04.631335}{doi:10.1101/2025.01.04.631335}.
\item Muniz, John Marco D.F. (2024). \textit{Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and Duration}. Journal of International Crisis and Risk Communication Research. [published; OpenAlex]. \href{https://stars.library.ucf.edu/hut2024/268}{source link}.
\item Siddhant Pusdekar (2024). \textit{Psilocybin rewires specific mouse cortical networks in lasting ways}. The Transmitter. [published; OpenAlex]. \href{https://doi.org/10.53053/pkim3530}{doi:10.53053/pkim3530}.
\item Koschützke, Leif (2024). \textit{Psychedelics induced modulation of motor recovery after stroke}. Bundesinstitut für Risikobewertung Fachgruppe ZEBET - Datenbank und Informationsbeschaffung Abteilung Experimentelle Toxikologie und ZEBET. [published; OpenAlex]. \href{https://doi.org/10.17590/asr.0000411}{doi:10.17590/asr.0000411}.
\item Marina D. Kostić, Jana Nedić, Jovana S. Dragojević, Vera M. Divac (2024). \textit{In Silico Evaluation of Tryptamine-Derived Schiff Bases as Modulators of the Serotonin 5-HT₂A Receptor}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.46793/iccbikg25.477k}{doi:10.46793/iccbikg25.477k}.
\item Andreia Machado Brito da Costa, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Diana Dias-da-Silva (2024). \textit{Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell Model}. RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia. [published; OpenAlex]. \href{https://doi.org/10.51126/revsalus.v7isup.1031}{doi:10.51126/revsalus.v7isup.1031}.
\item Michal Brownstien (2024). \textit{Long-term effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 model of OCD-like behavior}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2025.105450}{doi:10.1016/j.nsa.2025.105450}.
\item Tess L. Veuthey, Prasad Shirvalkar (2024). \textit{Uncovering the dynamics of psilocybin in human neural pain circuits with intracranial neural recordings}. Brain stimulation. [published; OpenAlex]. \href{https://doi.org/10.1016/j.brs.2024.12.653}{doi:10.1016/j.brs.2024.12.653}.
\item Mile Jevtić (2024). \textit{The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry}. Engrami. [published; OpenAlex]. \href{https://doi.org/10.5937/engrami47-57385}{doi:10.5937/engrami47-57385}.
\item Ramaekers JG, Reckweg JT, Mason NL. (2024). \textit{Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/appi.ajp.20230890}{doi:10.1176/appi.ajp.20230890}.
\item Cumming P, Egger K, Knudsen GM (2024). \textit{Molecular brain imaging of psychedelic action.}. International review of neurobiology. [published; PubMed]. \href{https://doi.org/10.1016/bs.irn.2025.02.005}{doi:10.1016/bs.irn.2025.02.005}.
\item Zitong Wang, Brett Robbins, Ryan Zhuang, Thaísa Meira Sandini, Rebekah van Bruggen, Xin-Min Li, Yanbo Zhang (2024). \textit{Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats}. Progress in Neuro-Psychopharmacology and Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pnpbp.2024.111243}{doi:10.1016/j.pnpbp.2024.111243}.
\item Mohammad Ali, Urbah Viqar (2024). \textit{Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy}. Annals of Punjab Medical College. [published; OpenAlex]. \href{https://doi.org/10.29054/apmc/2024.1658}{doi:10.29054/apmc/2024.1658}.
\item Georg Leistenschneider, Tomislav Majić, Simon Reiche, Thomas Riemer (2024). \textit{Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-82216-x}{doi:10.1038/s41598-024-82216-x}.
\item Johannes Jungwirth, Robin von Rotz, Isabel Dziobek, Franz X. Vollenweider, Katrin H. Preller (2024). \textit{Psilocybin increases emotional empathy in patients with major depression}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-024-02875-0}{doi:10.1038/s41380-024-02875-0}.
\item Barnett JH, Todd KT, Benetatos J, Rabichow BE, Gibson KA, Olney KC, Fryer JD. (2024). \textit{Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.12.16.628764}{doi:10.1101/2024.12.16.628764}.
\item Gitte Moos Knudsen (2024). \textit{The Neurobiological Effect of 5-HT2AR Modulation}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03289949}{source link}.
\item Christopher L. Robinson, Pawan Solanki, S Snyder, Adam Amir, Antje M. Barreveld, Rory Vu Mather, Ivo H. Cerda, Michael Motoc, Harman Chopra, R. Jason Yong, Joel Castellanos, Timothy Furnish, Alan D. Kaye, Vwaire Orhurhu, Trent Emerick (2024). \textit{Chronic pain education: past, present, and future of psychedelics for the management of chronic pain}. Pain Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/pm/pnae124}{doi:10.1093/pm/pnae124}.
\item Ethan G. Dutcher, Andrew D. Krystal (2024). \textit{Treatment Expectancies and Psilocybin vs Escitalopram for Depression}. JAMA Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/jamapsychiatry.2024.4387}{doi:10.1001/jamapsychiatry.2024.4387}.
\item Jonathan Brett, Elizabeth Knock, Kathy Watson, Steven M. Albert, Krista J. Siefried, Jeffrey Guss (2024). \textit{Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1490907}{doi:10.3389/fpsyt.2024.1490907}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML. (2024). \textit{Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41398-024-03187-1}{doi:10.1038/s41398-024-03187-1}.
\item Høgsted ES, Beliveau V, Ozenne B, Madsen MK, Svarer C, Dam VH, Johansen A, Fisher P, Knudsen GM, Frokjaer VG, Sankar A. (2024). \textit{Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1192/bjp.2024.143}{doi:10.1192/bjp.2024.143}.
\item Shabir Kanwal (2024). \textit{Psilocybin Microdosing for Anxiety Relief in Young Adults: A Comparative Review of Emerging Evidence}. Premier Journal of Science. [published; Crossref]. \href{https://doi.org/10.70389/pjs.100036}{doi:10.70389/pjs.100036}.
\item Eline Pottie, G.C. Glatfelter, M.H. Baumann, Christophe P. Stove (2024). \textit{Differential in Vitro Activation Profiles for Psychedelic versus Non-psychedelic Ergolines at the 5-HT2A Receptor}. Emerging Trends in Drugs Addictions and Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.etdah.2023.100109}{doi:10.1016/j.etdah.2023.100109}.
\item Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh, M. P. Singh, Manchala Raghunath (2024). \textit{Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease-Related Dementia}. Alzheimer s \& Dementia. [published; OpenAlex]. \href{https://doi.org/10.1002/alz.084413}{doi:10.1002/alz.084413}.
\item Arman Fard, Allison Cohen (2024). \textit{Exploring Psychotherapeutic Benefits of Psilocybin and Psychedelics In Controlled Medical Settings}. Journal of Student Research. [published; OpenAlex]. \href{https://doi.org/10.47611/jsrhs.v13i4.7602}{doi:10.47611/jsrhs.v13i4.7602}.
\item Frederick A. Bagdasarian, Kristian Larsen, Deng Hong, Patrick M. Fisher, Joseph B. Mandeville, Christin Y. Sander, Hsiao-Ying Wey, Hanne D. Hansen (2024). \textit{Neurochemical characterization of 5-HT2A R partial agonists with simultaneous PET-MRI}. Journal of Cerebral Blood Flow \& Metabolism. [published; OpenAlex]. \href{https://doi.org/10.1177/0271678x241302937}{doi:10.1177/0271678x241302937}.
\item Ben-Tal T, Pogodin I, Botvinnik A, Lifschytz T, Heresco-Levy U, Lerer B. (2024). \textit{Synergistic Behavioral and Neuroplastic Effects of Psilocybin-NMDAR Modulator Administration}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.28.625811}{doi:10.1101/2024.11.28.625811}.
\item Ande Bagdasarian, Kristian Larsen, Patrick M. Fisher, Hanne D. Hansen, Hsiao-Ying Wey (2024). \textit{Neuroimaging of Serotonergic and Psychedelic Agonist Drug Challenges in Non-Human Primates}. Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition. [published; OpenAlex]. \href{https://doi.org/10.58530/2024/1133}{doi:10.58530/2024/1133}.
\item Maximillian J. Wood, Rosalind McAlpine, Sunjeev K. Kamboj (2024). \textit{Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-79931-w}{doi:10.1038/s41598-024-79931-w}.
\item Reza Ghaffarzadegan, Mokhtar Karimi, Behnaz Hedayatjoo, Hamidreza Behnoud, Eghbal Jasemi, Mahsa Mohammadi, Samira Roustaei, Ali Razmi, Salar Vaseghi (2024). \textit{The Effect of Psilocybe cubensis on Spatial Memory and BDNF Expression in Male Rats Exposed to Chronic Unpredictable Mild Stress}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2024.2428241}{doi:10.1080/02791072.2024.2428241}.
\item Zhang M, Yang Y, Yang Z, Wen X, Zhang C, Xiao P, Wang Y, Sun J, Wang H, Wang X. (2024). \textit{Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT2A receptor activation and psychedelic-like activity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ejmech.2024.117049}{doi:10.1016/j.ejmech.2024.117049}.
\item Stéphanie Knatz Peck, Hannah M. Fisher, Jessie Kim, Samantha Shao, Julie Trim, Walter H. Kaye (2024). \textit{Psychedelic treatment for anorexia nervosa: A first-hand view of how psilocybin treatment did and did not help}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024e.0034}{doi:10.61373/pp024e.0034}.
\item Pasquini L, Vohryzek J, Escrichs A, Sanz Perl Y, Ponce-Alvarez A, Idesis S, Girn M, Roseman L, Mitchell JM, Gazzaley A, Kringelbach M, Nutt DJ, Lyons T, Carhart-Harris RL, Deco G. (2024). \textit{Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.06.622302}{doi:10.1101/2024.11.06.622302}.
\item Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke, Jaime E. C. Hallak (2024). \textit{Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1485337}{doi:10.3389/fpsyt.2024.1485337}.
\item Imperial College London (2024). \textit{PsilOCD: Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity (A Pharmacological-Challenge Feasibility Study)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06258031}{source link}.
\item Shao L, Liao C, Davoudian PA, Savalia NK, Jiang Q, Wojtasiewicz C, Tan D, Nothnagel JD, Liu R, Woodburn SC, Bilash OM, Kim H, Che A, Kwan AC. (2024). \textit{Pyramidal cell types and 5-HT2A receptors are essential for psilocybin’s lasting drug action}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.11.02.621692}{doi:10.1101/2024.11.02.621692}.
\item Sepehr Aghajanian, Arman Shafiee, Samira Parvizi Omran, Aida Rezaei Nejad, Kyana Jafarabady, Omid Kohandel Gargari, Shahryar Rajai Firouzabadi, Ida Mohammadi, Touran Bahrami Babaheidari, Mahmood Bakhtiyari (2024). \textit{Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241287542}{doi:10.1177/02698811241287542}.
\item Kennedy R. Wiens, Noah A. H. Brooks, Ishvin Riar, Bridget K. Greuel, Ivan A. Lindhout, Andis Klegeris (2024). \textit{Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner}. Molecules. [published; OpenAlex]. \href{https://doi.org/10.3390/molecules29215084}{doi:10.3390/molecules29215084}.
\item Imperial College London (2024). \textit{Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03429075}{source link}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T. (2024). \textit{Psilocybin Reduces Grooming in the SAPAP3 Knockout Mouse Model of Compulsive Behaviour}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.23.619763}{doi:10.1101/2024.10.23.619763}.
\item K S Kim, Abban Yusuf, Abhimanyu Sud, Nav Persaud, Abirami Kirubarajan, Monique Moller, Taryn Lloyd, Braden O’Neill (2024). \textit{Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0309911}{doi:10.1371/journal.pone.0309911}.
\item Mott, Sarah E., Clyde W. Hodge, Jessica L. Hoffman, Maria Echeveste Sanchez, Christian S. Rollison, Margaret W. High, Devin P. Effinger, Melissa A. Herman, Sarah N. Magee, Daniel Toedt, Sema G. Quadir (2024). \textit{Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administration}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/kg31-1v38}{doi:10.17615/kg31-1v38}.
\item Mallaroni P, Singleton P, Mason NL, Satterthwaite TD, Ramaekers JG. (2024). \textit{The forgotten psychedelic: Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.22.619393}{doi:10.1101/2024.10.22.619393}.
\item Fleury S, Nautiyal KM. (2024). \textit{The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.18.618582}{doi:10.1101/2024.10.18.618582}.
\item Stefanie Enriquez-Geppert, Jaroslav Krc, Fiachra O'Higgins, Morten Peter Lietz (2024). \textit{Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study}. Philosophical Transactions of the Royal Society B Biological Sciences. [published; OpenAlex]. \href{https://doi.org/10.1098/rstb.2023.0095}{doi:10.1098/rstb.2023.0095}.
\item University Health Network, Toronto (2024). \textit{Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT06506019}{source link}.
\item Szpręgiel I, Bysiek A. (2024). \textit{Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-024-00660-y}{doi:10.1007/s43440-024-00660-y}.
\item de la Fuente Revenga M, González-Maeso J. (2024). \textit{Snapshot of 5-HT2A receptor activation in the mouse brain via IP1 detection}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.10.11.617861}{doi:10.1101/2024.10.11.617861}.
\item Seong-Jin Yu, Kuo-Jen Wu, Yu-Syuan Wang, Eun-Kyung Bae, Fabio Chianelli, Nicholas C. Bambakidis, Yun Wang (2024). \textit{Neuroprotective effects of psilocybin in a rat model of stroke}. BMC Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1186/s12868-024-00903-x}{doi:10.1186/s12868-024-00903-x}.
\item Victorita E. Ivan, David P. Tomàs-Cuesta, Ingrid M. Esteves, Artur Luczak, Majid H. Mohajerani, Bruce L. McNaughton, Aaron J. Gruber (2024). \textit{Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex}. European Journal of Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1111/ejn.16558}{doi:10.1111/ejn.16558}.
\item Elizabeth L. Fisher, Ryan Smith, Kyna-Anne Conn, Andrew W. Corcoran, Laura K Milton, Jakob Hohwy, Claire J. Foldi (2024). \textit{Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-024-03103-7}{doi:10.1038/s41398-024-03103-7}.
\item Ordovich-Clarkson RD, Jabbour M, Pelayo DA, Lara D, La Croix S, Mumman M, Stukas S, Anderson R, Meraz D, Bangura A, Anderson B, Bamrud L, Blake C. (2024). \textit{Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2024.111155}{doi:10.1016/j.pnpbp.2024.111155}.
\item Carlos Henrique Marchiori, Marco Vinícios de Oliveira Santana, Klebert de Paula Malheiros (2024). \textit{The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive Enhancement}. Middle East Research Journal of Biological Sciences. [published; OpenAlex]. \href{https://doi.org/10.36348/merjbs.2024.v04i05.001}{doi:10.36348/merjbs.2024.v04i05.001}.
\item Bushra Yasin, Shivani Mehta, George Tewfik, Alex Bekker (2024). \textit{Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives}. Exploration of neuroscience. [published; OpenAlex]. \href{https://doi.org/10.37349/en.2024.00058}{doi:10.37349/en.2024.00058}.
\item Abe Y, Sugiura Y, Maeda R, Taira S, Yoshida K, Ibi D, Moritoh S, Hashimoto K, Yagishita S, Tanaka KF. (2024). \textit{Distinct classes of antidepressants commonly act to shape pallidal structure and function in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.09.23.614626}{doi:10.1101/2024.09.23.614626}.
\item Xi Zhu, Chen Zhang, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria J. Gomez, Franklin R. Schneier (2024). \textit{Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024r.0028}{doi:10.61373/pp024r.0028}.
\item David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi, Christopher Timmermann, Ashleigh Murphy-Beiner, Michelle Baker Jones, David Nutt, Brandon Weiss, Robin Carhart-Harris (2024). \textit{Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial}. EClinicalMedicine. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eclinm.2024.102799}{doi:10.1016/j.eclinm.2024.102799}.
\item Larsen K, Lindberg U, Ozenne B, McCulloch DE, Armand S, Madsen MK, Johansen A, Stenbæk DS, Knudsen GM, Fisher PM. (2024). \textit{Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.09.19.24313958}{doi:10.1101/2024.09.19.24313958}.
\item James Rucker, Matthew Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema, Kete Campbell-Coker, Carolina Maggio, Fiona Dunbar, Giorgio Lambru, Manjit Matharu (2024). \textit{Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study}. Headache The Journal of Head and Face Pain. [published; OpenAlex]. \href{https://doi.org/10.1111/head.14837}{doi:10.1111/head.14837}.
\item Gobbi G. (2024). \textit{CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1503/jpn.240037}{doi:10.1503/jpn.240037}.
\item Werle I, Bertoglio LJ. (2024). \textit{Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2024.105899}{doi:10.1016/j.neubiorev.2024.105899}.
\item James Perry, Cara C. Young, Julie Williams (2024). \textit{B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult Populations}. Archives of Clinical Neuropsychology. [published; OpenAlex]. \href{https://doi.org/10.1093/arclin/acae067.222}{doi:10.1093/arclin/acae067.222}.
\item Nikolic M, Mediano P, Froese T, Reydellet D, Palenicek T. (2024). \textit{Psilocybin alters brain activity related to sensory and cognitive processing in a time-dependent manner}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2024.09.09.24313316}{doi:10.1101/2024.09.09.24313316}.
\item Veronika Pohořalá, Martin Kuchař, Rainer Spanagel, Rick E. Bernardi (2024). \textit{Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice}. Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroscience.2024.09.006}{doi:10.1016/j.neuroscience.2024.09.006}.
\item Zhen Z, Sun X, Yuan S, Zhang J. (2024). \textit{Psychoactive substances for the treatment of neuropsychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ajp.2024.104193}{doi:10.1016/j.ajp.2024.104193}.
\item Amany E. Ayad (2024). \textit{G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2024-esra.582}{doi:10.1136/rapm-2024-esra.582}.
\item Albert Garcia-Romeu (2024). \textit{Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Psychedelic Medicine}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2024.65789.rfs2023}{doi:10.1089/psymed.2024.65789.rfs2023}.
\item Caspani G, Ruffell SGD, Tsang W, Netzband N, Rohani-Shukla C, Swann JR, Jefferies WA (2024). \textit{Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.}. Pharmacological research. [published; PubMed]. \href{https://doi.org/10.1016/j.phrs.2024.107338}{doi:10.1016/j.phrs.2024.107338}.
\item Treviranus GRS. (2024). \textit{Rapidly Trading Down Depression's 3 Pillars to 5HT3-Receptors Through ECT or Psilocybin?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/39378462}{source link}.
\item Charlotte Smith (2024). \textit{Psychedelics, Psychedelic-Assisted Therapy and Employees’ Wellbeing}. Journal of Management Inquiry. [published; OpenAlex]. \href{https://doi.org/10.1177/10564926241267208}{doi:10.1177/10564926241267208}.
\item Mark A. Frye, Balwinder Singh, Scott Breitinger, Tyler Oesterle (2024). \textit{Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction Relapse}. The Journal of Clinical Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4088/jcp.24cr15378}{doi:10.4088/jcp.24cr15378}.
\item Jensen ME, Stenbæk DS, Messell CD, Poulsen ED, Varga TV, Fisher PM, Nielsen MKK, Johansen SS, Volkow ND, Knudsen GM, Fink-Jensen A. (2024). \textit{­­­­Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label Study}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-4947184/v1}{doi:10.21203/rs.3.rs-4947184/v1}.
\item William M. Campo, Ann Marie Yali (2024). \textit{Psychedelic use and psychological flexibility: The role of meaningful intention and decentering}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2024.00350}{doi:10.1556/2054.2024.00350}.
\item Frederick A. Bagdasarian, Hanne D. Hansen, Chi-Hyeon Yoo, Michael S. Placzek, Jacob M. Hooker, Hsiao-Ying Wey (2024). \textit{Acute Effects of Psilocybin and Salvinorin-A on Functional Connectivity}. Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition. [published; OpenAlex]. \href{https://doi.org/10.58530/2023/3494}{doi:10.58530/2023/3494}.
\item Rodolfo Myronn de Melo Rodrigues (2024). \textit{Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression}. Psychedelics.. [published; OpenAlex]. \href{https://doi.org/10.61373/pp024c.0022}{doi:10.61373/pp024c.0022}.
\item Michael P. Bogenschutz (2024). \textit{A clinical research perspective on the regulation of medical and non-medical use of psychedelic drugs}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.16647}{doi:10.1111/add.16647}.
\item Kaiserman A, Vanderjist L, Kornreich C. (2024). \textit{CURRENT STATE OF PSILOCYBIN-ASSISTED THERAPY IN MOOD DISORDERS.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24869/psyd.2024.174}{doi:10.24869/psyd.2024.174}.
\item Owe-Larsson M, Kamińska K, Buchalska B, Mirowska-Guzel D, Cudnoch-Jędrzejewska A. (2024). \textit{Psilocybin in pharmacotherapy of obsessive-compulsive disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-024-00633-1}{doi:10.1007/s43440-024-00633-1}.
\item Ibrahim Lanre Folorunsho, Nkechinyere Mary Harry, Chukwubueze Obiajunwa, Oluwatosin Arubuolawe, Adeniyi Kayode Busari, Chidalu Ibeneme, Gibson Anugwom (2024). \textit{PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin}. Journal of Advances in Medicine and Medical Research. [published; OpenAlex]. \href{https://doi.org/10.9734/jammr/2024/v36i85525}{doi:10.9734/jammr/2024/v36i85525}.
\item Viohl N, Zanjani AAH, Khandelia H. (2024). \textit{Molecular insights into the modulation of the 5HT 2A receptor by serotonin, psilocin, and the G protein subunit Gqα}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.07.23.604750}{doi:10.1101/2024.07.23.604750}.
\item Joshua S. Siegel, Subha Subramanian, Demetrius Perry, Benjamin P. Kay, Evan M. Gordon, Timothy O. Laumann, Travis R. Reneau, Nicholas V. Metcalf, Ravi V. Chacko, Caterina Gratton, Christine Horan, Samuel R. Krimmel, Joshua S. Shimony, Julia Schweiger, Dean F. Wong, David A. Bender, Kristen M. Scheidter, Forrest I. Whiting, Jonah A. Padawer-Curry, Russell T. Shinohara, Yong Chen, Julia Moser, Essa Yacoub, Steven M. Nelson, Luca Vizioli, Damien A. Fair, Eric J. Lenze, Robin Carhart-Harris, Charles L. Raison, Marcus E. Raichle, Abraham Z. Snyder, Ginger E. Nicol, Nico U.F. Dosenbach (2024). \textit{Psilocybin desynchronizes the human brain}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/s41586-024-07624-5}{doi:10.1038/s41586-024-07624-5}.
\item André Do, Vanessa Michaud, Jean-François Stephan, Miltiadis Moreau, Élise Benoît, Felix-Antoine Berubé, Antoine Bibaud-De Serres, Alain Taillefer, Philippe Vincent (2024). \textit{Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1394962}{doi:10.3389/fpsyt.2024.1394962}.
\item Anders Fink-Jensen, MD, DMSci (2024). \textit{Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04718792}{source link}.
\item Zheng S, Ma R, Yang Y, Li G. (2024). \textit{Psilocybin for the treatment of Alzheimer's disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fnins.2024.1420601}{doi:10.3389/fnins.2024.1420601}.
\item Amir Khajavinia, Déborah Michel, Udoka C. Ezeaka, Randy W. Purves, Robert B. Laprairie, Anas El-Aneed (2024). \textit{Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method}. Journal of Chromatography A. [published; OpenAlex]. \href{https://doi.org/10.1016/j.chroma.2024.465123}{doi:10.1016/j.chroma.2024.465123}.
\item Magdalena Kolasa, Agnieszka Nikiforuk, Agata Korlatowicz, Joanna Solich, Agnieszka Potasiewicz, Marta Dziedzicka-Wasylewska, Ryszard Bugno, Adam S. Hogendorf, Andrzej J. Bojarski, Agata Faron-Górecka (2024). \textit{Unraveling psilocybin’s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-024-06644-3}{doi:10.1007/s00213-024-06644-3}.
\item Jasmine Shakir, Megan Pedicini, Brianna C Bullock, Penn W Hoen, Lindsey Macias, Jackson Freiman, Mikhail V Pletnikov, Kellie L. Tamashiro, Zachary A. Cordner (2024). \textit{Effects of psilocybin on body weight, body composition, and metabolites in male and female mice}. Physiology \& Behavior. [published; OpenAlex]. \href{https://doi.org/10.1016/j.physbeh.2024.114627}{doi:10.1016/j.physbeh.2024.114627}.
\item Shelby A. McGriff, Grant C. Glatfelter, David R. Manke, A.R. Chadeayne, Charles W. Schindler, Michaël Baumann (2024). \textit{Physiological Effects of Psilocybin, Psilacetin, and DOI in Rats}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2023.110445}{doi:10.1016/j.drugalcdep.2023.110445}.
\item S. Parker Singleton, Amy Kuceyeski (2024). \textit{Bridging Psilocybin-Induced Changes in the Brain’s Dynamic Functional Connectome With an Individual’s Subjective Experience}. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bpsc.2024.05.003}{doi:10.1016/j.bpsc.2024.05.003}.
\item Shadani S, Conn K, Andrews ZB, Foldi CJ (2024). \textit{Potential Differences in Psychedelic Actions Based on Biological Sex.}. Endocrinology. [published; PubMed]. \href{https://doi.org/10.1210/endocr/bqae083}{doi:10.1210/endocr/bqae083}.
\item DeBattista C, Schatzberg AF. (2024). \textit{The Black Book of Psychotropic Dosing and Monitoring.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.64719/pb.4493}{doi:10.64719/pb.4493}.
\item Nauman Ashraf (2024). \textit{IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?}. Journal of Pakistan Psychiatric Society. [published; OpenAlex]. \href{https://doi.org/10.63050/jpps.21.02.935}{doi:10.63050/jpps.21.02.935}.
\item Daisuke Ibi (2024). \textit{Up-to-Date on clinical and preclinical studies of psilocybin therapy}. Folia Pharmacologica Japonica. [published; OpenAlex]. \href{https://doi.org/10.1254/fpj.24007}{doi:10.1254/fpj.24007}.
\item Bennett Lange, Luke Morgan, Christopher Mattox, Suhrud Pathak, Keyi Liu, Rishi Nadar, Jun Ren, Jeyaram Bharathi Jeyabalan, Timothy Moore, Muralikrishnan Dhanasekaran (2024). \textit{Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare}. Trends in Medical Research. [published; OpenAlex]. \href{https://doi.org/10.3923/tmr.2024.245.273}{doi:10.3923/tmr.2024.245.273}.
\item Frederick A. Bagdasarian, Hanne D. Hansen, Jingyuan Chen, Chi-Hyeon Yoo, Michael S. Placzek, Jacob M. Hooker, Hsiao-Ying Wey (2024). \textit{Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.4c00245}{doi:10.1021/acschemneuro.4c00245}.
\item Brian S. Barnett, Curtis J. Koons, Vincent Van den Eynde, Peter Kenneth Gillman, J. Alexander Bodkin (2024). \textit{Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2024.2368617}{doi:10.1080/02791072.2024.2368617}.
\item Ippolito A, Vasudevan S, Hurley S, Gilmour G, Westhorpe F, Churchill G, Sharp T. (2024). \textit{Increased 5-HT2A receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.06.13.594677}{doi:10.1101/2024.06.13.594677}.
\item Joachim Neumann, Kiril Dimov, Karyna Azatsian, Britt Hofmann, Ulrich Gergs (2024). \textit{Effects of psilocin and psilocybin on human 5-HT4 serotonin receptors in atrial preparations of transgenic mice and humans}. Toxicology Letters. [published; OpenAlex]. \href{https://doi.org/10.1016/j.toxlet.2024.06.006}{doi:10.1016/j.toxlet.2024.06.006}.
\item Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska, Gniewko Więckiewicz (2024). \textit{Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2024.1406888}{doi:10.3389/fpsyt.2024.1406888}.
\item Linda Nguyen, Sona Regonda, Adam Gaisinsky (2024). \textit{Therapeutic Potential of Fungally Derived Psilocybin Extract in Morphine-Dependent Mice: A Research Protocol}. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. [published; OpenAlex]. \href{https://doi.org/10.26685/urncst.588}{doi:10.26685/urncst.588}.
\item Ouliana Panova, Nichols D.E, Shoichet B.K, Lyu J, Georgios Skiniotis, Che T, Roth B.L, DiBerto J.F, Daniel Wacker, Robertson M.J, Kami Kim, Krumm B.E, Seven A.B (2024). \textit{Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor}. UNC Libraries. [published; OpenAlex]. \href{https://doi.org/10.17615/yb2v-ca64}{doi:10.17615/yb2v-ca64}.
\item Sean M. Viña (2024). \textit{Minorities’ Diminished Psychedelic Returns: Gender, Perceived Stigma, and Distress}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3020019}{doi:10.3390/psychoactives3020019}.
\item Ryan J. Rakoczy, Grace N. Runge, Abhishek K. Sen, Oscar Sandoval, Hunter G. Wells, Quynh Nguyen, B. Roberts, Jon H. Sciortino, William J. Gibbons, Lucas M. Friedberg, J. Andrew Jones, Matthew S. McMurray (2024). \textit{Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms}. British Journal of Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1111/bph.16466}{doi:10.1111/bph.16466}.
\item Amrit Baral, Yue Pan, Alberto J. Caban Martinez, Paulo S. Pinheiro, WayWay M. Hlaing, Denise C. Vidot (2024). \textit{Psilocybin, peyote, mescaline, and lysergic acid diethylamide (LSD) use in a nationally representative population by cancer history.}. Journal of Clinical Oncology. [published; OpenAlex]. \href{https://doi.org/10.1200/jco.2024.42.16\_suppl.e22518}{doi:10.1200/jco.2024.42.16\_suppl.e22518}.
\item Floris G, Dabrowski KR, Zanda MT, Daws SE. (2024). \textit{Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.28.596205}{doi:10.1101/2024.05.28.596205}.
\item Adam T. Brockett, Nikolas A. Francis (2024). \textit{Psilocybin decreases neural responsiveness and increases functional connectivity while preserving pure-tone frequency selectivity in mouse auditory cortex}. Journal of Neurophysiology. [published; OpenAlex]. \href{https://doi.org/10.1152/jn.00124.2024}{doi:10.1152/jn.00124.2024}.
\item McGovern H, Wellman N, Hutchinson B, Oestreich LKL, Cooper SE, Fonzo G, Doss M. (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/y8sb7}{doi:10.31234/osf.io/y8sb7}.
\item Unknown authors (2024). \textit{Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/y8sb7\_v1}{source link}.
\item Hoyer D. (2024). \textit{On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.171648613.31141136/v1}{doi:10.22541/au.171648613.31141136/v1}.
\item Korkmaz ND, Cikrikcili U, Akan M, Yucesan E. (2024). \textit{Psychedelic therapy in depression and substance use disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/ejn.16421}{doi:10.1111/ejn.16421}.
\item Shane Darke, Johan Duflou, Amy Peacock, Michael Farrell, Wayne Hall, Julia Lappin (2024). \textit{A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.16518}{doi:10.1111/add.16518}.
\item Andrea Casanova, Andres Ort, John W Smallridge, Katrin H. Preller, Erich Seifritz, Franz X. Vollenweider (2024). \textit{The influence of psilocybin on subconscious and conscious emotional learning}. iScience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.isci.2024.110034}{doi:10.1016/j.isci.2024.110034}.
\item Eric S. Jackson, Noam Goldway, Hope Gerlach, Noah D. Gold (2024). \textit{Stutterers’ experiences on classic psychedelics: A preliminary self-report study}. Journal of Fluency Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jfludis.2024.106062}{doi:10.1016/j.jfludis.2024.106062}.
\item Nathan Bryson, Robert Alexander, Aviva Asnis-Alibozek, Michael Ehlers (2024). \textit{RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.4c00058}{doi:10.1021/acschemneuro.4c00058}.
\item Shunichiro Ikeda, Toshihiko Kinoshita (2024). \textit{Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens}. Psychiatry and Clinical Neurosciences Reports. [published; OpenAlex]. \href{https://doi.org/10.1002/pcn5.196}{doi:10.1002/pcn5.196}.
\item M. Imad Damaj, Javier González-Maeso, Belle Buzzi (2024). \textit{The Classical Psychedelic Psilocybin Mitigates Oxycodone Withdrawal}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1124/jpet.320.935210}{doi:10.1124/jpet.320.935210}.
\item N. Jones, John A. Razidlo, Zarmeen Zahid, Cody J. Wenthur (2024). \textit{Psilocybin-induced anxiolytic effects supported by transient elevation of corticosterone}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1124/jpet.337.128335}{doi:10.1124/jpet.337.128335}.
\item Nova Mentis Life Science Corp (2024). \textit{An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05832255}{source link}.
\item Warren AL, Lankri D, Cunningham MJ, Serrano IC, Parise LF, Kruegel AC, Duggan P, Zilberg G, Capper MJ, Havel V, Russo SJ, Sames D, Wacker D. (2024). \textit{Structural pharmacology and therapeutic potential of 5-methoxytryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41586-024-07403-2}{doi:10.1038/s41586-024-07403-2}.
\item Woodburn SC, Levitt CM, Koester AM, Kwan AC. (2024). \textit{Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptors}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.05.04.592469}{doi:10.1101/2024.05.04.592469}.
\item Jérôme Jeanblanc, Romain Bordy, Grégory Fouquet, Virginie Jeanblanc, Mickaël Naassïla (2024). \textit{Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats}. Brain. [published; OpenAlex]. \href{https://doi.org/10.1093/brain/awae136}{doi:10.1093/brain/awae136}.
\item Prince Patel, Samrat Gollapudi, Brian Joseph Mathew, Bhaumik B. Patel (2024). \textit{Brain Connectivity Pattern Changes Associated With Psychedelic-Assisted Psychotherapy}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.31986/issn.2689-0690\_rdw.stratford\_research\_day.179\_2024}{doi:10.31986/issn.2689-0690\_rdw.stratford\_research\_day.179\_2024}.
\item Claire Parker, Bethany Wood (2024). \textit{At the Forefront: Social Workers’ Role in Psilocybin Treatment for Depression and Substance Misuse}. Social Work. [published; OpenAlex]. \href{https://doi.org/10.1093/sw/swae019}{doi:10.1093/sw/swae019}.
\item Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie (2024). \textit{From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine}. European Journal of Arts Humanities and Social Sciences. [published; OpenAlex]. \href{https://doi.org/10.59324/ejahss.2024.1(3).10}{doi:10.59324/ejahss.2024.1(3).10}.
\item Ruan Y, Yuan R, He J, Jiang Y, Chu S, Chen N. (2024). \textit{New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41420-024-01974-9}{doi:10.1038/s41420-024-01974-9}.
\item Kimberly Sakai, Ellen Bradley, Joseph A. Zamaria, Gabrielle Agin-Liebes, D. Parker Kelley, Alexander Fish, Valeria Martini, Michelle C. Ferris, Emma Morton, Erin E. Michalak, Aoife O’Donovan, Joshua Woolley (2024). \textit{Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-024-06585-x}{doi:10.1007/s00213-024-06585-x}.
\item Jan Thomann, Karolina E. Kolaczynska, Oliver V Stoeckmann, Deborah Rudin, Patrick Vizeli, Marius C. Hoener, Christopher R. Pryce, Franz X. Vollenweider, Matthias E. Liechti, Urs Duthaler (2024). \textit{In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2024.1391689}{doi:10.3389/fphar.2024.1391689}.
\item Xiangting Zhao, Yingjie Du, Yishan Yao, Wei Dai, Yong-Yu Yin, Guyan Wang, Yunfeng Li, Liming Zhang (2024). \textit{Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241249436}{doi:10.1177/02698811241249436}.
\item Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Janika Ruuska, M. B. Lemus, Erin Greaves, Jihane Homman-Ludiye, Brian J. Oldfield, Claire J. Foldi (2024). \textit{Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-024-02575-9}{doi:10.1038/s41380-024-02575-9}.
\item Tobias P. Whelan, Eileen Daly, Nicolaas A.J. Puts, Paula Smith, Carrie Allison, Simon Baron-Cohen, Ekaterina Malievskaia, Declan Murphy, Gráinne McAlonan (2024). \textit{The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin}. BMC Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1186/s12888-024-05768-2}{doi:10.1186/s12888-024-05768-2}.
\item Terri D’Arrigo (2024). \textit{MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2024.05.5.1}{doi:10.1176/appi.pn.2024.05.5.1}.
\item Jensen AA, Cecchi CR, Hibicke M, Bach AH, Kaadt E, Märcher-Rørsted E, Nichols CD, Elfving B, Kristensen JL. (2024). \textit{The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.04.19.590212}{doi:10.1101/2024.04.19.590212}.
\item Ivan V, Tomas-Cuesta D, Esteves I, Luczak A, Mohajerani M, McNaughton B, Gruber A. (2024). \textit{Psilocybin reduces functional connectivity and the encoding of spatial information by neurons in mouse retrosplenial cortex}. Authorea Preprints. [preprint; Europe PMC]. \href{https://doi.org/10.22541/au.171378690.00112411/v1}{doi:10.22541/au.171378690.00112411/v1}.
\item Emil Märcher-Rørsted, Anders A. Jensen, Gints Šmits, Karla Frydenvang, Jesper L. Kristensen (2024). \textit{Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists}. Journal of Medicinal Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1021/acs.jmedchem.4c00082}{doi:10.1021/acs.jmedchem.4c00082}.
\item Tipado Z, Kuypers KPC, Sorger B, Ramaekers JG. (2024). \textit{Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2024.04.011}{doi:10.1016/j.euroneuro.2024.04.011}.
\item Elad Lerer, Alexander Botvinnik, Orr Shahar, Meitar Grad, Karin Blakolmer, Noam Shomron, Amit Lotan, Bernard Lerer, Tzuri Lifschytz (2024). \textit{Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2024.1391412}{doi:10.3389/fphar.2024.1391412}.
\item Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, Robert Krause, Hamideh Safi-Aghdam, Surbhi Pathania, Brian Pittman, Deepak Cyril D’Souza (2024). \textit{Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-58318-x}{doi:10.1038/s41598-024-58318-x}.
\item Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger, David B. Yaden (2024). \textit{Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3020014}{doi:10.3390/psychoactives3020014}.
\item Juliani A, Chelu V, Graesser L, Safron A. (2024). \textit{A dual-receptor model of serotonergic psychedelics}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.04.12.589282}{doi:10.1101/2024.04.12.589282}.
\item Ram Harari, Ipsita Chatterjee, Dmitriy Getselter, Evan Elliott (2024). \textit{Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor}. iScience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.isci.2024.109686}{doi:10.1016/j.isci.2024.109686}.
\item Gayle Maloney, Terence H. W. Ching, Stephen A. Kichuk, Christopher Pittenger, Benjamin Kelmendi (2024). \textit{Mechanisms of therapeutic change after psychedelic treatment in OCD}. Psychiatry Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.psychres.2024.115907}{doi:10.1016/j.psychres.2024.115907}.
\item López E, Yngwe H, Beckman M, Tiger M, Hieronymus F, Lundberg J. (2024). \textit{[Psychedelic psychiatry].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/38572715}{source link}.
\item M. Imad Damaj, Eda Köşeli, Belle Buzzi, Yogesh Rakholia, Melissa J. Lewis, Javier González-Maeso (2024). \textit{Pharmacology of Classical Psychedelic in Mouse Models of Chronic Pain}. Journal of Pain. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpain.2024.01.093}{doi:10.1016/j.jpain.2024.01.093}.
\item Tap SC. (2024). \textit{The potential of 5-methoxy-N,N-dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/adb.13386}{doi:10.1111/adb.13386}.
\item David Nutt (2024). \textit{Psychedelics: reconnecting the brain to heal the mind}. The Biochemist. [published; OpenAlex]. \href{https://doi.org/10.1042/bio\_2023\_156}{doi:10.1042/bio\_2023\_156}.
\item David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Carhart-Harris (2024). \textit{Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811241237870}{doi:10.1177/02698811241237870}.
\item Natalie Ertl, Matthew B. Wall (2024). \textit{Scanning the new frontier of mental health: psychedelic brain imaging}. The Biochemist. [published; OpenAlex]. \href{https://doi.org/10.1042/bio\_2023\_171}{doi:10.1042/bio\_2023\_171}.
\item Ben Seal (2024). \textit{Psychedelic drugs and the law: What’s next?}. Knowable Magazine. [published; OpenAlex]. \href{https://doi.org/10.1146/knowable-031424-2}{doi:10.1146/knowable-031424-2}.
\item Aleksandr V. Kulikov, Ilya Yu. Zheleznyak (2024). \textit{Problems of Qualification of Trafficking in Plants and Plant Parts Containing Psychoactive Substances and Mushrooms Containing Psilocybin and (or) Psilocin}. Drug control. [published; OpenAlex]. \href{https://doi.org/10.18572/2072-4160-2024-1-23-26}{doi:10.18572/2072-4160-2024-1-23-26}.
\item Brandon Weiss, Leor Roseman, Bruna Giribaldi, David Nutt, Robin Carhart-Harris, David Erritzøe (2024). \textit{Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-024-01253-9}{doi:10.1007/s11469-024-01253-9}.
\item Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir (2024). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview}. American Journal of Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1097/mjt.0000000000001727}{doi:10.1097/mjt.0000000000001727}.
\item Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir (2024). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin}. American Journal of Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1097/mjt.0000000000001724}{doi:10.1097/mjt.0000000000001724}.
\item Clarice Ho, John R. Crawford (2024). \textit{Neuroimaging features of psilocybin-induced toxic-metabolic encephalopathy in an adolescent}. BMJ Case Reports. [published; OpenAlex]. \href{https://doi.org/10.1136/bcr-2024-259721}{doi:10.1136/bcr-2024-259721}.
\item Christopher L. Robinson, Alexandra Fonseca, Efemena Diejomaoh, Ryan S. D’Souza, Michael E Schatman, Vwaire Orhurhu, Trent Emerick (2024). \textit{Scoping Review: The Role of Psychedelics in the Management of Chronic Pain}. Journal of Pain Research. [published; OpenAlex]. \href{https://doi.org/10.2147/jpr.s439348}{doi:10.2147/jpr.s439348}.
\item Norred MA, Zuschlag ZD, Hamner MB. (2024). \textit{A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40265-023-01983-5}{doi:10.1007/s40265-023-01983-5}.
\item Meghan Hibicke, Gerald Billac, Charles D. Nichols (2024). \textit{Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0037}{doi:10.1089/psymed.2023.0037}.
\item Hashimoto K. (2024). \textit{Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00406-024-01770-7}{doi:10.1007/s00406-024-01770-7}.
\item Avisha D Amarnani, Melissa F Free, Ritika Baweja (2024). \textit{Psilocybin and the Development of Serotonin Toxicity}. The Primary Care Companion For CNS Disorders. [published; OpenAlex]. \href{https://doi.org/10.4088/pcc.23cr03648}{doi:10.4088/pcc.23cr03648}.
\item Salma Laabi, Claire LeMmon, Callie Vogel, M. Chacón, Víctor M. Jiménez (2024). \textit{Deciphering psilocybin: Cytotoxicity, anti-inflammatory effects, and mechanistic insights}. International Immunopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.intimp.2024.111753}{doi:10.1016/j.intimp.2024.111753}.
\item Habelt B, Afanasenkau D, Schwarz C, Domanegg K, Kuchar M, Werner C, Minev IR, Spanagel R, Meinhardt MW, Bernhardt N. (2024). \textit{Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol Addiction}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3905152/v1}{doi:10.21203/rs.3.rs-3905152/v1}.
\item Kush Bhatt, Cory R. Weissman (2024). \textit{The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects}. npj Mental Health Research. [published; OpenAlex]. \href{https://doi.org/10.1038/s44184-023-00053-8}{doi:10.1038/s44184-023-00053-8}.
\item Balázs Szigeti, Boris D. Heifets (2024). \textit{Expectancy Effects in Psychedelic Trials}. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bpsc.2024.02.004}{doi:10.1016/j.bpsc.2024.02.004}.
\item Rosalind McAlpine, Matthew D. Sacchet, Otto Simonsson, Maisha M. Khan, Katarina Krajnović, Larisa Morometescu, Sunjeev K. Kamboj (2024). \textit{Development of a digital intervention for psychedelic preparation (DIPP)}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-54642-4}{doi:10.1038/s41598-024-54642-4}.
\item Alison Knopf (2024). \textit{NIDA: Psilocybin mushroom seizures rose significantly}. Alcoholism \& Drug Abuse Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/adaw.34037}{doi:10.1002/adaw.34037}.
\item Dirk Trauner, Kenny Calderon-Godinez (2024). \textit{Tryptamine Derivatives of Norpsilocin Induce Psychedelic-Like Responses in Mice}. Synfacts. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0043-1773080}{doi:10.1055/s-0043-1773080}.
\item Hatzipantelis CJ, Olson DE (2024). \textit{The Effects of Psychedelics on Neuronal Physiology.}. Annual review of physiology. [published; PubMed]. \href{https://doi.org/10.1146/annurev-physiol-042022-020923}{doi:10.1146/annurev-physiol-042022-020923}.
\item Alyssa F. Harlow, Peter S. Hendricks, Adam M. Leventhal, Jessica L. Barrington-Trimis (2024). \textit{Psychedelic Microdosing among Young Adults from Southern California}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2024.2313684}{doi:10.1080/02791072.2024.2313684}.
\item Broc A. Pagni, Petros Petridis, Samantha K. Podrebarac, Jack Grinband, Eric D. Claus, Michael P. Bogenschutz (2024). \textit{Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-52967-8}{doi:10.1038/s41598-024-52967-8}.
\item Tommaso Barba, Hannes Kettner, Caterina Radu, Joseph Peill, Leor Roseman, David Nutt, David Erritzøe, Robin Carhart-Harris, Bruna Giribaldi (2024). \textit{Psychedelics and sexual functioning: a mixed-methods study}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-023-49817-4}{doi:10.1038/s41598-023-49817-4}.
\item Timmermann C, Zeifman RJ, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2024). \textit{Effects of DMT on mental health outcomes in healthy volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-024-53363-y}{doi:10.1038/s41598-024-53363-y}.
\item Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, T.L. Karsten, Jeanine Kamphuis, Eric Vermetten, Wim van den Brink, Robert A. Schoevers (2024). \textit{Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-024-53188-9}{doi:10.1038/s41598-024-53188-9}.
\item Rogers SA, Heller EA, Corder G. (2024). \textit{Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.02.04.578811}{doi:10.1101/2024.02.04.578811}.
\item Neumann J, Dhein S, Kirchhefer U, Hofmann B, Gergs U. (2024). \textit{Effects of hallucinogenic drugs on the human heart.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2024.1334218}{doi:10.3389/fphar.2024.1334218}.
\item Jitendra Kumar Sinha, Anchal Trisal, Shampa Ghosh, Saurabh Gupta, Krishna Kumar Singh, Sung Soo Han, Madhumita Mahapatra, Mosleh Mohammad Abomughaid, Ali M. Abomughayedh, Abdulmajeed G. Almutary, Danish Iqbal, Rakesh Bhaskar, Prabhu Chandra Mishra, Saurabh Kumar Jha, Niraj Kumar Jha, Abhishek Kumar Singh (2024). \textit{Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways}. Ageing Research Reviews. [published; OpenAlex]. \href{https://doi.org/10.1016/j.arr.2024.102211}{doi:10.1016/j.arr.2024.102211}.
\item Holze F, Singh N, Liechti ME, D'Souza DC. (2024). \textit{Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsc.2024.01.007}{doi:10.1016/j.bpsc.2024.01.007}.
\item Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, Olga Kovalchuk, Igor Kovalchuk (2024). \textit{The Impact of Psilocybin on High Glucose/Lipid-Induced Changes in INS-1 Cell Viability and Dedifferentiation}. Genes. [published; OpenAlex]. \href{https://doi.org/10.3390/genes15020183}{doi:10.3390/genes15020183}.
\item Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, Olga Kovalchuk, Igor Kovalchuk (2024). \textit{The Effects of Psilocybin on Lipopolysaccharide-Induced Inflammation in THP-1 Human Macrophages}. Psychoactives. [published; OpenAlex]. \href{https://doi.org/10.3390/psychoactives3010004}{doi:10.3390/psychoactives3010004}.
\item University Hospital, Basel, Switzerland (2024). \textit{Comparative Acute Effects of LSD, Psilocybin and Mescaline in a Random-Order Placebo-Controlled Cross-Over Study in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04227756}{source link}.
\item Payal Ghosh, Debjeet Sur (2024). \textit{Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists}. Current Psychiatry Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/0126660822258502231120074036}{doi:10.2174/0126660822258502231120074036}.
\item Javier González-Maeso (2024). \textit{Psychedelics for mental health: a biochemical perspective}. The Biochemist. [published; OpenAlex]. \href{https://doi.org/10.1042/bio\_2023\_161}{doi:10.1042/bio\_2023\_161}.
\item Roberto De Filippo, Dietmar Schmitz (2024). \textit{Synthetic surprise as the foundation of the psychedelic experience}. Neuroscience \& Biobehavioral Reviews. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neubiorev.2024.105538}{doi:10.1016/j.neubiorev.2024.105538}.
\item Rouaud A, Calder AE, Hasler G. (2024). \textit{Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231225609}{doi:10.1177/02698811231225609}.
\item Mehdi Sekssaoui, Joël Bockaert, Philippe Marin, Carine Bécamel (2024). \textit{Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-024-01794-6}{doi:10.1038/s41386-024-01794-6}.
\item Alexander M. Sherwood, Elise K. Burkhartzmeyer, Samuel E. Williamson, Michael H. Baumann, Grant C. Glatfelter (2024). \textit{Psychedelic-like Activity of Norpsilocin Analogues}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.3c00610}{doi:10.1021/acschemneuro.3c00610}.
\item Huang Z, Wei X, Wang Y, Tian J, Dong J, Liang B, Lu L, Zhang W. (2024). \textit{Psilocybin Promotes Cell-Type-Specific Changes in the Orbitofrontal Cortex Revealed by Single-Nucleus RNA-seq}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2024.01.07.573163}{doi:10.1101/2024.01.07.573163}.
\item Douglas Funk, Joseph A. Araujo, Malik Slassi, James Lanthier, Jason Atkinson, Daniel Feng, Winnie Lau, Anh Lê, Guy A. Higgins (2024). \textit{Effect of a single psilocybin treatment on Fos protein expression in male rat brain}. Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroscience.2024.01.001}{doi:10.1016/j.neuroscience.2024.01.001}.
\item Barajas, Carlos (2023). \textit{Psilocybin’s Role in Major Depressive Disorder: A Scoping Review}. Digital Commons - George Fox University (George Fox University). [published; OpenAlex]. \href{https://digitalcommons.georgefox.edu/dmsc/31}{source link}.
\item R.S. Treviranus, Gottfried (2023). \textit{RAPIDLY TRADING DOWN DEPRESSION'S3 PILLARS TO 5HT3-RECEPTORS THROUGH ECT OR PSILOCYBIN?}. University of Zagreb University Computing Centre (SRCE). [published; OpenAlex]. \href{https://doi.org/10.24869/psyd.2024.134}{doi:10.24869/psyd.2024.134}.
\item Kyna-Anne Conn, Laura K Milton, Kaixin Huang, Hermany Munguba, Jaana Ruuska, Mónica Lemus, Erin Greaves, Jihane Homman-Ludiye, Brian J. Oldfield, Claire J. Foldi (2023). \textit{Insights into the serotonergic mechanisms of psilocybin-induced improvements in anorexia-like behaviour in female rats}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104774}{doi:10.1016/j.nsa.2024.104774}.
\item Unknown authors (2023). \textit{Government-funded trial will test psilocybin as treatment for opioid use disorder}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2024.1.335169}{doi:10.1211/pj.2024.1.335169}.
\item Unknown authors (2023). \textit{Psilocybin may be as effective as escitalopram in treating depression, study suggests}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2024.1.327949}{doi:10.1211/pj.2024.1.327949}.
\item Prosenjit Ghosh, Avinash Desousa (2023). \textit{Psychedelics: The New Kid on the Block}. Annals of Indian Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.4103/aip.aip\_195\_23}{doi:10.4103/aip.aip\_195\_23}.
\item Agata Korlatowicz, Katarzyna Latocha, Paulina Pabian, Ryszard Bugno, Adam S. Hogendorf, Tamás Kovács, Andrzej J. Bojarski, Zoltán V. Varga, Agata Faron-Górecka (2023). \textit{Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapy}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104020}{doi:10.1016/j.nsa.2024.104020}.
\item Ewald Kolesnik, Ma Luisa Masó Navarro, Nakul Ravi Raval, Brice Ozenne, Hanne D. Hansen (2023). \textit{Pharmacological characterization of psilocin affinity towards different 5-HT receptors and receptor regulation after psilocybin administration in pigs}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.105133}{doi:10.1016/j.nsa.2024.105133}.
\item Gukasyan N, Narayan SK (2023). \textit{Menstrual Changes and Reversal of Amenorrhea Induced by Classic Psychedelics: A Case Series.}. Journal of psychoactive drugs. [published; PubMed]. \href{https://doi.org/10.1080/02791072.2022.2157350}{doi:10.1080/02791072.2022.2157350}.
\item Nutt DJ, Peill JM, Weiss B, Godfrey K, Carhart-Harris RL, Erritzoe D. (2023). \textit{Psilocybin and Other Classic Psychedelics in Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2023\_451}{doi:10.1007/7854\_2023\_451}.
\item Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R. (2023). \textit{The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1570159x22666231027111147}{doi:10.2174/1570159x22666231027111147}.
\item Isabelle Straumann, Friederike Holze, A. Becker, Laura Ley, Nepomuk Halter, Matthias E. Liechti (2023). \textit{Safety pharmacology of acute psilocybin administration in healthy participants}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2024.104060}{doi:10.1016/j.nsa.2024.104060}.
\item Marthe Vandevelde, Andreas Simoens, Bavo Vandekerckhove, Christian V. Stevens (2023). \textit{Synthesis and bioactivity of psilocybin analogues containing a stable carbon-phosphorus bond}. RSC Medicinal Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1039/d4md00043a}{doi:10.1039/d4md00043a}.
\item Verheijen Marcha C.T. (2023). \textit{Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge}. Journal of the Netherlands Society of Toxicology. [published; Crossref]. \href{https://doi.org/10.61833/jnst.2024.0002}{doi:10.61833/jnst.2024.0002}.
\item Sophia Armand, Kristian Larsen, M. Madsen, Brice Ozenne, Katrin H. Preller, Gitte M. Knudsen, Dea Siggaard Stenbæk, Patrick M. Fisher (2023). \textit{Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103934}{doi:10.1016/j.nsa.2023.103934}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/byms6}{doi:10.31234/osf.io/byms6}.
\item Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS. (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/a8xwk}{doi:10.31234/osf.io/a8xwk}.
\item Unknown authors (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part I. Historical Perspective and Overview}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/byms6\_v1}{source link}.
\item Unknown authors (2023). \textit{Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/a8xwk\_v1}{source link}.
\item Paul Fletcher, Zhaoxia Li, Xiao Dong Ji, Anh D. Lê (2023). \textit{Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT2A receptor agonist TCB-2 in male DBA/2J mice}. Pharmacology Biochemistry and Behavior. [published; OpenAlex]. \href{https://doi.org/10.1016/j.pbb.2023.173703}{doi:10.1016/j.pbb.2023.173703}.
\item Wojtas A, Gołembiowska K. (2023). \textit{Molecular and Medical Aspects of Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms25010241}{doi:10.3390/ijms25010241}.
\item Falchi-Carvalho M, Wießner I, Silva SRB, O Maia L, Barros H, Laborde S, Arichelle F, Tullman S, Silva-Costa N, Assunção A, Almeida R, Pantrigo ÉJ, Bolcont R, Costa-Macedo JV, Arcoverde E, Galvão-Coelho N, Araujo DB, Palhano-Fontes F. (2023). \textit{Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2023.12.006}{doi:10.1016/j.euroneuro.2023.12.006}.
\item Jingxuan Chen (2023). \textit{Application of psilocybin in mental health disorders}. Theoretical and Natural Science. [published; OpenAlex]. \href{https://doi.org/10.54254/2753-8818/21/20230859}{doi:10.54254/2753-8818/21/20230859}.
\item Shah FI, Shehzadi S, Akram F, Haq IU, Javed B, Sabir S, Kazim Y, Ashfaq S. (2023). \textit{Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s12033-023-00994-7}{doi:10.1007/s12033-023-00994-7}.
\item Gregory Ian Robinson, Dongping Li, Bo Wang, Tahiat Rahman, Marta Gerasymchuk, Darryl Hudson, Olga Kovalchuk, Igor Kovalchuk (2023). \textit{Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue}. Life. [published; OpenAlex]. \href{https://doi.org/10.3390/life13122345}{doi:10.3390/life13122345}.
\item McCulloch DE, Lopez JP, Dalla C, Castrén E, Erritzoe D, Frokjaer VG, Lundberg J, Preller KH, Fisher PM, Knudsen GM. (2023). \textit{Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nsa.2023.103929}{doi:10.1016/j.nsa.2023.103929}.
\item Jonathan Reinwald, Christian N. Schmitz, Ivan Skorodumov, Martin Kuchař, Wolfgang Weber-Fahr, Rainer Spanagel, Marcus W. Meinhardt (2023). \textit{Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats}. Translational Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41398-023-02690-1}{doi:10.1038/s41398-023-02690-1}.
\item Conn K, Milton L, Huang K, Munguba H, Ruuska J, Lemus M, Greaves E, Homman-Ludiye J, Oldfield B, Foldi C. (2023). \textit{Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.12.12.571374}{doi:10.1101/2023.12.12.571374}.
\item Ivana Turek (2023). \textit{Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybin}. Medical Writing. [published; OpenAlex]. \href{https://doi.org/10.56012/tsen2260}{doi:10.56012/tsen2260}.
\item Erika Dyck, Gregory P. Marchildon (2023). \textit{A history and future of psychedelics: The case of the Canadian military}. Journal of Military Veteran and Family Health. [published; OpenAlex]. \href{https://doi.org/10.3138/jmvfh-2023-0010}{doi:10.3138/jmvfh-2023-0010}.
\item Emmanuelle A. D. Schindler, Jason J. Sico (2023). \textit{Studying classic psychedelics for the management of headache disorders: Considerations for Veterans}. Journal of Military Veteran and Family Health. [published; OpenAlex]. \href{https://doi.org/10.3138/jmvfh-2023-0006}{doi:10.3138/jmvfh-2023-0006}.
\item Christopher R. Nicholas, David Horton, Julia Malicki, Amelia Baltes, Paul R. Hutson, Randall Brown (2023). \textit{Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0012}{doi:10.1089/psymed.2023.0012}.
\item Nicholas Kolbman, Tiecheng Liu, Peter R. Guzzo, Jim Gilligan, George A. Mashour, Giancarlo Vanini, Dinesh Pal (2023). \textit{Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain}. Current Biology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cub.2023.10.016}{doi:10.1016/j.cub.2023.10.016}.
\item Duan W, Cao D, Wang S, Cheng J. (2023). \textit{Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acs.chemrev.3c00375}{doi:10.1021/acs.chemrev.3c00375}.
\item Wang SM, Kim S, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM. (2023). \textit{Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.9758/cpn.23.1134}{doi:10.9758/cpn.23.1134}.
\item Adam Waldbillig, Maria Baranova, Sarah Neumann, Jonathan Andrade, Sharan Sidhu (2023). \textit{Exploring Psilocybe spp. mycelium and fruiting body chemistry for potential therapeutic compounds}. Frontiers in Fungal Biology. [published; OpenAlex]. \href{https://doi.org/10.3389/ffunb.2023.1295223}{doi:10.3389/ffunb.2023.1295223}.
\item Gattuso JJ, Wilson C, Hannan AJ, Renoir T. (2023). \textit{Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/jnc.16017}{doi:10.1111/jnc.16017}.
\item Geyer MA. (2023). \textit{A Brief Historical Overview of Psychedelic Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bpsc.2023.11.003}{doi:10.1016/j.bpsc.2023.11.003}.
\item Tasker NR, Pazur EJ, Wipf P. (2023). \textit{Biological studies of clavine alkaloids targeting CNS receptors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2023.1286941}{doi:10.3389/fpsyt.2023.1286941}.
\item Tor-Morten Kvam, Malin V. Uthaug, Kristoffer Andreas Aamodt Andersen, Birk Berggrav Refsum, Paula Aarseth Tunstad, Lowan H. Stewart, Henrik Børsting Jacobsen, Cato Grønnerød (2023). \textit{Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1287196}{doi:10.3389/fpsyt.2023.1287196}.
\item Raj P, Rauniyar S, Sapkale B. (2023). \textit{Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.48719}{doi:10.7759/cureus.48719}.
\item Heresco-Levy U, Lerer B. (2023). \textit{Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-023-02312-8}{doi:10.1038/s41380-023-02312-8}.
\item Chruścicka-Smaga B, Machaczka A, Szewczyk B, Pilc A. (2023). \textit{Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00547-4}{doi:10.1007/s43440-023-00547-4}.
\item Wojtas A. (2023). \textit{The possible place for psychedelics in pharmacotherapy of mental disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00550-9}{doi:10.1007/s43440-023-00550-9}.
\item Ana-Maria Iorgu, Andrei-Nicolae Vasilescu, Natascha Pfeiffer, Rainer Spanagel, Anne Stephanie Mallien, Dragoš Inta, Peter Gass (2023). \textit{Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney’s lesions}. European Archives of Psychiatry and Clinical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1007/s00406-023-01699-3}{doi:10.1007/s00406-023-01699-3}.
\item Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A. (2023). \textit{Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.1384-23.2023}{doi:10.1523/jneurosci.1384-23.2023}.
\item Banushi B, Polito V (2023). \textit{A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics.}. Biology. [published; PubMed]. \href{https://doi.org/10.3390/biology12111380}{doi:10.3390/biology12111380}.
\item Jules Evans, Oliver Robinson, Eirini K. Argyri, Shayam Suseelan, Ashleigh Murphy-Beiner, Rosalind McAlpine, David Luke, Katrina Michelle, Ed Prideaux (2023). \textit{Extended difficulties following the use of psychedelic drugs: A mixed methods study}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0293349}{doi:10.1371/journal.pone.0293349}.
\item Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maeda K, González-Maeso J, Kitagaki S, Hiramatsu M. (2023). \textit{Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00210-023-02778-x}{doi:10.1007/s00210-023-02778-x}.
\item Wsół A. (2023). \textit{Cardiovascular safety of psychedelic medicine: current status and future directions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s43440-023-00539-4}{doi:10.1007/s43440-023-00539-4}.
\item Rakoczy RJ, Runge GN, Sen AK, Sandoval O, Nguyen Q, Roberts BR, Sciortino JH, Gibbons WJ, Friedberg LM, Andrew Jones J, McMurray MS. (2023). \textit{Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.19.563138}{doi:10.1101/2023.10.19.563138}.
\item Arya Rahbarnia, Zhaoxia Li, Paul Fletcher (2023). \textit{Effects of psilocybin, the 5-HT2A receptor agonist TCB-2, and the 5-HT2A receptor antagonist M100907 on visual attention in male mice in the continuous performance test}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-023-06474-9}{doi:10.1007/s00213-023-06474-9}.
\item Watford T, Masood N. (2023). \textit{Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.9758/cpn.23.1120}{doi:10.9758/cpn.23.1120}.
\item Nathalie M. Rieser, Ladina P Gubser, Flora Moujaes, Patricia Duerler, Candace R. Lewis, Lars Michels, Franz X. Vollenweider, Katrin H. Preller (2023). \textit{Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-023-44153-z}{doi:10.1038/s41598-023-44153-z}.
\item Anna Douglas, Daniel Staas, Anna Hampton, Kylie Burns, F. Suter (2023). \textit{Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future}. Georgetown Scientific Research Journal. [published; OpenAlex]. \href{https://doi.org/10.48091/gsr.v3i2.62}{doi:10.48091/gsr.v3i2.62}.
\item Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML. (2023). \textit{Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.10.06.561183}{doi:10.1101/2023.10.06.561183}.
\item Robert H. Dworkin, Michael McDermott, Sandeep M. Nayak, Eric C. Strain (2023). \textit{Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?}. Clinical Pharmacology \& Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1002/cpt.3050}{doi:10.1002/cpt.3050}.
\item C Donegan, Dimitri Daldegan-Bueno, Rachael L. Sumner, David B Menkes, William J. Evans, Nicholas Hoeh, Frederick Sundram, Lisa Reynolds, Rhys Ponton, Alana Cavadino, Todd Smith, Partha S. Roop, Nathan Allen, Binu Abeysinghe, Darren Svirskis, Anna Forsyth, Mahima Bansal, Suresh Muthukumaraswamy (2023). \textit{An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)}. Pilot and Feasibility Studies. [published; OpenAlex]. \href{https://doi.org/10.1186/s40814-023-01399-8}{doi:10.1186/s40814-023-01399-8}.
\item Unknown authors (2023). \textit{Psilocybin shows promising results in subjects continuing to use an antidepressant}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.31089}{doi:10.1002/pu.31089}.
\item Chloé Galipeau, Miguel Farinha-Ferreira, Jean-Charles Mariani, Samuel Diebolt, Louis Barthe, Renata Santos, Zsolt Lenkei, Ana M. Sebastião (2023). \textit{UNRAVELLING THE ROLE OF5-HT2AR ACTIVATION IN THE LONG-LASTING BEHAVIORAL EFFECTS OF PSILOCYBIN}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1116}{doi:10.1016/j.ibneur.2023.08.1116}.
\item Aneta Petrušková, Eva-Maria Weiss, Debarpan Guhathakurta, Enes Yağız Akdaş, Bartomeu Perelló, Renato Frischknecht, Tomáš Páleníček, Anna Fejtová (2023). \textit{MODULATION OF SYNAPTIC FUNCTION AND NEURONAL NETWORK ACTIVITY BY SEROTONERGIC PSYCHEDELICS}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.608}{doi:10.1016/j.ibneur.2023.08.608}.
\item Ines Erkizia-Santamaría, J. Javier Meana, Igor Horrillo, Jorge E. Ortega (2023). \textit{PSILOCYBIN EXERTS ANTIDEPRESSANT EFFECTS IN A CHRONIC UNPREDICTABLE MILD STRESS (CUMS) ANIMAL MODEL}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1097}{doi:10.1016/j.ibneur.2023.08.1097}.
\item Amanda E. Downey (2023). \textit{6.3 Psilocybin Therapy for the Treatment of Young Adults With Anorexia Nervosa: State of the Research}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2023.07.666}{doi:10.1016/j.jaac.2023.07.666}.
\item Kevin M. Gray, Paul E. Croarkin (2023). \textit{Psychedelics as Therapeutics: Research Advances and Implications for Practice}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2023.07.1001}{doi:10.1016/j.jaac.2023.07.1001}.
\item Čestmír Vejmola, Kateřina Syrová, Klára Šíchová, Vlastimil Koudelka, Jan Hubený, Tereza Klučková, M. Nikolič, Eduard Kelemen, Tomáš Páleníček (2023). \textit{CROSS-SPECIES EVIDENCE FOR PSILOCIN-INDUCED VISUAL HALLUCINATIONS: RATS PERCEIVE QUALITATIVELY SIMILAR CHANGES AS HUMANS}. IBRO Neuroscience Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ibneur.2023.08.1471}{doi:10.1016/j.ibneur.2023.08.1471}.
\item Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H, Ladha KS. (2023). \textit{Use of Psychedelics for Pain: A Scoping Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/aln.0000000000004673}{doi:10.1097/aln.0000000000004673}.
\item Wall MB, Harding R, Zafar R, Rabiner EA, Nutt DJ, Erritzoe D. (2023). \textit{Neuroimaging in psychedelic drug development: past, present, and future.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41380-023-02271-0}{doi:10.1038/s41380-023-02271-0}.
\item Chiu Y, Deutch AY, Wang W, Schmitz GP, Huang KL, Kocak DD, Llorach P, Bowyer K, Liu B, Sciaky N, Hua K, Chen C, Mott SE, Niehaus J, DiBerto JF, English J, Walsh JJ, Scherrer G, Herman MA, Wu Z, Wetsel WC, Roth BL. (2023). \textit{A suite of engineered mice for interrogating psychedelic drug actions}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.09.25.559347}{doi:10.1101/2023.09.25.559347}.
\item Sierra Carter, Grace Packard, Callan Coghlan, Jamilah R. George, Ashanti J. Brown, Terence H. W. Ching, Jacob Julian, Jessica L. Maples-Keller (2023). \textit{Perceptions of psychedelic-assisted therapy among Black Americans}. Journal of Mood and Anxiety Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.xjmad.2023.100023}{doi:10.1016/j.xjmad.2023.100023}.
\item Thomas J. Kelly, Emma M. Bonniwell, Lianwei Mu, Xiaojie Liu, Ying Hu, Vladislav Friedman, Hao Yu, Wantang Su, John D. McCorvy, Qing-song Liu (2023). \textit{Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-023-01744-8}{doi:10.1038/s41386-023-01744-8}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Maćkowiak M, Gołembiowska K. (2023). \textit{Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202309.1649.v1}{doi:10.20944/preprints202309.1649.v1}.
\item Padawer-Curry JA, Krentzman OJ, Kuo C, Wang X, Bice AR, Nicol GE, Snyder AZ, Siegel JS, McCall JG, Bauer AQ. (2023). \textit{Psychedelic 5-HT2A receptor agonism: neuronal signatures and altered neurovascular coupling.}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.09.23.559145}{doi:10.1101/2023.09.23.559145}.
\item Mitch Earleywine, Maha N. Mian, Joseph A. De Leo (2023). \textit{Expectancies for Subjective and Antidepressant Effects in Psilocybin Users}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678231194798}{doi:10.1177/00221678231194798}.
\item Haniya J. Halim, Bradley G. Burk, Rachel E. Fargason, Badari Birur (2023). \textit{Manic episode following psilocybin use in a man with bipolar II disorder: a case report}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1221131}{doi:10.3389/fpsyt.2023.1221131}.
\item Milan Scheidegger (2023). \textit{Mindfulness and Psychedelics: A Combined Neurophenomenological and Pharmacological Approach to the Characterization of Mindfulness States in Experienced Meditators}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05780216}{source link}.
\item University of Zurich (2023). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04141501}{source link}.
\item Richa Tyagi, Tanishka S. Saraf, Clinton E. Canal (2023). \textit{The Psychedelic N,N-Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.3c00137}{doi:10.1021/acsptsci.3c00137}.
\item Guy M. Goodwin (2023). \textit{The psychedelic experience and treatment-resistant depression}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.21140}{doi:10.1002/wps.21140}.
\item Kargbo RB. (2023). \textit{Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.3c00390}{doi:10.1021/acsmedchemlett.3c00390}.
\item Chen Xue, Jing Li, Lisa Yu, Francesca Maule, Li-Mei Chang, Jonathan Gallant, David J. Press, Sheetal A. Raithatha, Jillian M. Hagel, Peter J. Facchini (2023). \textit{A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines}. Journal of Biological Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jbc.2023.105231}{doi:10.1016/j.jbc.2023.105231}.
\item Lawrence Canale, Dhvanit Raval, Preet Chatha, Katie Penn, Claudia Weber, Catherine Stout, Jeremy Weleff (2023). \textit{Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training}. American Journal of Psychiatry Residents Journal. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp-rj.2023.190103}{doi:10.1176/appi.ajp-rj.2023.190103}.
\item Natasha L. Mason, Attila Szabó, Kim P. C. Kuypers, Pablo Mallaroni, R. de la Torre Fornell, Johannes T. Reckweg, Desmond H. Y. Tse, Nadia R. P. W. Hutten, Amanda Feilding, Johannes G. Ramaekers (2023). \textit{Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study}. Brain Behavior and Immunity. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bbi.2023.09.004}{doi:10.1016/j.bbi.2023.09.004}.
\item Sofia Audrey B. Gonzales, Christine Alexopoulos, Daniel G. Arkfeld (2023). \textit{Potential Benefits of Psilocybin for Lupus Pain: A Case Report}. Current Rheumatology Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/1573397119666230904150750}{doi:10.2174/1573397119666230904150750}.
\item Kat F. Kiilerich, Joe Lorenz, Malthe B. Scharff, Nikolaj Speth, T Brandt, Julia Czurylo, Mengfei Xiong, Naja S. Jessen, Agata Casado-Sainz, Vladimir Shalgunov, Celia Kjærby, Grzegorz Satała, Andrzej J. Bojarski, Anders A. Jensen, Matthias M. Herth, Paul Cumming, Agnete Overgaard, Mikael Palner (2023). \textit{Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats}. Molecular Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1038/s41380-023-02280-z}{doi:10.1038/s41380-023-02280-z}.
\item David W. Lawrence (2023). \textit{Self-administration of Psilocybin for the Acute Treatment of Migraine: A Case Report.}. PubMed. [published; OpenAlex]. \href{https://pubmed.ncbi.nlm.nih.gov/37817818}{source link}.
\item Kalfas M, Taylor RH, Tsapekos D, Young AH. (2023). \textit{Psychedelics for treatment resistant depression: are they game changers?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14656566.2023.2281582}{doi:10.1080/14656566.2023.2281582}.
\item Evelyn Attia, Joanna Steinglass (2023). \textit{Psilocybin for anorexia nervosa: If it helps, let’s learn how}. Med. [published; OpenAlex]. \href{https://doi.org/10.1016/j.medj.2023.08.003}{doi:10.1016/j.medj.2023.08.003}.
\item Alexsandra Kovacevich, Jeremy Weleff, Benjamin Claytor, Brian S. Barnett (2023). \textit{Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2023.2253538}{doi:10.1080/02791072.2023.2253538}.
\item David S. Mathai, Samantha Hilbert, Nathan D. Sepeda, Justin C. Strickland, Roland R. Griffiths, Albert Garcia-Romeu (2023). \textit{Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2023.0035}{doi:10.1089/psymed.2023.0035}.
\item Natália Bernardi Videira, Vijayalekshmi Nair, Valérie Paquet, Dean Calhoun (2023). \textit{The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits}. Journal of Applied Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1002/jat.4533}{doi:10.1002/jat.4533}.
\item Xuehan Du (2023). \textit{Pharmacology and Therapeutic Effects of Psilocybin}. Highlights in Science Engineering and Technology. [published; OpenAlex]. \href{https://doi.org/10.54097/hset.v65i.11331}{doi:10.54097/hset.v65i.11331}.
\item Marilia Santoro Cardoso, Kelly Francisco da Cunha, Izabelly Geraldes Silva, Taís Regina Fiorentin, Eduardo Geraldo de Campos, José Luiz Costa (2023). \textit{Development and validation of a sensitive LC-MS-MS method to quantify psilocin in authentic oral fluid samples}. Journal of Analytical Toxicology. [published; OpenAlex]. \href{https://doi.org/10.1093/jat/bkad064}{doi:10.1093/jat/bkad064}.
\item Wong S, Yu AY, Fabiano N, Finkelstein O, Pasricha A, Jones BDM, Rosenblat JD, Blumberger DM, Mulsant BH, Husain MI. (2023). \textit{Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2251133}{doi:10.1080/02791072.2023.2251133}.
\item Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, Austin J. Mallard, Daniel E. Roberts, David Erritzøe, Stephen Ross, Robin Carhart-Harris (2023). \textit{Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-023-40856-5}{doi:10.1038/s41598-023-40856-5}.
\item Benjamin M. Ross, James T. Neill (2023). \textit{Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapy}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2023.00264}{doi:10.1556/2054.2023.00264}.
\item Joseph J. Palamar, Caroline Rutherford, Austin Le, Katherine M. Keyes (2023). \textit{Seasonal Variation of Use of Common Psychedelics and Party Drugs Among Nightclub/Festival Attendees in New York City}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2023.2240322}{doi:10.1080/02791072.2023.2240322}.
\item Robinson GI, Li D, Wang B, Zahoruiko Y, Gerasymchuk M, Hudson D, Kovalchuk O, Kovalchuk I. (2023). \textit{Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cimb45080427}{doi:10.3390/cimb45080427}.
\item Tagen M, Mantuani D, van Heerden L, Holstein A, Klumpers LE, Knowles R. (2023). \textit{The risk of chronic psychedelic and MDMA microdosing for valvular heart disease.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811231190865}{doi:10.1177/02698811231190865}.
\item Grant Jones, Felipe Herrmann, Erica Wang (2023). \textit{Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use}. Addictive Behaviors Reports. [published; OpenAlex]. \href{https://doi.org/10.1016/j.abrep.2023.100513}{doi:10.1016/j.abrep.2023.100513}.
\item Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X (2023). \textit{A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms241512513}{doi:10.3390/ijms241512513}.
\item N. Jones, Zarmeen Zahid, Sean M. Grady, Ziyad W. Sultan, Zhen Zheng, John A. Razidlo, Matthew I. Banks, Cody J. Wenthur (2023). \textit{Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in Mice}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.3c00123}{doi:10.1021/acsptsci.3c00123}.
\item Terri D’Arrigo (2023). \textit{Med Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and Lumryz}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.08.8.3}{doi:10.1176/appi.pn.2023.08.8.3}.
\item Lin M, Lee H, Tsang V, Chai B, Howard A, Uy C, Elefante J. (2023). \textit{Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC10434693}{source link}.
\item Nicolas Garel, Julien Thibault Lévesque, Dasha A. Sandra, Justin Lessard-Wajcer, Elizaveta Solomonova, Michael Lifshitz, Stéphane Richard-Devantoy, Kyle T. Greenway (2023). \textit{Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings}. Frontiers in Human Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnhum.2023.1200393}{doi:10.3389/fnhum.2023.1200393}.
\item Nkadimeng SM, Hay L, Steinmann CM, Eloff JN. (2023). \textit{Administration effects of four psilocybin mushroom extracts on serotonin levels and endothelial nitric oxide synthase activity levels in vivo and in vitro after one hour}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3088850/v1}{doi:10.21203/rs.3.rs-3088850/v1}.
\item Alan K. Davis, Christopher Timmermann, Ana María Ortiz Bernal, Rafael Lancelotta, Sandeep M. Nayak, Nathan D. Sepeda, Aki Nikolaidis, Roland R. Griffiths (2023). \textit{Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2023.2232379}{doi:10.1080/02791072.2023.2232379}.
\item Guy M. Goodwin, Megan Croal, David Feifel, John R. Kelly, Lindsey Marwood, Sunil Mistry, Veronica O’Keane, Stéphanie Knatz Peck, Hollie Simmons, Claudia Sisa, S. C. Stansfield, Joyce Tsai, Sam Williams, Ekaterina Malievskaia (2023). \textit{Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-023-01648-7}{doi:10.1038/s41386-023-01648-7}.
\item Guy M. Goodwin, Ekaterina Malievskaia, Gregory A. Fonzo, Charles B. Nemeroff (2023). \textit{Must Psilocybin Always “Assist Psychotherapy”?}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.20221043}{doi:10.1176/appi.ajp.20221043}.
\item Jim Gilligan (2023). \textit{Leveraging psychedelic therapies for binge eating disorder}. Open Access Government. [published; OpenAlex]. \href{https://doi.org/10.56367/oag-039-10936}{doi:10.56367/oag-039-10936}.
\item Chernoff T, Kliger B, Venturini DH. (2023). \textit{Psychedelic Experiences: Phenomenology, Therapeutic Potentials and Explanatory Models}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.53680/vertex.v34i160.463}{doi:10.53680/vertex.v34i160.463}.
\item Takaba R, Ibi D, Yoshida K, Hosomi E, Kawase R, Kitagawa H, Goto H, Achiwa M, Mizutani K, Maede K, González-Maeso J, Kitagaki S, Hiramatsu M. (2023). \textit{Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-3138705/v1}{doi:10.21203/rs.3.rs-3138705/v1}.
\item Cybin Therapeutics Inc. (2023). \textit{Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05594667}{source link}.
\item Scott R. Walker, Glenn A. Pullella, Matthew Piggott, Peter J. Duggan (2023). \textit{Introduction to the chemistry and pharmacology of psychedelic drugs}. Australian Journal of Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1071/ch23050}{doi:10.1071/ch23050}.
\item McIntyre RS. (2023). \textit{Serotonin 5-HT2B receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14740338.2023.2248883}{doi:10.1080/14740338.2023.2248883}.
\item Muhammad Ishrat Husain, Daniel M. Blumberger, David Castle, Nicole Ledwos, Elise Fellows, Brett D. M. Jones, Abigail Ortiz, Stefan Kloiber, Wei Wang, Joshua D. Rosenblat, Benoit H. Mulsant (2023). \textit{Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2023.535}{doi:10.1192/bjo.2023.535}.
\item Scala M, Fanelli G, De Ronchi D, Serretti A, Fabbri C. (2023). \textit{Clinical specificity profile for novel rapid acting antidepressant drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/yic.0000000000000488}{doi:10.1097/yic.0000000000000488}.
\item Halucenex Life Sciences Inc. (2023). \textit{Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05243329}{source link}.
\item Lee HJ, Tsang VW, Chai BS, Lin MC, Howard A, Uy C, Elefante JO. (2023). \textit{Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2023.2223195}{doi:10.1080/02791072.2023.2223195}.
\item Terri D’Arrigo (2023). \textit{Experts Offer Tips on Talking With Patients About Psychedelics}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.07.7.51}{doi:10.1176/appi.pn.2023.07.7.51}.
\item Nick Zagorski (2023). \textit{Psychedelic Therapy Requires Enhanced Consent Discussions}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.07.7.46}{doi:10.1176/appi.pn.2023.07.7.46}.
\item Vojin Rakić (2023). \textit{Psilocybin: The most effective moral bio-enhancer?}. Bioethics. [published; OpenAlex]. \href{https://doi.org/10.1111/bioe.13196}{doi:10.1111/bioe.13196}.
\item Simon Zhornitsky, Henrique Nunes Pereira Oliva, Laura A. Jayne, AZA Stephen Allsop, Alfred P. Kaye, Marc N. Potenza, Gustavo A. Angarita (2023). \textit{Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1197890}{doi:10.3389/fpsyt.2023.1197890}.
\item Chen T, Cheng L, Ma J, Yuan J, Pi C, Xiong L, Chen J, Liu H, Tang J, Zhong Y, Zhang X, Liu Z, Zuo Y, Shen H, Wei Y, Zhao L. (2023). \textit{Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.phrs.2023.106837}{doi:10.1016/j.phrs.2023.106837}.
\item Filip Tylš, Čestmír Vejmola, Vlastimil Koudelka, Václava Piorecká, L. Kadeřábek, Marcel Bochin, Tomáš Novák, Martin Kuchař, Zdeňka Bendová, Martin Brunovský, Jiřı́ Horáček, Tomáš Pálení ček (2023). \textit{Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2023.1152578}{doi:10.3389/fnins.2023.1152578}.
\item M. Nikolič, Vojtěch Viktorin, Peter Zach, Filip Tylš, Daniela Dudysová, Karolína Janků, Jana Kopřivová, Martin Kuchař, Martin Brunovský, Jiřı́ Horáček, Tomáš Páleníček (2023). \textit{Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2023.04.019}{doi:10.1016/j.euroneuro.2023.04.019}.
\item Romain Nardou, Edward J. Sawyer, Young Jun Song, M. F. Wilkinson, Yasmin Padovan-Hernandez, Júnia L. de Deus, Noelle Wright, Carine Lama, Sehr Faltin, Loyal A. Goff, Genevieve Stein-O’Brien, Gül Dölen (2023). \textit{Psychedelics reopen the social reward learning critical period}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/s41586-023-06204-3}{doi:10.1038/s41586-023-06204-3}.
\item Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C, Golkowski D, Ranft A, Ilg R, Jordan D, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Alnagger NLN, Cardone P, Peattie ARD, Manktelow AE, de Araujo DB, Sensi SL, Owen AM, Naci L, Menon DK, Misic B, Stamatakis EA. (2023). \textit{In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/sciadv.adf8332}{doi:10.1126/sciadv.adf8332}.
\item O'Grady C. (2023). \textit{No trip needed for psychedelics to lift mood?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.adj1031}{doi:10.1126/science.adj1031}.
\item Natalie Gukasyan, Roland R. Griffiths, David B. Yaden, Denis Antoine, Sandeep M. Nayak (2023). \textit{Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811231179910}{doi:10.1177/02698811231179910}.
\item Katherine M. Keyes, Megan E. Patrick (2023). \textit{Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.16259}{doi:10.1111/add.16259}.
\item Nkadimeng SM, Steinmann CM, Eloff JN. (2023). \textit{Cardioprotective Potential of the Ethanol and Water Extracts of Four Psilocybin Mushrooms on Angiotensin II-Induced Hypertrophy and Oxidative Stress on H9C2 Cardiomyocytes}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202306.0362.v1}{doi:10.20944/preprints202306.0362.v1}.
\item Wall MB, Demetriou L, Giribaldi B, Roseman L, Ertl N, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2023). \textit{Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.05.29.23290667}{doi:10.1101/2023.05.29.23290667}.
\item Tooba Noor, Areej Shakil, Aimen Waqar Khan, Syeda Mahrukh Fatima Zaidi, Hussain Sohail Rangwala, Burhanuddin Sohail Rangwala (2023). \textit{Psilocybin therapy: A novel approach to treating depression}. International Journal of Surgery Global Health. [published; OpenAlex]. \href{https://doi.org/10.1097/gh9.0000000000000175}{doi:10.1097/gh9.0000000000000175}.
\item Federica Benvenuti, Daniele Colombo, Laura Soverchia, Nazzareno Cannella, Esi Domi, Roberto Ciccocioppo (2023). \textit{Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-023-06384-w}{doi:10.1007/s00213-023-06384-w}.
\item Brandon Weiss, Induni Ginige, Lu Shannon, Bruna Giribaldi, Ashleigh Murphy-Beiner, Roberta Murphy, Michelle Baker-Jones, Jonny Martell, David Nutt, Robin Carhart-Harris, David Erritzøe (2023). \textit{Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression}. Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/s0033291723001514}{doi:10.1017/s0033291723001514}.
\item Rafael Moliner, Mykhailo Girych, Cecilia A. Brunello, Vera Kovaleva, Caroline Biojone, Giray Enkavi, Lina Antenucci, Erik F. Kot, Sergey A. Goncharuk, Katja Kaurinkoski, Mirjami Kuutti, Senem Merve Fred, Lauri Elsilä, Sven Sakson, Cecilia Cannarozzo, Cassiano R.A.F. Diniz, Nina Seiffert, Anna Rubiolo, Hele Haapaniemi, Elsa Meshi, Elina Nagaeva, Tiina Öhman, Tomasz Róg, Esko Kankuri, Marçal Vilar, Markku Varjosalo, Esa R. Korpi, Perttu Permi, Константин С. Минеев, Märt Saarma, Ilpo Vattulainen, Plínio Casarotto, Eero Ċastrén (2023). \textit{Psychedelics promote plasticity by directly binding to BDNF receptor TrkB}. Nature Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1038/s41593-023-01316-5}{doi:10.1038/s41593-023-01316-5}.
\item James Rucker (2023). \textit{Evidence versus expectancy: the development of psilocybin therapy}. BJPsych Bulletin. [published; OpenAlex]. \href{https://doi.org/10.1192/bjb.2023.28}{doi:10.1192/bjb.2023.28}.
\item Whelan TP, Daly E, Puts NA, Malievskaia E, Murphy DG, McAlonan GM. (2023). \textit{Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autism}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2023.05.25.23290521}{doi:10.1101/2023.05.25.23290521}.
\item Laura Ley, Friederike Holze, Denis Arikci, A. Becker, Isabelle Straumann, Aaron Klaiber, Fabio Coviello, Sophie Dierbach, Jan Thomann, Urs Duthaler, Dino Luethi, Nimmy Varghese, Anne Eckert, Matthias E. Liechti (2023). \textit{Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-023-01607-2}{doi:10.1038/s41386-023-01607-2}.
\item Junhong Liu, Yuanyuan Wang, Ke Xia, Jinfeng Wu, Danhao Zheng, Aoling Cai, Haitao Yan, Ruibin Su (2023). \textit{Acute psilocybin increased cortical activities in rats}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2023.1168911}{doi:10.3389/fnins.2023.1168911}.
\item Catharine Carfagno, M Vest, Kevin S. Murnane, Kariann Lamon, Bo Jarrett Wood (2023). \textit{Characterization of Novel Tryptamines’ Anxiolytic and Anti-Inflammatory Effects in Relation to their Psychoactive Effects}. Journal of Pharmacology and Experimental Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1124/jpet.122.192360}{doi:10.1124/jpet.122.192360}.
\item Raithatha SA, Hagel JM, Matinkhoo K, Yu L, Press D, Cook SG, Sharma G, D D, Jensen G, Lee JB, Cai C, Gallant J, Bains JS, Tucker JE, Facchini PJ. (2023). \textit{Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disorders}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.05.16.540994}{doi:10.1101/2023.05.16.540994}.
\item Meyer M, Slot J. (2023). \textit{The evolution and ecology of psilocybin in nature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.fgb.2023.103812}{doi:10.1016/j.fgb.2023.103812}.
\item Singleton SP, Timmermann C, Luppi AI, Eckernäs E, Roseman L, Carhart-Harris RL, Kuceyeski A. (2023). \textit{Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.05.11.540409}{doi:10.1101/2023.05.11.540409}.
\item Kargbo RB. (2023). \textit{Microbiome-Gut-Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acsmedchemlett.3c00168}{doi:10.1021/acsmedchemlett.3c00168}.
\item Suhwoo Bae, Michael Vaysblat, Edward Jong Bae, Ilja Dejanovic, Matthew Pierce (2023). \textit{Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis}. Cureus. [published; OpenAlex]. \href{https://doi.org/10.7759/cureus.38669}{doi:10.7759/cureus.38669}.
\item Goodwin GM, Croal M, Marwood L, Malievskaia E (2023). \textit{Unblinding and demand characteristics in the treatment of depression.}. Journal of affective disorders. [published; PubMed]. \href{https://doi.org/10.1016/j.jad.2023.02.030}{doi:10.1016/j.jad.2023.02.030}.
\item Elisabeth Jean Wood (2023). \textit{Psychedelic Sensationalism: An Analysis of the Schedule Classification of Psilocybin}. Vanderbilt Undergraduate Research Journal. [published; OpenAlex]. \href{https://doi.org/10.15695/vurj.v13i1.5403}{doi:10.15695/vurj.v13i1.5403}.
\item Braun D, Rosenberg A, Haruvi R, Malamud D, Barbara R, Kawashima T. (2023). \textit{High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.04.13.536830}{doi:10.1101/2023.04.13.536830}.
\item David Nutt (2023). \textit{Psychedelic Medicine: From Brain Science to Clinical Trials}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.022}{doi:10.1016/j.biopsych.2023.02.022}.
\item Jonah H. Shepherd, Caitlin Baten, Amanda M. Klassen, Gladys Zamora, Sarah Saravia, Elizabeth Pritchard, Zulaikha Ali, Saneh K. Kahlon, Kyla Whitelock, Fabiola A. Reyes, Dawson H. Hedges, J. Paul Hamilton, Matthew D. Sacchet, Chris H. Miller (2023). \textit{509. Meta-Analysis of Functional Neuroimaging Studies of the Effects of Serotonergic Psychedelics on Neural Activity}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.749}{doi:10.1016/j.biopsych.2023.02.749}.
\item Aron Amaev, Jianmeng Song, Yasaman Kambari, Fumihiko Ueno, Edgardo Torres-Carmona, Ali Abdolizadeh, Teruki Koizumi, Vincenzo De Luca, Bruce G. Pollock, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen (2023). \textit{118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.358}{doi:10.1016/j.biopsych.2023.02.358}.
\item Xi Zhu, David J. Hellerstein, Jamie D. Feusner, Michael G. Wheaton, Gloria Gómez, Franklin R. Schneier (2023). \textit{347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic Disorder}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2023.02.587}{doi:10.1016/j.biopsych.2023.02.587}.
\item Ort A, Smallridge JW, Sarasso S, Casarotto S, von Rotz R, Casanova A, Seifritz E, Preller KH, Tononi G, Vollenweider FX. (2023). \textit{TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.isci.2023.106589}{doi:10.1016/j.isci.2023.106589}.
\item Jianmeng Song, Yasaman Kambari, Aron Amaev, Fumihiko Ueno, Edgardo Torres Carmona, Vincenzo De Luca, Bruce G. Pollock, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen (2023). \textit{Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment}. Medical Hypotheses. [published; OpenAlex]. \href{https://doi.org/10.1016/j.mehy.2023.111068}{doi:10.1016/j.mehy.2023.111068}.
\item Yingjie Du, Yunfeng Li, Xiangting Zhao, Yishan Yao, Bin Wang, Liming Zhang, Guyan Wang (2023). \textit{Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity}. Chinese Medical Journal. [published; OpenAlex]. \href{https://doi.org/10.1097/cm9.0000000000002647}{doi:10.1097/cm9.0000000000002647}.
\item University Hospital, Basel, Switzerland (2023). \textit{Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04849013}{source link}.
\item Ibi D. (2023). \textit{[Contribution of serotonin 5-HT2A receptor to antidepressant effect of serotonergic psychedelics].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1254/fpj.22141}{doi:10.1254/fpj.22141}.
\item Franklin R. Schneier, Jamie D. Feusner, Michael G. Wheaton, Gloria J. Gomez, Giselle Cornejo, Akansha M. Naraindas, David J. Hellerstein (2023). \textit{Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder}. Journal of Psychiatric Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jpsychires.2023.03.031}{doi:10.1016/j.jpsychires.2023.03.031}.
\item Domanegg K, Sommer WH, Meinhardt MW. (2023). \textit{Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cells12060963}{doi:10.3390/cells12060963}.
\item New York State Psychiatric Institute (2023). \textit{Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04656301}{source link}.
\item Wulff AB, Nichols CD, Thompson SM. (2023). \textit{Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2023.109504}{doi:10.1016/j.neuropharm.2023.109504}.
\item Grant C. Glatfelter, Marilyn Naeem, Duyen N. K. Pham, James A. Golen, A.R. Chadeayne, David R. Manke, Michael H. Baumann (2023). \textit{Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.2c00222}{doi:10.1021/acsptsci.2c00222}.
\item Chen MH, Tu PC, Su TP. (2023). \textit{Next generation antidepressants with novel mechanisms for treatment resistant depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2023.02.005}{doi:10.1016/bs.pbr.2023.02.005}.
\item Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett, Laura Labay, James Mullally, Alexander M. Sherwood, Frank Wiegand (2023). \textit{Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?}. Clinical Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1093/clinchem/hvad016}{doi:10.1093/clinchem/hvad016}.
\item Kalkman HO (2023). \textit{Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles.}. Biomedicines. [published; PubMed]. \href{https://doi.org/10.3390/biomedicines11030806}{doi:10.3390/biomedicines11030806}.
\item Shi En Kim (2023). \textit{How psychedelics spark neuronal growth}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10108-scicon1}{doi:10.1021/cen-10108-scicon1}.
\item Emma I Kopra, Jason Ferris, Adam Winstock, Kim P. C. Kuypers, Allan H. Young, James Rucker (2023). \textit{Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811231158245}{doi:10.1177/02698811231158245}.
\item Lazur J, Hnatyk K, Kała K, Sułkowska-Ziaja K, Muszyńska B. (2023). \textit{Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/antiox12030623}{doi:10.3390/antiox12030623}.
\item J. H. Shepherd, C.T.M. Baten, A. C. Klassen, G. Zamora, Sarah Saravia, Elizabeth Pritchard, Ziad A. Ali, S. K. Kahlon, Kyla Whitelock, F. A. Reyes, D. W. Hedges, J. Paul Hamilton, Matthew D. Sacchet, Chris H. Miller (2023). \textit{The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging Studies}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2023.1948}{doi:10.1192/j.eurpsy.2023.1948}.
\item Zohairi F, Khandelia H, Hakami Zanjani AA (2023). \textit{Interaction of psychedelic tryptamine derivatives with a lipid bilayer.}. Chemistry and physics of lipids. [published; PubMed]. \href{https://doi.org/10.1016/j.chemphyslip.2023.105279}{doi:10.1016/j.chemphyslip.2023.105279}.
\item Anne Karow (2023). \textit{Psychedelische Therapie mit Psilocybin und Psychotherapie - Wo stehen wir?}. PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-2010-7640}{doi:10.1055/a-2010-7640}.
\item Daniel A Kinderlehrer (2023). \textit{The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study}. International Medical Case Reports Journal. [published; OpenAlex]. \href{https://doi.org/10.2147/imcrj.s395342}{doi:10.2147/imcrj.s395342}.
\item Meghan Hibicke, Hannah M. Kramer, Charles D. Nichols (2023). \textit{A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression}. Psychedelic Medicine. [published; OpenAlex]. \href{https://doi.org/10.1089/psymed.2022.0012}{doi:10.1089/psymed.2022.0012}.
\item Stephanie Karzon Abrams, Brenden Samuel Rabinovitch, Rayyan Zafar, Aly Shah Aziz, Nicholas P. Cherup, David W. McMillan, Jessica L. Nielson, Evan Lewis (2023). \textit{Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics}. Neurotrauma Reports. [published; OpenAlex]. \href{https://doi.org/10.1089/neur.2023.0022}{doi:10.1089/neur.2023.0022}.
\item 飯倉 洋治, 馬場 實, 三河 春樹, 西間 三馨, 前田 和一, 赤坂 徹, 正木 拓朗, 有田 昌彦 (2023). \textit{Effect of psilocybin on decision-making and motivation in the healthy rat.}. PubMed. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bbr.2022.114262}{doi:10.1016/j.bbr.2022.114262}.
\item Jacques Ambrose, J.S. Zabinski (2023). \textit{Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.03.3.43}{doi:10.1176/appi.pn.2023.03.3.43}.
\item Terri D’Arrigo (2023). \textit{Psychedelics Legislation Gains Momentum}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2023.03.3.4}{doi:10.1176/appi.pn.2023.03.3.4}.
\item Ashish Sarangi, Omotola Akinkunmi (2023). \textit{Psychedelics for the Neuropsychiatric Symptoms of Alzheimer's disease}. American Journal of Geriatric Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jagp.2022.12.201}{doi:10.1016/j.jagp.2022.12.201}.
\item Yahong Chen, Junhong Liu, Yishan Yao, Haitao Yan, Ruibin Su (2023). \textit{Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2023.1021729}{doi:10.3389/fphar.2023.1021729}.
\item Grant Jones, Joshua Lipson, Erica Wang (2023). \textit{Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-023-29763-x}{doi:10.1038/s41598-023-29763-x}.
\item Jennings Hernandez (2023). \textit{Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental Health}. Advances in Research. [published; OpenAlex]. \href{https://doi.org/10.9734/air/2023/v24i1931}{doi:10.9734/air/2023/v24i1931}.
\item Washington University School of Medicine (2023). \textit{SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05601648}{source link}.
\item Nadav Liam Modlin, Tammy M. Miller, James Rucker, Namik Kirlić, Molly Lennard-Jones, Danielle Schlosser, Scott T. Aaronson (2023). \textit{Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2023.01.077}{doi:10.1016/j.jad.2023.01.077}.
\item Deborah Rudin, Alexander Areesanan, Matthias E. Liechti, Carsten Gründemann (2023). \textit{Classic psychedelics do not affect T cell and monocyte immune responses}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2023.1042440}{doi:10.3389/fpsyt.2023.1042440}.
\item Dragana Marković, Eleonora Čapelja (2023). \textit{Therapeutic potential of psilocybin: a promising agent in treating major depressive disorder}. AIDASCO Reviews. [published; OpenAlex]. \href{https://doi.org/10.59783/aire.2023.15}{doi:10.59783/aire.2023.15}.
\item Lindsay P. Cameron, Seona D. Patel, Maxemiliano V. Vargas, Eden V. Barragan, Hannah N. Saeger, Hunter T. Warren, Winston L. Chow, J.A. Gray, David E. Olson (2023). \textit{5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.2c00718}{doi:10.1021/acschemneuro.2c00718}.
\item Kooijman NI, Willegers T, Reuser A, Mulleners WM, Kramers C, Vissers KCP, van der Wal SEI. (2023). \textit{Are psychedelics the answer to chronic pain: A review of current literature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/papr.13203}{doi:10.1111/papr.13203}.
\item Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M. (2023). \textit{The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms24021329}{doi:10.3390/ijms24021329}.
\item Jing Wang, Min Liang, Qing Shang, Hongyan Qian, Ran An, Hua Liu, Gaojie Shao, Tao Li, Xinshe Liu (2023). \textit{Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling}. CNS Neuroscience \& Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1111/cns.14054}{doi:10.1111/cns.14054}.
\item Pacheco AT, Olson RJ, Garza G, Moghaddam B. (2023). \textit{Acute psilocybin enhances cognitive flexibility in rats}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2023.01.09.523291}{doi:10.1101/2023.01.09.523291}.
\item Kenneth Alper, Janelle Cange, Ria Sah, Deanna Schreiber-Gregory, Henry Sershen, K. Yaragudri Vinod (2023). \textit{Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2022.1074633}{doi:10.3389/fphar.2022.1074633}.
\item Klaus Richter Larsen, Ulrich Lindberg, Brice Ozenne, Drummond E-Wen McCulloch, Sophia Armand, M. Madsen, Annette Johansen, Dea Siggaard Stenbæk, Gitte M. Knudsen, Patrick M. Fisher (2022). \textit{Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labelling}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102665}{doi:10.1016/j.nsa.2023.102665}.
\item Ines Erkizia-Santamaría, Guadalupe Rivero, Igor Horrillo, J. Javier Meana, Jorge E. Ortega (2022). \textit{Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102452}{doi:10.1016/j.nsa.2023.102452}.
\item Agata Machaczka, Jane Turek, Dorota Bederska-Łojewska, Bartłomiej Pochwat, Łukasz Gąsior, Bernadeta Szewczyk, Andrzej Pilc (2022). \textit{Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depression}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.102939}{doi:10.1016/j.nsa.2023.102939}.
\item Sofia Nasini, Martina Colognesi, Sara Tidei, Sara De Martin, Marco Banzato, Andrea Mattarei, Franco Folli, P. Marco, Paolo L. Manfredi, Stefano Comai (2022). \textit{Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J mice}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2023.103378}{doi:10.1016/j.nsa.2023.103378}.
\item Ling-Xiao Shao, Clara Liao, Ian Gregg, Pasha A. Davoudian, Neil K. Savalia, Kristina Delagarza, Alex C. Kwan (2022). \textit{Visualizing drug actions on dendrites: psilocybin and other classic psychedelics}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1364/brain.2023.btu2b.2}{doi:10.1364/brain.2023.btu2b.2}.
\item Adriana D’Arienzo, Giorgio Samorini (2022). \textit{Italian psychedelic therapies of the past century: An historical overview}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/20503245231179687}{doi:10.1177/20503245231179687}.
\item Peter Hess (2022). \textit{Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data}. The Transmitter. [published; OpenAlex]. \href{https://doi.org/10.53053/etcr6498}{doi:10.53053/etcr6498}.
\item John R. Rossiter (2022). \textit{Psychedelic Drug Therapy for Mental Disorders?}. Open Journal of Medical Psychology. [published; OpenAlex]. \href{https://doi.org/10.4236/ojmp.2023.123010}{doi:10.4236/ojmp.2023.123010}.
\item Vejmola Č., Hubený J., Koudelka V., Griškova-Bulanova I., Páleníček T. (2022). \textit{Electrophysiological study of visual and auditory processing in psilocin-induced hallucinations: exploring evoked potentials and 5-HT2A receptor involvement}. Neuroscience Applied. [published; Crossref]. \href{https://doi.org/10.1016/j.nsa.2023.103662}{doi:10.1016/j.nsa.2023.103662}.
\item Jack E. Henningfield, Judy Ashworth, David J. Heal, Sharon L. Smith (2022). \textit{Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/02698811221140004}{doi:10.1177/02698811221140004}.
\item Rivera-García MT, Cruz SL. (2022). \textit{The Resurgence of Hallucinogen Drugs in Clinical Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.24875/ric.23000108}{doi:10.24875/ric.23000108}.
\item Kelly JR, Clarke G, Harkin A, Corr SC, Galvin S, Pradeep V, Cryan JF, O'Keane V, Dinan TG (2022). \textit{Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis.}. International journal of clinical and health psychology: IJCHP. [published; PubMed]. \href{https://doi.org/10.1016/j.ijchp.2022.100349}{doi:10.1016/j.ijchp.2022.100349}.
\item Unzueta-Larrinaga P, Urigüen L. (2022). \textit{Evaluation of Sensorimotor Gating Deficits in Mice Through Prepulse Inhibition (PPI) of the Startle Response.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/978-1-0716-3307-6\_5}{doi:10.1007/978-1-0716-3307-6\_5}.
\item Tamman AJF, Jiang L, Averill CL, Mason GF, Averill LA, Abdallah CG. (2022). \textit{Biological embedding of early trauma: the role of higher prefrontal synaptic strength.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/20008066.2023.2246338}{doi:10.1080/20008066.2023.2246338}.
\item Joshua C. Gray, Mikela A. Murphy, Sierra Carter, Matthew W. Johnson, Aaron Wolfgang, Michael J. Roy, Jessica L. Maples-Keller (2022). \textit{Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury}. Military Medicine. [published; OpenAlex]. \href{https://doi.org/10.1093/milmed/usac400}{doi:10.1093/milmed/usac400}.
\item Priel Meir, Leslie Taylor, Jair C. Soares, Thomas D. Meyer (2022). \textit{Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment}. Journal of Affective Disorders. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jad.2022.12.050}{doi:10.1016/j.jad.2022.12.050}.
\item Heal DJ, Gosden J, Smith SL, Atterwill CK. (2022). \textit{Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109375}{doi:10.1016/j.neuropharm.2022.109375}.
\item Friederike Holze, A. Becker, Karolina E. Kolaczynska, Urs Duthaler, Matthias E. Liechti (2022). \textit{Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants}. Clinical Pharmacology \& Therapeutics. [published; OpenAlex]. \href{https://doi.org/10.1002/cpt.2821}{doi:10.1002/cpt.2821}.
\item Unknown authors (2022). \textit{History of epilepsy increases risk of psychedelic-induced seizures}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.30967}{doi:10.1002/pu.30967}.
\item Geoffrey M. Bove, David J. Mokler (2022). \textit{Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serum}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00230}{doi:10.1556/2054.2022.00230}.
\item Daniel Burmester, M. Madsen, Attila Szabó, Sanjay S. Aripaka, Dea Siggaard Stenbæk, Vibe G. Frøkjær, Betina Elfving, Jens D. Mikkelsen, Gitte M. Knudsen, Patrick M. Fisher (2022). \textit{Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation}. Comprehensive Psychoneuroendocrinology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cpnec.2022.100163}{doi:10.1016/j.cpnec.2022.100163}.
\item Lee HJ, Stein MB. (2022). \textit{Update on treatments for anxiety-related disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/yco.0000000000000841}{doi:10.1097/yco.0000000000000841}.
\item Valeria Buzzelli, Emilia Carbone, Antonia Manduca, Sara Schiavi, Alessandro Feo, Julia V. Perederiy, Kyle Ambert, M Hausman, Viviana Trezza (2022). \textit{Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-022-06286-3}{doi:10.1007/s00213-022-06286-3}.
\item Błażej D. Pędzich, Mireia Medrano, An Buckinx, Ilse Smolders, Dimitri De Bundel (2022). \textit{Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice}. International Journal of Molecular Sciences. [published; OpenAlex]. \href{https://doi.org/10.3390/ijms232315284}{doi:10.3390/ijms232315284}.
\item Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS (2022). \textit{Psychedelic-Assisted Therapy for People with Eating Disorders.}. Current psychiatry reports. [published; PubMed]. \href{https://doi.org/10.1007/s11920-022-01394-5}{doi:10.1007/s11920-022-01394-5}.
\item Gregory Barber, Charles B. Nemeroff, Steven Siegel (2022). \textit{A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability}. American Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.ajp.22010073}{doi:10.1176/appi.ajp.22010073}.
\item Benjamin Kelmendi, Stephen A. Kichuk, Giuliana DePalmer, Gayle Maloney, Terence H. W. Ching, Alexander Belser, Christopher Pittenger (2022). \textit{Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report}. Heliyon. [published; OpenAlex]. \href{https://doi.org/10.1016/j.heliyon.2022.e12135}{doi:10.1016/j.heliyon.2022.e12135}.
\item Marten Dooper (2022). \textit{Antidepressant properties of psilocybin might be related to changes in sleep}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.55788/c6e5fc91}{doi:10.55788/c6e5fc91}.
\item Calderon SN, Bonson KR, Reissig CJ, Lloyd JM, Galati S, Chiapperino D. (2022). \textit{Considerations in assessing the abuse potential of psychedelics during drug development.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109352}{doi:10.1016/j.neuropharm.2022.109352}.
\item NWTraumatherapies (2022). \textit{NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT05042466}{source link}.
\item Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Lotan A, Wolf G, Lerer B, Lifschytz T. (2022). \textit{Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.}. International Journal of Molecular Sciences. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms232214148}{doi:10.3390/ijms232214148}.
\item Schmitz GP, Chiu Y, König GM, Kostenis E, Roth BL, Herman MA. (2022). \textit{Psychedelic compounds directly excite 5-HT2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT2A Gq -mediated activation mechanism}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.11.15.516655}{doi:10.1101/2022.11.15.516655}.
\item Spriggs MJ, Giribaldi B, Lyons T, Rosas FE, Kärtner LS, Buchborn T, Douglass HM, Roseman L, Timmermann C, Erritzoe D, Nutt DJ, Carhart-Harris RL. (2022). \textit{Body mass index (BMI) does not predict responses to psilocybin.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221131994}{doi:10.1177/02698811221131994}.
\item Strauss D, Ghosh S, Murray Z, Gryzenhout M. (2022). \textit{Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s13205-022-03355-4}{doi:10.1007/s13205-022-03355-4}.
\item VanderZwaag J, Halvorson T, Dolhan K, Šimončičová E, Ben-Azu B, Tremblay MÈ. (2022). \textit{The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11064-022-03772-0}{doi:10.1007/s11064-022-03772-0}.
\item Glatfelter GC, Pottie E, Partilla JS, Sherwood AM, Kaylo K, Pham DNK, Naeem M, Sammeta VR, DeBoer S, Golen JA, Hulley EB, Stove CP, Chadeayne AR, Manke DR, Baumann MH. (2022). \textit{Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.}. ACS Pharmacology \& Translational Science. [published; Europe PMC]. \href{https://doi.org/10.1021/acsptsci.2c00177}{doi:10.1021/acsptsci.2c00177}.
\item O'Donnell KC, Mennenga SE, Owens LT, Podrebarac SK, Baron T, Rotrosen J, Ross S, Forcehimes AA, Bogenschutz MP. (2022). \textit{Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.}. Contemporary Clinical Trials. [published; Europe PMC]. \href{https://doi.org/10.1016/j.cct.2022.106976}{doi:10.1016/j.cct.2022.106976}.
\item Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA. (2022). \textit{Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1111/adb.13229}{doi:10.1111/adb.13229}.
\item Unknown authors (2022). \textit{Serotonergic antidepressant use is associated with weaker psilocybin effects}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/2zys9\_v1}{source link}.
\item Alison Knopf (2022). \textit{Psilocybin treatment for AUD: Promise in new study}. Alcoholism \& Drug Abuse Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/adaw.33584}{doi:10.1002/adaw.33584}.
\item Vamvakopoulou IA, Narine KAD, Campbell I, Dyck JRB, Nutt DJ. (2022). \textit{Mescaline: The forgotten psychedelic.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2022.109294}{doi:10.1016/j.neuropharm.2022.109294}.
\item Goel DB, Zilate S. (2022). \textit{Potential Therapeutic Effects of Psilocybin: A Systematic Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.30214}{doi:10.7759/cureus.30214}.
\item Merlin Kirubakarababu, Arputharaj Samson Nesaraj (2022). \textit{Fungal Hallucinogens: Chemistry, Synthesis, Behavior, Toxicity and Detection Methods in Forensic Perspective}. Indian Journal of Forensic Medicine \& Toxicology. [published; OpenAlex]. \href{https://doi.org/10.37506/ijfmt.v16i4.18608}{doi:10.37506/ijfmt.v16i4.18608}.
\item Søndergaard A, Madsen MK, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS. (2022). \textit{Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2022.948729}{doi:10.3389/fpsyg.2022.948729}.
\item Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, Deco G, Kringelbach ML, Stamatakis EA, Kuceyeski A. (2022). \textit{Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.}. Nature Communications. [published; Europe PMC]. \href{https://doi.org/10.1038/s41467-022-33578-1}{doi:10.1038/s41467-022-33578-1}.
\item Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI. (2022). \textit{A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/jcp.0000000000001608}{doi:10.1097/jcp.0000000000001608}.
\item Natalie Gukasyan (2022). \textit{19.3 Psilocybin-Assisted Therapy for MDD: Current Evidence and Clinical Considerations}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2022.07.664}{doi:10.1016/j.jaac.2022.07.664}.
\item Pochwat B, Krupa AJ, Siwek M, Szewczyk B (2022). \textit{New investigational agents for the treatment of major depressive disorder.}. Expert opinion on investigational drugs. [published; PubMed]. \href{https://doi.org/10.1080/13543784.2022.2113376}{doi:10.1080/13543784.2022.2113376}.
\item Odland AU, Kristensen JL, Andreasen JT. (2022). \textit{Animal Behavior in Psychedelic Research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pharmrev.122.000590}{doi:10.1124/pharmrev.122.000590}.
\item Vohryzek J, Cabral J, Lord L, Fernandes H, Roseman L, Nutt D, Carhart-Harris R, Deco G, Kringelbach M. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2060381/v1}{doi:10.21203/rs.3.rs-2060381/v1}.
\item Stoliker D, Preller KH, Novelli L, Anticevic A, Egan GF, Vollenweider FX, Razi A. (2022). \textit{Neural mechanisms of psychedelic visual imagery}. medRxiv. [preprint; medRxiv]. \href{https://doi.org/10.1101/2022.09.07.22279700}{doi:10.1101/2022.09.07.22279700}.
\item Lerer B, Singh S, Botvinnik A, Shahar O, Wolf G, Yakobi C, Saban M, Salama A, Lotan A, Lifschytz T. (2022). \textit{Effect of psilocybin on marble-burying in ICR mice: Role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder}. Research Square. [preprint; Europe PMC]. \href{https://doi.org/10.21203/rs.3.rs-2001983/v1}{doi:10.21203/rs.3.rs-2001983/v1}.
\item Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R. (2022). \textit{Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.}. BJPsych Open. [published; Europe PMC]. \href{https://doi.org/10.1192/bjo.2022.565}{doi:10.1192/bjo.2022.565}.
\item Johnston CB, Mangini M, Grob C, Anderson B. (2022). \textit{The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jagp.2022.08.007}{doi:10.1016/j.jagp.2022.08.007}.
\item special to C EN Attabey Rodríguez Benítez (2022). \textit{Psychedelics’ binding depends on receptor mutations}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10031-scicon6}{doi:10.1021/cen-10031-scicon6}.
\item Diana Dias da Silva, Andreia Machado Brito-da-Costa, Silveira Martins, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho (2022). \textit{P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applications}. Toxicology Letters. [published; OpenAlex]. \href{https://doi.org/10.1016/j.toxlet.2022.07.283}{doi:10.1016/j.toxlet.2022.07.283}.
\item Brian S. Barnett, Jeremy Weleff (2022). \textit{Psychedelics in the Treatment of Substance Use Disorders}. Psychiatric Annals. [published; OpenAlex]. \href{https://doi.org/10.3928/00485713-20220804-01}{doi:10.3928/00485713-20220804-01}.
\item Rodrigues J, Nombora O, Ribeiro L. (2022). \textit{Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9567436}{source link}.
\item Chue P, Andreiev A, Bucuci E, Els C, Chue J. (2022). \textit{A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9568164}{source link}.
\item Kurtz JS, Patel NA, Gendreau JL, Yang C, Brown N, Bui N, Picton B, Harris M, Hatter M, Beyer R, Sahyouni R, Diaz-Aguilar LD, Castellanos J, Schuster N, Abraham ME (2022). \textit{The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.}. Cureus. [published; PubMed]. \href{https://doi.org/10.7759/cureus.29167}{doi:10.7759/cureus.29167}.
\item Nutt D. (2022). \textit{Psychedelic Psychiatry}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9565852}{source link}.
\item Erkizia-Santamaría I, Alles-Pascual R, Horrillo I, Meana JJ, Ortega JE. (2022). \textit{Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response.}. Biomedicine \& Pharmacotherapy. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopha.2022.113612}{doi:10.1016/j.biopha.2022.113612}.
\item Graham Zoe (2022). \textit{‘Shrooms for the Blues: Psilocybin to alleviate difficult-to-treat depression}. Journal of High School Science. [published; Crossref]. \href{https://doi.org/10.64336/001c.37945}{doi:10.64336/001c.37945}.
\item Doss MK, Barrett FS, Corlett PR. (2022). \textit{Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds.}. ACS Chemical Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.2c00461}{doi:10.1021/acschemneuro.2c00461}.
\item Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM. (2022). \textit{Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.}. Expert Opinion on Drug Discovery. [published; Europe PMC]. \href{https://doi.org/10.1080/17460441.2022.2111415}{doi:10.1080/17460441.2022.2111415}.
\item Ken Garber (2022). \textit{Delix Therapeutics: psychedelics without the trip}. Nature Biotechnology. [published; OpenAlex]. \href{https://doi.org/10.1038/d41587-022-00006-0}{doi:10.1038/d41587-022-00006-0}.
\item Mark Molumby, Keith Gaynor, Suzanne Guérin, Róisín McNamara (2022). \textit{Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test?}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/00221678221110331}{doi:10.1177/00221678221110331}.
\item Brian Peacock (2022). \textit{A-118 Psychedelic Interventions for Neuropsychological Conditions}. Archives of Clinical Neuropsychology. [published; OpenAlex]. \href{https://doi.org/10.1093/arclin/acac060.118}{doi:10.1093/arclin/acac060.118}.
\item Gitte Moos Knudsen (2022). \textit{Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging Study}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT04280055}{source link}.
\item Jaster AM, Younkin J, Cuddy T, de la Fuente Revenga M, Poklis JL, Dozmorov MG, González-Maeso J. (2022). \textit{Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neulet.2022.136836}{doi:10.1016/j.neulet.2022.136836}.
\item Gumpper RH, Fay JF, Roth BL. (2022). \textit{Molecular insights into the regulation of constitutive activity by RNA editing of 5HT2C serotonin receptors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.celrep.2022.111211}{doi:10.1016/j.celrep.2022.111211}.
\item Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Wolf G, Lerer B, Lifschytz T. (2022). \textit{Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: Translational implications}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.22.501026}{doi:10.1101/2022.07.22.501026}.
\item Singh S, Botvinnik A, Shahar O, Wolf G, Yakobi C, Saban M, Salama A, Lotan A, Lerer B, Lifschytz T. (2022). \textit{Effect of psilocybin on marble-burying in ICR mice: Role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.13.498401}{doi:10.1101/2022.07.13.498401}.
\item Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C, Golkowski D, Golkowski D, Ranft A, Ilg R, Jordan D, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Alnagger NL, Cardone P, Peattie ARD, Manktelow AE, de Araujo DB, Sensi SL, Owen AM, Naci L, Menon DK, Misic B, Stamatakis EA. (2022). \textit{Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter Landscape}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.07.12.499688}{doi:10.1101/2022.07.12.499688}.
\item Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, Berk M. (2022). \textit{Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852922000888}{doi:10.1017/s1092852922000888}.
\item Bosch OG, Halm S, Seifritz E. (2022). \textit{Psychedelics in the treatment of unipolar and bipolar depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1186/s40345-022-00265-5}{doi:10.1186/s40345-022-00265-5}.
\item Glatfelter GC, Pham DNK, Walther D, Golen JA, Chadeayne AR, Baumann MH, Manke DR. (2022). \textit{Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.}. ACS Omega. [published; Europe PMC]. \href{https://doi.org/10.1021/acsomega.2c03476}{doi:10.1021/acsomega.2c03476}.
\item Vohryzek J, Cabral J, Lord L, Fernandes HM, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML. (2022). \textit{Brain dynamics predictive of response to psilocybin for treatment-resistant depression}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.06.30.497950}{doi:10.1101/2022.06.30.497950}.
\item Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS. (2022). \textit{Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.}. NeuroImage. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroimage.2022.119434}{doi:10.1016/j.neuroimage.2022.119434}.
\item McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM (2022). \textit{Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2022.104689}{doi:10.1016/j.neubiorev.2022.104689}.
\item Saeger HN, Olson DE (2022). \textit{Psychedelic-inspired approaches for treating neurodegenerative disorders.}. Journal of neurochemistry. [published; PubMed]. \href{https://doi.org/10.1111/jnc.15544}{doi:10.1111/jnc.15544}.
\item Vorobyeva N, Kozlova AA. (2022). \textit{Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2022.927984}{doi:10.3389/fphar.2022.927984}.
\item Knudsen GM. (2022). \textit{Sustained effects of single doses of classical psychedelics in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-022-01361-x}{doi:10.1038/s41386-022-01361-x}.
\item Viktorin V, Griškova-Bulanova I, Voicikas A, Dojčánová D, Zach P, Bravermanová A, Andrashko V, Tylš F, Korčák J, Viktorinová M, Koudelka V, Hájková K, Kuchař M, Horáček J, Brunovský M, Páleníček T. (2022). \textit{Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.}. Journal of Personalized Medicine. [published; Europe PMC]. \href{https://doi.org/10.3390/jpm12061004}{doi:10.3390/jpm12061004}.
\item Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Szych Z, Majcher-Maślanka I, Herian M, Maćkowiak M, Gołembiowska K. (2022). \textit{Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior.}. International Journal of Molecular Sciences. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms23126713}{doi:10.3390/ijms23126713}.
\item Annie M. McCartney, H. T. McGovern, Alexander De Foe (2022). \textit{Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2022.00211}{doi:10.1556/2054.2022.00211}.
\item M Rekatsina, E Moka, A Vadalouca, G Varrassi (2022). \textit{SP56 Psychedelic drugs and pain}. Unknown journal. [published; OpenAlex]. \href{https://doi.org/10.1136/rapm-2022-esra.62}{doi:10.1136/rapm-2022-esra.62}.
\item Anthony Principe (2022). \textit{Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin}. SURG Journal. [published; OpenAlex]. \href{https://doi.org/10.21083/surg.v14i1.6870}{doi:10.21083/surg.v14i1.6870}.
\item Malcolm B, Thomas K (2022). \textit{Serotonin toxicity of serotonergic psychedelics.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05876-x}{doi:10.1007/s00213-021-05876-x}.
\item Vohra HZ, Saunders JM, Jaster AM, de la Fuente Revenga M, Jimenez J, Fernández-Teruel A, Wolstenholme JT, Beardsley PM, González-Maeso J (2022). \textit{Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice.}. Psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1007/s00213-021-05913-9}{doi:10.1007/s00213-021-05913-9}.
\item Smausz R, Neill J, Gigg J. (2022). \textit{Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811221092508}{doi:10.1177/02698811221092508}.
\item Al-Imam A, Motyka MA, Witulska Z, Younus M, Michalak M. (2022). \textit{Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland.}. International Journal of Environmental Research and Public Health. [published; Europe PMC]. \href{https://doi.org/10.3390/ijerph19116619}{doi:10.3390/ijerph19116619}.
\item Brandt SD, Kavanagh PV, Westphal F, Pulver B, Schwelm HM, Whitelock K, Stratford A, Auwärter V, Halberstadt AL. (2022). \textit{Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.}. Drug Testing and Analysis. [published; Europe PMC]. \href{https://doi.org/10.1002/dta.3281}{doi:10.1002/dta.3281}.
\item Sotille R, Singh H, Weisman A, Vida T. (2022). \textit{Unraveling the Mysteries of Mental Illness With Psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.25414}{doi:10.7759/cureus.25414}.
\item Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M. (2022). \textit{New Paradigms of Old Psychedelics in Schizophrenia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph15050640}{doi:10.3390/ph15050640}.
\item Edinoff AN, Fort JM, Singh C, Wagner SE, Rodriguez JR, Johnson CA, Cornett EM, Murnane KS, Kaye AM, Kaye AD. (2022). \textit{Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/neurolint14020035}{doi:10.3390/neurolint14020035}.
\item Huang J, Pham M, Panenka WJ, Honer WG, Barr AM. (2022). \textit{Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity.}. Frontiers in Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyt.2022.891512}{doi:10.3389/fpsyt.2022.891512}.
\item Andrew Hodge, Suporn Sukpraprut-Braaten, Robert Strayhan (2022). \textit{The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis}. Current Psychiatry Research and Reviews. [published; OpenAlex]. \href{https://doi.org/10.2174/2666082218666220513142002}{doi:10.2174/2666082218666220513142002}.
\item Stephan Schleim (2022). \textit{Grounded in Biology: Why the Context-Dependency of Psychedelic Drug Effects Means Opportunities, Not Problems for Anthropology and Pharmacology}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2022.906487}{doi:10.3389/fpsyt.2022.906487}.
\item Nguyen TQT, Lund FW, Zanjani AAH, Khandelia H. (2022). \textit{Magic mushroom extracts in lipid membranes.}. Biochimica et Biophysica Acta (BBA) - Biomembranes. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bbamem.2022.183957}{doi:10.1016/j.bbamem.2022.183957}.
\item Grant C. Glatfelter, David R. Manke, Andrew R. Chadayne, Michael H. Baumann (2022). \textit{Receptor binding profiles and behavioral effects of psilocybin analogs}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2022.36.s1.r3639}{doi:10.1096/fasebj.2022.36.s1.r3639}.
\item University of Zurich (2022). \textit{Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03715127}{source link}.
\item Stéphanie Knatz Peck, Samatha Shao, Susan Murray, Walter H. Kaye (2022). \textit{P450. Pilot Study Evaluation of Psilocybin Therapy for Anorexia Nervosa: Safety, Acceptability, and Preliminary Efficacy}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2022.02.686}{doi:10.1016/j.biopsych.2022.02.686}.
\item Girn M, Roseman L, Bernhardt B, Smallwood J, Carhart-Harris R, Nathan Spreng R. (2022). \textit{Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.}. NeuroImage. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroimage.2022.119220}{doi:10.1016/j.neuroimage.2022.119220}.
\item Rudzki S. (2022). \textit{Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?}. Military Medicine. [published; Europe PMC]. \href{https://doi.org/10.1093/milmed/usac095}{doi:10.1093/milmed/usac095}.
\item Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R. (2022). \textit{Increased global integration in the brain after psilocybin therapy for depression.}. Nature Medicine. [published; Europe PMC]. \href{https://doi.org/10.1038/s41591-022-01744-z}{doi:10.1038/s41591-022-01744-z}.
\item Doss MK, Madden MB, Gaddis A, Nebel MB, Griffiths RR, Mathur BN, Barrett FS. (2022). \textit{Models of psychedelic drug action: modulation of cortical-subcortical circuits.}. Brain. [published; Europe PMC]. \href{https://doi.org/10.1093/brain/awab406}{doi:10.1093/brain/awab406}.
\item Michael Avissar, Adrian Jacques H. Ambrose (2022). \textit{Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2022.04.4.35}{doi:10.1176/appi.pn.2022.04.4.35}.
\item Davoudian PA, Shao L, Kwan AC. (2022). \textit{Shared and distinct brain regions targeted for immediate early gene expression by ketamine and psilocybin}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.03.18.484437}{doi:10.1101/2022.03.18.484437}.
\item Benjamin Hearn, Michael D. Brubaker, George B. Richardson (2022). \textit{Counselors’ attitudes toward psychedelics and their use in therapy}. Journal of Counseling \& Development. [published; OpenAlex]. \href{https://doi.org/10.1002/jcad.12429}{doi:10.1002/jcad.12429}.
\item McClure-Begley TD, Roth BL. (2022). \textit{The promises and perils of psychedelic pharmacology for psychiatry.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41573-022-00421-7}{doi:10.1038/s41573-022-00421-7}.
\item Adams AM, Anas NA, Sen AK, Hinegardner-Hendricks JD, O'Dell PJ, Gibbons WJ, Flower JE, McMurray MS, Jones JA. (2022). \textit{Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats.}. Metabolic Engineering Communications. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mec.2022.e00196}{doi:10.1016/j.mec.2022.e00196}.
\item Amrutha Garimella, Bradley Kerr, Reese H. Hyzer, Megan A. Moreno (2022). \textit{184. Hallucinogens on TikTok}. Journal of Adolescent Health. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jadohealth.2022.01.101}{doi:10.1016/j.jadohealth.2022.01.101}.
\item Bates N, Bello JK, Osazuwa-Peters N, Sullivan MD, Scherrer JF. (2022). \textit{Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s11864-022-00954-4}{doi:10.1007/s11864-022-00954-4}.
\item Sarparast A, Thomas K, Malcolm B, Stauffer CS. (2022). \textit{Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06083-y}{doi:10.1007/s00213-022-06083-y}.
\item Gaddis A, Lidstone DE, Nebel MB, Griffiths R, Mostofsky SH, Mejia A, Barrett F. (2022). \textit{Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2022.02.28.482395}{doi:10.1101/2022.02.28.482395}.
\item Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J. (2022). \textit{Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-022-06092-x}{doi:10.1007/s00213-022-06092-x}.
\item Popik P, Hogendorf A, Bugno R, Khoo SY, Zajdel P, Malikowska-Racia N, Nikiforuk A, Golebiowska J. (2022). \textit{Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-021-06020-5}{doi:10.1007/s00213-021-06020-5}.
\item Bethany Halford﻿ (2022). \textit{Hallucinogen chemistry guides antidepressant drug discovery}. C\&EN Global Enterprise. [published; OpenAlex]. \href{https://doi.org/10.1021/cen-10005-leadcon}{doi:10.1021/cen-10005-leadcon}.
\item Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR. (2022). \textit{Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.7759/cureus.21944}{doi:10.7759/cureus.21944}.
\item Markopoulos A, Inserra A, De Gregorio D, Gobbi G. (2022). \textit{Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.749068}{doi:10.3389/fphar.2021.749068}.
\item Cao D, Yu J, Wang H, Luo Z, Liu X, He L, Qi J, Fan L, Tang L, Chen Z, Li J, Cheng J, Wang S. (2022). \textit{Structure-based discovery of nonhallucinogenic psychedelic analogs.}. Science. [published; Europe PMC]. \href{https://doi.org/10.1126/science.abl8615}{doi:10.1126/science.abl8615}.
\item James Bailey Sanford (2022). \textit{Psychedelics hold promise for primary care research}. Family Practice. [published; OpenAlex]. \href{https://doi.org/10.1093/fampra/cmac009}{doi:10.1093/fampra/cmac009}.
\item Barrett FS, Zhou Y, Carbonaro TM, Roberts JM, Smith GS, Griffiths RR, Wong DF. (2022). \textit{Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.}. Frontiers in Neuroergonomics. [published; Europe PMC]. \href{https://doi.org/10.3389/fnrgo.2021.784576}{doi:10.3389/fnrgo.2021.784576}.
\item Khan FI, Hassan F, Lai D. (2022). \textit{In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor.}. Frontiers in Immunology. [published; Europe PMC]. \href{https://doi.org/10.3389/fimmu.2021.794780}{doi:10.3389/fimmu.2021.794780}.
\item Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH. (2022). \textit{The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211064720}{doi:10.1177/02698811211064720}.
\item Klaus Richter Larsen, Drummond E-Wen McCulloch, Brice Ozenne, Ulrich Lindberg, Sophia Armand, M. Madsen, Dea Siggaard Stenbæk, Gitte M. Knudsen, Patrick M. Fisher (2021). \textit{Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humans}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100335}{doi:10.1016/j.nsa.2022.100335}.
\item A. Wojtas, A. Bysiek, Z. Szych, M. Herian, K. Gołembiowska (2021). \textit{Neurochemical properties of psilocybin in comparison to ketamine in vivo}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100408}{doi:10.1016/j.nsa.2022.100408}.
\item Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, Albert Adell, J. Javier Meana, J.E. Ortega (2021). \textit{Neurochemical and behavioural characterisation of the psychedelic 5HT2AR agonist psilocybin in mice}. Neuroscience Applied. [published; OpenAlex]. \href{https://doi.org/10.1016/j.nsa.2022.100407}{doi:10.1016/j.nsa.2022.100407}.
\item Daisuke Ibi (2021). \textit{Investigation of the neural network responsible for antidepressant effect of serotonergic psychedelics}. Proceedings for Annual Meeting of The Japanese Pharmacological Society. [published; OpenAlex]. \href{https://doi.org/10.1254/jpssuppl.96.0\_4-b-s43-2}{doi:10.1254/jpssuppl.96.0\_4-b-s43-2}.
\item Jeff Tarrant (2021). \textit{SPECIAL ISSUE: Do Biofeedback, Neurofeedback, and Neuromeditation Have a Role in Psychedelic-Assisted Therapies?}. Biofeedback. [published; OpenAlex]. \href{https://doi.org/10.5298/1081-5937-50.03.03}{doi:10.5298/1081-5937-50.03.03}.
\item Daisuke Ibi (2021). \textit{Investigation of neuronal basis underlying antidepressant effect of serotonergic psychedelics}. Proceedings for Annual Meeting of The Japanese Pharmacological Society. [published; OpenAlex]. \href{https://doi.org/10.1254/jpssuppl.95.0\_3-s35-1}{doi:10.1254/jpssuppl.95.0\_3-s35-1}.
\item Josh Nagra (2021). \textit{Psychedelic Agents as Potential Therapeutics for Obsessive Compulsive Disorder}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doaj.org/article/7ce75968f7bc41c58d82163435d80b03}{source link}.
\item Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P (2021). \textit{Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2021\_267}{doi:10.1007/7854\_2021\_267}.
\item Flanagan TW, Nichols CD (2021). \textit{Psychedelics and Anti-inflammatory Activity in Animal Models.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2022\_367}{doi:10.1007/7854\_2022\_367}.
\item Johnson MW. (2021). \textit{Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2022\_327}{doi:10.1007/7854\_2022\_327}.
\item Roseman L, Preller KH, Fotiou E, Winkelman MJ (2021). \textit{Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives.}. Frontiers in pharmacology. [published; PubMed]. \href{https://doi.org/10.3389/fphar.2022.979764}{doi:10.3389/fphar.2022.979764}.
\item Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM, Mulsant BH, Castle DJ (2021). \textit{Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?}. Frontiers in psychiatry. [published; PubMed]. \href{https://doi.org/10.3389/fpsyt.2022.1076459}{doi:10.3389/fpsyt.2022.1076459}.
\item Louk J. M. J. Vanderschuren, Paul Willner, Emily M. Jutkiewicz, Bart Ellenbroek (2021). \textit{Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs}. Behavioural Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1097/fbp.0000000000000662}{doi:10.1097/fbp.0000000000000662}.
\item Hannah Douglass, Meg J. Spriggs, R.J. Park, Tim Read, Jennifer L. Danby, Frederico José Coelho de Magalhães, Kirsty L. Alderton, Adèle Lafrance, Dasha Nicholls, David Erritzøe, David Nutt, Robin Carhart-Harris (2021). \textit{P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.335}{doi:10.1016/j.euroneuro.2021.10.335}.
\item A. Andreiev, E. Bucuci, James Chue, Charl Els, Pierre Chue (2021). \textit{P.0623 The clinical relevance of the pharmacokinetics of psilocybin}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.588}{doi:10.1016/j.euroneuro.2021.10.588}.
\item Matthew B. Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David Nutt, Robin Carhart-Harris (2021). \textit{P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to music}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.741}{doi:10.1016/j.euroneuro.2021.10.741}.
\item Angenoorth TJF, Stankovic S, Niello M, Holy M, Brandt SD, Sitte HH, Maier J (2021). \textit{Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms222312995}{doi:10.3390/ijms222312995}.
\item Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P. (2021). \textit{Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/ph14121213}{doi:10.3390/ph14121213}.
\item Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS. (2021). \textit{Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s40263-021-00877-y}{doi:10.1007/s40263-021-00877-y}.
\item Gass P, Vasilescu AN, Inta D. (2021). \textit{[Rapid-acting antidepressants-neurobiological mechanisms of action].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00115-021-01225-7}{doi:10.1007/s00115-021-01225-7}.
\item Duerler P, Brem S, Fraga-González G, Neef T, Allen M, Zeidman P, Stämpfli P, Vollenweider FX, Preller KH. (2021). \textit{Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study.}. Cerebral Cortex. [published; Europe PMC]. \href{https://doi.org/10.1093/cercor/bhab202}{doi:10.1093/cercor/bhab202}.
\item Fitzgerald PJ (2021). \textit{Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo.}. International journal of molecular sciences. [published; PubMed]. \href{https://doi.org/10.3390/ijms221910706}{doi:10.3390/ijms221910706}.
\item Matt T. Keener (2021). \textit{6.2 OVERVIEW OF PSYCHEDELIC COMPOUNDS AND THEIR USE IN TREATMENT}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2021.07.052}{doi:10.1016/j.jaac.2021.07.052}.
\item Gonda X, Dome P, Neill JC, Tarazi FI. (2021). \textit{Novel antidepressant drugs: Beyond monoamine targets.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1092852921000791}{doi:10.1017/s1092852921000791}.
\item Castelhano J, Lima G, Teixeira M, Soares C, Pais M, Castelo-Branco M. (2021). \textit{The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.739053}{doi:10.3389/fphar.2021.739053}.
\item Rodríguez Arce JM, Winkelman MJ. (2021). \textit{Psychedelics, Sociality, and Human Evolution.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2021.729425}{doi:10.3389/fpsyg.2021.729425}.
\item Aleksandrova LR, Phillips AG. (2021). \textit{Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2021.08.003}{doi:10.1016/j.tips.2021.08.003}.
\item Pascal Kintz, Jean-Sébastien Raul, Alice Ameline (2021). \textit{Testing human hair after magic mushrooms abuse by LC-MS/MS: Pitfalls and limitations}. Forensic Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.forc.2021.100364}{doi:10.1016/j.forc.2021.100364}.
\item Matthias Forstmann, Christina Sagioglou (2021). \textit{New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances}. European Psychologist. [published; OpenAlex]. \href{https://doi.org/10.1027/1016-9040/a000447}{doi:10.1027/1016-9040/a000447}.
\item Basedow LA, Riemer TG, Reiche S, Kreutz R, Majić T. (2021). \textit{Neuropsychological Functioning in Users of Serotonergic Psychedelics - A Systematic Review and Meta-Analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.739966}{doi:10.3389/fphar.2021.739966}.
\item Dan Cătălin Oprea, Loretta Epure, Vasile Chiriță, Adrian Cantemir (2021). \textit{The therapeutical role of psychedelic drugs in treatment of mental disorders}. Bulletin of Integrative Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.36219/bpi.2021.3.09}{doi:10.36219/bpi.2021.3.09}.
\item Benjamin R. Lewis, Kevin Byrne (2021). \textit{Is MDD the right target for early-stage psychedelic-assisted therapy trials?}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2021.00180}{doi:10.1556/2054.2021.00180}.
\item Leger RF, Unterwald EM. (2021). \textit{Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211044688}{doi:10.1177/02698811211044688}.
\item Tehseen Noorani, Jonny Martell (2021). \textit{New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2021.727050}{doi:10.3389/fpsyt.2021.727050}.
\item Gonçalo Cotovio, Ana Maia, Ana Velosa, Carolina Seybert, Albino J. Oliveira-Maia (2021). \textit{Treating Major Depression Disorder with Psychedelics: A Potential Therapeutic Application for Psilocybin?}. Revista Portuguesa de Psiquiatria e Saúde Mental. [published; OpenAlex]. \href{https://doi.org/10.51338/rppsm.2021.v7.i3.241}{doi:10.51338/rppsm.2021.v7.i3.241}.
\item Hagsäter SM, Pettersson R, Pettersson C, Atanasovski D, Näslund J, Eriksson E. (2021). \textit{A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.}. The International Journal of Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyab040}{doi:10.1093/ijnp/pyab040}.
\item Peixoto C, Santos F, Rego D, Medeiros H. (2021). \textit{Psychedelics and psychiatric disorders: A emerging role}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9470409}{source link}.
\item Miranda J, Barbosa M, Figueiredo I, Mota P, Tarelho A. (2021). \textit{Treating addiction with psychedelics - are we waking up?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9480123}{source link}.
\item Torres S. (2021). \textit{Psychedelics: A new era of treatment?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9475866}{source link}.
\item Descalço N, Medeiros A, Santos C, Borges G. (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/PMC/PMC9476072}{source link}.
\item Wayne Hall, Michael Farrell (2021). \textit{What can we learn from the history of research on psychedelic drugs in the addictions?}. Addiction. [published; OpenAlex]. \href{https://doi.org/10.1111/add.15560}{doi:10.1111/add.15560}.
\item Waters K. (2021). \textit{Pharmacologic Similarities and Differences Among Hallucinogens.}. The Journal of Clinical Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1002/jcph.1917}{doi:10.1002/jcph.1917}.
\item Chong Siew Koon, Tuan Sharipah binti Tuan Hadi, Izatt Syafieq bin Abd Rashad, Ruzila binti Ali (2021). \textit{A Case Series Describing the Tale of ‘The Magic Mushroom’; An Increasing Trend of Psychedelic Misuse Among Substance Abusers in Terengganu}. Unknown journal. [published; OpenAlex]. \href{https://openalex.org/W3186346443}{source link}.
\item Borroto-Escuela DO, Ambrogini P, Narvaez M, Di Liberto V, Beggiato S, Ferraro L, Fores-Pons R, Alvarez-Contino JE, Lopez-Salas A, Mudò G, Díaz-Cabiale Z, Fuxe K. (2021). \textit{Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia-Relevance for Mental Diseases.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/cells10081902}{doi:10.3390/cells10081902}.
\item Tim Hirschfeld, Laura Smit-Rigter, Daan van der Gouwe, Simon Reiche, Heino Stöver, Tomislav Majić (2021). \textit{Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis}. Current Addiction Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s40429-021-00385-5}{doi:10.1007/s40429-021-00385-5}.
\item Madsen MK, Stenbæk DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS, Linnet K, Ozenne B, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience.}. European Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2021.06.001}{doi:10.1016/j.euroneuro.2021.06.001}.
\item Philipp Matteo Härter (2021). \textit{The Influence of Psychedelic Drugs on the 'Sense of Self'}. Unknown journal. [published; OpenAlex]. \href{https://openjournals.maastrichtuniversity.nl/MSJPN/article/view/661}{source link}.
\item McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM. (2021). \textit{Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/02698811211026454}{doi:10.1177/02698811211026454}.
\item Sarah-Catherine Rodan, Phillip Aouad, Iain S. McGregor, Sarah Maguire (2021). \textit{Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa}. OBM Neurobiology. [published; OpenAlex]. \href{https://doi.org/10.21926/obm.neurobiol.2102102}{doi:10.21926/obm.neurobiol.2102102}.
\item Prochazkova L, van Elk M, Marschall JC, Rifkin BD, Fejer G, Schoen N, Fiacchino D, Kuchar M, Hommel B. (2021). \textit{Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/emcxw}{doi:10.31234/osf.io/emcxw}.
\item Unknown authors (2021). \textit{Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials}. PsyArXiv. [preprint; PsyArXiv]. \href{https://osf.io/preprints/psyarxiv/emcxw\_v1}{source link}.
\item Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft (2021). \textit{Psilocybin: the magic medicine for depression?}. BJPsych Open. [published; OpenAlex]. \href{https://doi.org/10.1192/bjo.2021.456}{doi:10.1192/bjo.2021.456}.
\item Chao YS, Horton J. (2021). \textit{Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders}. Canadian Agency for Drugs and Technologies in Health, Ottawa (ON). [published; Europe PMC]. \href{https://europepmc.org/article/MED/36170470}{source link}.
\item Wayne Hall (2021). \textit{The need for publicly funded research on therapeutic use of psychedelic drugs}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.20847}{doi:10.1002/wps.20847}.
\item Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, Deco G, Kringelbach ML, Stamatakis EA, Kuceyeski A. (2021). \textit{LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theory}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.05.14.444193}{doi:10.1101/2021.05.14.444193}.
\item Fabiana Venancio Santana Silva, Alexandre Libanio Silva Reis, Amanda Prazeres Costa, Maria Carolaine Souza da Silva, Rafaela da Conceição de Lemos, Elisângela Marcionilo Da Conceição, Joyce Kelly Soares da Silva, Carlos Alberto Tiburcio Valeriano, David Filipe de Santana (2021). \textit{A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depressive disorder: a narrative literature review}. Brazilian Journal of Health Review. [published; OpenAlex]. \href{https://doi.org/10.34119/bjhrv4n3-012}{doi:10.34119/bjhrv4n3-012}.
\item Madison Hagood (2021). \textit{Non-Traditional Psychotherapy Techniques: An Assessment of the Value of MDMA, Psilocybin and LSD.}. Unknown journal. [published; OpenAlex]. \href{https://repository.asu.edu/items/63943}{source link}.
\item Romeo B, Hermand M, Pétillion A, Karila L, Benyamina A (2021). \textit{Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.}. Journal of psychiatric research. [published; PubMed]. \href{https://doi.org/10.1016/j.jpsychires.2021.03.002}{doi:10.1016/j.jpsychires.2021.03.002}.
\item Katrin H. Preller (2021). \textit{Altered Prediction-Error Processing May Underlie Psilocybin-Induced Changes in Self-Processing}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2021.02.036}{doi:10.1016/j.biopsych.2021.02.036}.
\item University Hospital, Basel, Switzerland (2021). \textit{Direct Comparison of Altered States of Consciousness Induced by LSD and Psilocybin in a Random-order Placebo-controlled Cross-over Study in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03604744}{source link}.
\item Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C. (2021). \textit{Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3390/molecules26092451}{doi:10.3390/molecules26092451}.
\item Giovanni Pereira Pio, Aline Moreira Vitorino, Naira Braga Aidar, Alissa Amoras Magalhães, Eduardo Cammerer Mombelli, Gabriela Marques Ferraz, Rodrigo Pereira Pio (2021). \textit{O papel da Psilocibina no tratamento de depressão resistente / The role of Psilocybin in the treatment of resistant depression}. Brazilian Journal of Health Review. [published; OpenAlex]. \href{https://doi.org/10.34119/bjhrv4n2-395}{doi:10.34119/bjhrv4n2-395}.
\item Nelson Descalço, Ana Beatriz Medeiros, Cátia Fernandes Santos, Guilherme Borges (2021). \textit{Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1114}{doi:10.1192/j.eurpsy.2021.1114}.
\item A. Fraga, Daniel Esteves-Sousa, João Facucho-Oliveira, Margarida Albuquerque, M. Costa, Paulo Santos, Nuno Moura, A. Moutinho (2021). \textit{Effects of psilocybin-assisted therapy on treatment-resistant depression}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1192/j.eurpsy.2021.1836}{doi:10.1192/j.eurpsy.2021.1836}.
\item Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ. (2021). \textit{Trial of Psilocybin versus Escitalopram for Depression.}. New England Journal of Medicine. [published; Europe PMC]. \href{https://doi.org/10.1056/nejmoa2032994}{doi:10.1056/nejmoa2032994}.
\item Hesselgrave N, Troppoli TA, Wulff AB, Cole AB, Thompson SM. (2021). \textit{Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice.}. Proceedings of the National Academy of Sciences. [published; Europe PMC]. \href{https://doi.org/10.1073/pnas.2022489118}{doi:10.1073/pnas.2022489118}.
\item Earleywine M, Ueno LF, Mian MN, Altman BR. (2021). \textit{Cannabis-induced oceanic boundlessness.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881121997099}{doi:10.1177/0269881121997099}.
\item Dos Santos RG, Hallak JE, Baker G, Dursun S. (2021). \textit{Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881120986422}{doi:10.1177/0269881120986422}.
\item Musikaphongsakul P, Ya K, Subsoontorn P, Lohitnavy M. (2021). \textit{Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans}. F1000Res. [preprint; Europe PMC]. \href{https://doi.org/10.12688/f1000research.28133.1}{doi:10.12688/f1000research.28133.1}.
\item Kozłowska U, Klimczak A, Wiatr K, Figiel M. (2021). \textit{The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.03.07.434103}{doi:10.1101/2021.03.07.434103}.
\item Dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE. (2021). \textit{The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges.}. DOAJ (DOAJ: Directory of Open Access Journals). [published; Europe PMC]. \href{https://doi.org/10.2147/rmhp.s300656}{source link}.
\item Unknown authors (2021). \textit{Stroke and Adverse Effects on The Immune and Cardiovascular Systems: The Danger of the Rise and Use of Psychedelic Drugs for Depression and PTSD}. Journal of Clinical \& Experimental Immunology. [published; OpenAlex]. \href{https://doi.org/10.33140/jcei.06.02.01}{doi:10.33140/jcei.06.02.01}.
\item Winkelman MJ. (2021). \textit{The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2021.619890}{doi:10.3389/fphar.2021.619890}.
\item Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR. (2021). \textit{Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881121991822}{doi:10.1177/0269881121991822}.
\item Peter G. Brindley (2021). \textit{How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence}. Anesthesia \& Analgesia. [published; OpenAlex]. \href{https://doi.org/10.1213/ane.0000000000005349}{doi:10.1213/ane.0000000000005349}.
\item Madsen MK, Stenbæk DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS, Linnet K, Ozenne B, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.02.03.429325}{doi:10.1101/2021.02.03.429325}.
\item R. Andrew Yockey, Keith A. King (2021). \textit{Use of psilocybin (“mushrooms”) among US adults: 2015-2018}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2020.00159}{doi:10.1556/2054.2020.00159}.
\item McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM. (2021). \textit{Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/2021.01.28.428377}{doi:10.1101/2021.01.28.428377}.
\item Higgins GA, Sellers EM. (2021). \textit{5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2021.01.007}{doi:10.1016/bs.pbr.2021.01.007}.
\item Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM. (2021). \textit{A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain.}. International Journal of Molecular Sciences. [published; Europe PMC]. \href{https://doi.org/10.3390/ijms22020835}{doi:10.3390/ijms22020835}.
\item Galvão-Coelho NL, Marx W, Gonzalez M, Sinclair J, de Manincor M, Perkins D, Sarris J. (2021). \textit{Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-020-05719-1}{doi:10.1007/s00213-020-05719-1}.
\item Michael W. Dzierlenga (2020). \textit{Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.31120.r81816}{doi:10.5256/f1000research.31120.r81816}.
\item Quoc Ba Tran (2020). \textit{Referee report. For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 approved with reservations, 1 not approved]}. Faculty of 1000 Research Ltd. [published; OpenAlex]. \href{https://doi.org/10.5256/f1000research.31120.r81474}{doi:10.5256/f1000research.31120.r81474}.
\item Unknown authors (2020). \textit{Psilocybin therapy appears as effective as escitalopram, small study finds}. Pharmaceutical journal/The pharmaceutical journal. [published; OpenAlex]. \href{https://doi.org/10.1211/pj.2021.1.91592}{doi:10.1211/pj.2021.1.91592}.
\item Harmony I. Risca (2020). \textit{Preclinical Behavioral Assessment of Chronic, Intermittent Low-Dose Psilocybin in Rodent Models of Depression and Anxiety}. Unknown journal. [published; OpenAlex]. \href{https://scholarworks.wmich.edu/cgi/viewcontent.cgi?article=4777\&context=dissertations}{source link}.
\item Inserra A, De Gregorio D, Gobbi G. (2020). \textit{Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pharmrev.120.000056}{doi:10.1124/pharmrev.120.000056}.
\item Tullis P. (2020). \textit{How ecstasy and psilocybin are shaking up psychiatry.}. Nature. [published; Europe PMC]. \href{https://doi.org/10.1038/d41586-021-00187-9}{doi:10.1038/d41586-021-00187-9}.
\item Castro Santos H, Gama Marques J. (2020). \textit{What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/j.pbj.0000000000000128}{doi:10.1097/j.pbj.0000000000000128}.
\item Strickland JC, Garcia-Romeu A, Johnson M. (2020). \textit{Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy}. PsyArXiv. [preprint; PsyArXiv]. \href{https://doi.org/10.31234/osf.io/f5dmt}{doi:10.31234/osf.io/f5dmt}.
\item Michael B. Gatch, Adam C. Hoch, Theresa M. Carbonaro (2020). \textit{Discriminative Stimulus Effects of Substituted Tryptamines in Rats}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.0c00173}{doi:10.1021/acsptsci.0c00173}.
\item Anna U. Odland, Jesper L. Kristensen, Jesper T. Andreasen (2020). \textit{Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice}. Behavioural Brain Research. [published; OpenAlex]. \href{https://doi.org/10.1016/j.bbr.2020.113093}{doi:10.1016/j.bbr.2020.113093}.
\item Savalia NK, Shao LX, Kwan AC. (2020). \textit{A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tins.2020.11.008}{doi:10.1016/j.tins.2020.11.008}.
\item Sanah Malomile Nkadimeng, Christiaan M.L. Steinmann, J.N. Eloff (2020). \textit{Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-020-79328-5}{doi:10.1038/s41598-020-79328-5}.
\item Adam K. Klein, Muhammad Chatha, Lauren J. Laskowski, Emilie I. Anderson, Simon D. Brandt, Stephen J. Chapman, John D. McCorvy, Adam L. Halberstadt (2020). \textit{Investigation of the Structure-Activity Relationships of Psilocybin Analogues}. ACS Pharmacology \& Translational Science. [published; OpenAlex]. \href{https://doi.org/10.1021/acsptsci.0c00176}{doi:10.1021/acsptsci.0c00176}.
\item Karolina E. Kolaczynska, Matthias E. Liechti, Urs Duthaler (2020). \textit{Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma}. Journal of Chromatography B. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jchromb.2020.122486}{doi:10.1016/j.jchromb.2020.122486}.
\item Lene Lundgaard Donovan, Jens Vilstrup Johansen, Nídia Fernandez Ros, Elham Jaberi, Kristían Línnet, Sys Stybe Johansen, Brice Ozenne, Shohreh Issazadeh-Navikas, Hanne D. Hansen, Gitte M. Knudsen (2020). \textit{Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.11.013}{doi:10.1016/j.euroneuro.2020.11.013}.
\item Daniela Dudysová, Karolína Janků, Michal Šmotek, Elizaveta Saifutdinová, Jana Kopřivová, Jitka Bušková, Bryce A. Mander, Martin Brunovský, Peter Zach, Jakub Korčák, Veronika Andrashko, Michaela Viktorinová, Filip Tylš, Anna Bravermanová, Tom Froese, Tomáš Páleníček, Jiřı́ Horáček (2020). \textit{The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action}. Frontiers in Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.3389/fphar.2020.602590}{doi:10.3389/fphar.2020.602590}.
\item University Hospital, Basel, Switzerland (2020). \textit{Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy Subjects}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03912974}{source link}.
\item Raval NR, Johansen A, Donovan LL, Ros NF, Ozenne B, Hansen HD, Knudsen GM. (2020). \textit{A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain}. Preprints.org. [preprint; Europe PMC]. \href{https://doi.org/10.20944/preprints202011.0742.v1}{doi:10.20944/preprints202011.0742.v1}.
\item Felix Müller, Friederike Holze, Patrick C. Dolder, Laura Ley, Patrick Vizeli, Alain Soltermann, Matthias E. Liechti, Stefan Borgwardt (2020). \textit{MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-020-00906-2}{doi:10.1038/s41386-020-00906-2}.
\item Emmanuelle A. D. Schindler, R. Andrew Sewell, Christopher Gottschalk, Christina Luddy, L. Taylor Flynn, Hayley Lindsey, Brian Pittman, Nicholas V. Cozzi, Deepak Cyril D’Souza (2020). \textit{Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin}. Neurotherapeutics. [published; OpenAlex]. \href{https://doi.org/10.1007/s13311-020-00962-y}{doi:10.1007/s13311-020-00962-y}.
\item Bottemanne H, Claret A, Fossati P. (2020). \textit{[Ketamine, psilocybin, and rapid acting antidepressant: new promise for psychiatry?]}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.encep.2020.08.006}{doi:10.1016/j.encep.2020.08.006}.
\item Oskar Hougaard Jefsen, Betina Elfving, Gregers Wegener, Heidi Kaastrup Müller (2020). \textit{Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881120959614}{doi:10.1177/0269881120959614}.
\item Nakul Ravi Raval, Annette Johansen, Lene Lundgaard Donovan, Nelson Ros, Brice Ozenne, Hanne D. Hansen, Gitte M. Knudsen (2020). \textit{P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.09.589}{doi:10.1016/j.euroneuro.2020.09.589}.
\item Klára Gotvaldová, Kateřina Hájková, Jan Borovička, Radek Jurok, Petra Cihlářová, Martin Kuchař (2020). \textit{Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis}. Drug Testing and Analysis. [published; OpenAlex]. \href{https://doi.org/10.1002/dta.2950}{doi:10.1002/dta.2950}.
\item Dea Siggaard Stenbæk, M. Madsen, Brice Ozenne, Sara Kristiansen, Daniel Burmester, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher (2020). \textit{Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881120959609}{doi:10.1177/0269881120959609}.
\item Rotem Petranker, Thomas Anderson, Larissa J. Maier, Monica J. Barratt, Jason Ferris, Adam Winstock (2020). \textit{Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention}. Journal of Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1177/0269881120953994}{doi:10.1177/0269881120953994}.
\item Russ Curtis, Lisen C. Roberts, Elizabeth Graves, Heather Thompson Rainey, D. D. Wynn, Daphne Krantz, Verena Wieloch (2020). \textit{The Role of Psychedelics and Counseling in Mental Health Treatment}. Journal of Mental Health Counseling. [published; OpenAlex]. \href{https://doi.org/10.17744/mehc.42.4.03}{doi:10.17744/mehc.42.4.03}.
\item Romeo B, Karila L, Martelli C, Benyamina A (2020). \textit{Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis.}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881120919957}{doi:10.1177/0269881120919957}.
\item Nicole Harrington Cirino (2020). \textit{Wait for the Science Before Widespread Use of Psilocybin}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.10a32}{doi:10.1176/appi.pn.2020.10a32}.
\item Agata Tadeja (2020). \textit{Drugs in therapy. LSD, MDMA, marijuana, psilocybin, designer drugs and its potential in modern medicine.}. Farmacja Polska. [published; OpenAlex]. \href{https://doi.org/10.32383/farmpol/127922}{doi:10.32383/farmpol/127922}.
\item Shevaugn Johnson, Quentin Black (2020). \textit{Classic Psychedelics as a Psychotherapeutic Aid in the Treatment of Stimulant Use Disorder: a Case Report}. International Journal of Mental Health and Addiction. [published; OpenAlex]. \href{https://doi.org/10.1007/s11469-020-00398-7}{doi:10.1007/s11469-020-00398-7}.
\item Lukasz Smigielski, Michael Kometer, Milan Scheidegger, Cornelia Stress, Katrin H. Preller, Thomas Koenig, Franz X. Vollenweider (2020). \textit{P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlap}. Human Brain Mapping. [published; OpenAlex]. \href{https://doi.org/10.1002/hbm.25174}{doi:10.1002/hbm.25174}.
\item John R. Kelly, Matthew Crockett, Laith Alexander, Martin Haran, Amanda Baker, Lisa M. Burke, Christine Brennan, Veronica O’Keane (2020). \textit{Psychedelic science in post-COVID-19 psychiatry}. Irish Journal of Psychological Medicine. [published; OpenAlex]. \href{https://doi.org/10.1017/ipm.2020.94}{doi:10.1017/ipm.2020.94}.
\item Robin Carhart-Harris (2020). \textit{4 Psychedelics: therapeutic mechanisms}. Journal of Neurology Neurosurgery \& Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1136/jnnp-2020-bnpa.4}{doi:10.1136/jnnp-2020-bnpa.4}.
\item Edward Jacobs (2020). \textit{A potential role for psilocybin in the treatment of obsessive-compulsive disorder}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2020.00128}{doi:10.1556/2054.2020.00128}.
\item Frederick S. Barrett, Samuel R. Krimmel, Roland R. Griffiths, David A. Seminowicz, Brian N. Mathur (2020). \textit{Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2020.116980}{doi:10.1016/j.neuroimage.2020.116980}.
\item Natasha L. Mason, Kim P. C. Kuypers, Felix Müller, Johannes T. Reckweg, Desmond H. Y. Tse, Stefan W. Toennes, Nadia R. P. W. Hutten, Jacobus F.A. Jansen, Peter Stiers, Amanda Feilding, Johannes G. Ramaekers (2020). \textit{Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-020-0718-8}{doi:10.1038/s41386-020-0718-8}.
\item Abbott KL, Gill KS, Flannery PC, Boothe DM, Dhanasekaran M, Pondugula SR. (2020). \textit{Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.0c00241}{doi:10.1021/acschemneuro.0c00241}.
\item Unknown authors (2020). \textit{Data justify further research on potential of psychedelics in treating psychiatric disorders}. The Brown University Psychopharmacology Update. [published; OpenAlex]. \href{https://doi.org/10.1002/pu.30581}{doi:10.1002/pu.30581}.
\item Katie R. Barnes, Stephanie N. Lewis (2020). \textit{Binding Interactions of Psilocin and Serotonin in the 5-HT2A Receptor}. VTechWorks (Virginia Tech). [published; OpenAlex]. \href{http://hdl.handle.net/10919/99299}{source link}.
\item Marcus W. Meinhardt, Cansu Güngör, Ivan Skorodumov, Lea J. Mertens, Rainer Spanagel (2020). \textit{Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-020-0694-z}{doi:10.1038/s41386-020-0694-z}.
\item Halberstadt AL, Chatha M, Klein AK, Wallach J, Brandt SD (2020). \textit{Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.}. Neuropharmacology. [published; PubMed]. \href{https://doi.org/10.1016/j.neuropharm.2019.107933}{doi:10.1016/j.neuropharm.2019.107933}.
\item Morten Hesse (2020). \textit{Klassiske psykedeliske stoffer - inkl. psilocybin og LSD}. Unknown journal. [published; OpenAlex]. \href{https://pure.au.dk/portal/en/publications/45be7e79-66e2-4f51-af03-6c20860526cd}{source link}.
\item Nick Zagorski (2020). \textit{Psychedelics for Psychiatric Disorders: More Research Needed}. Psychiatric News. [published; OpenAlex]. \href{https://doi.org/10.1176/appi.pn.2020.4a14}{doi:10.1176/appi.pn.2020.4a14}.
\item Kringelbach ML, Cruzat J, Cabral J, Knudsen GM, Carhart-Harris R, Whybrow PC, Logothetis NK, Deco G. (2020). \textit{Dynamic coupling of whole-brain neuronal and neurotransmitter systems.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1073/pnas.1921475117}{doi:10.1073/pnas.1921475117}.
\item Elyes Dahmane, Paul R. Hutson, Jogarao Gobburu (2020). \textit{Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin}. Clinical Pharmacology in Drug Development. [published; OpenAlex]. \href{https://doi.org/10.1002/cpdd.796}{doi:10.1002/cpdd.796}.
\item Meghan Hibicke, Charles D. Nichols (2020). \textit{One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2020.34.s1.02912}{doi:10.1096/fasebj.2020.34.s1.02912}.
\item David Nutt, David Erritzøe, Robin Carhart-Harris (2020). \textit{Psychedelic Psychiatry’s Brave New World}. Cell. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cell.2020.03.020}{doi:10.1016/j.cell.2020.03.020}.
\item Anna Poliwoda, Katarzyna Zielińska, Piotr Wieczorek (2020). \textit{Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary Electrophoresis}. Molecules. [published; OpenAlex]. \href{https://doi.org/10.3390/molecules25071566}{doi:10.3390/molecules25071566}.
\item Meghan Hibicke, Alexus N. Landry, Hannah M. Kramer, Zoe K. Talman, Charles D. Nichols (2020). \textit{Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression}. ACS Chemical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.1021/acschemneuro.9b00493}{doi:10.1021/acschemneuro.9b00493}.
\item M. Madsen, Patrick M. Fisher, Dea Siggaard Stenbæk, Sara Kristiansen, Daniel Burmester, Szabolcs Lehel, Tomáš Páleníček, Martin Kuchař, Claus Svarer, Brice Ozenne, Gitte M. Knudsen (2020). \textit{A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.02.001}{doi:10.1016/j.euroneuro.2020.02.001}.
\item Alexander M. Sherwood, Adam L. Halberstadt, Adam K. Klein, John D. McCorvy, Kristi W. Kaylo, Robert B. Kargbo, Poncho Meisenheimer (2020). \textit{Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin}. Journal of Natural Products. [published; OpenAlex]. \href{https://doi.org/10.1021/acs.jnatprod.9b01061}{doi:10.1021/acs.jnatprod.9b01061}.
\item Candace R. Lewis, Katrin H. Preller, B. Blair Braden, Cory Riecken, Franz X. Vollenweider (2020). \textit{Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience}. Biomedicines. [published; OpenAlex]. \href{https://doi.org/10.3390/biomedicines8020034}{doi:10.3390/biomedicines8020034}.
\item Frederick S. Barrett, Manoj K. Doss, Nathan D. Sepeda, James J. Pekar, Roland R. Griffiths (2020). \textit{Emotions and brain function are altered up to one month after a single high dose of psilocybin}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-020-59282-y}{doi:10.1038/s41598-020-59282-y}.
\item Maho Hirasawa (2020). \textit{Effects of psilocin on the striatal monoamine contents in mice and rats}. The Pharmaceutical Society of Japan. [published; OpenAlex]. \href{https://confit.atlas.jp/guide/event/pharm140/subject/4P156-201-13/detail}{source link}.
\item Unknown authors (2020). \textit{LSD und Psilocybin als Selbstmedikation}. Suchttherapie. [published; OpenAlex]. \href{https://doi.org/10.1055/a-1085-0309}{doi:10.1055/a-1085-0309}.
\item Heidi Bush (2020). \textit{Psychedelic therapy: Fresh promise for mental health}. Mental Health Weekly. [published; OpenAlex]. \href{https://doi.org/10.1002/mhw.32207}{doi:10.1002/mhw.32207}.
\item Albert Garcia-Romeu, Alan K. Davis, Earth Erowid, Fire Erowid, Roland R. Griffiths, Matthew W. Johnson (2020). \textit{Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey}. Frontiers in Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.3389/fpsyt.2019.00955}{doi:10.3389/fpsyt.2019.00955}.
\item Case Medical Research (2020). \textit{Comparative Acute Effects of LSD, Psilocybin and Mescaline}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04227756}{doi:10.31525/ct1-nct04227756}.
\item Michael Draper (2020). \textit{Matthew Oram, The Trials of Psychedelic Therapy: LSD Psychotherapy in America}. Journal of the History of Medicine and Allied Sciences. [published; OpenAlex]. \href{https://doi.org/10.1093/jhmas/jraa002}{doi:10.1093/jhmas/jraa002}.
\item Katrin H. Preller, Patricia Duerler, Joshua B. Burt, Jie Lisa Ji, Brendan Adkinson, Philipp Stämpfli, Erich Seifritz, Grega Repovš, John H. Krystal, John D. Murray, Alan Anticevic, Franz X. Vollenweider (2020). \textit{Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2019.12.027}{doi:10.1016/j.biopsych.2019.12.027}.
\item Courtney Hutchison, Sara Bressi (2020). \textit{Social Work and Psychedelic-Assisted Therapies: Practice Considerations for Breakthrough Treatments}. Clinical Social Work Journal. [published; OpenAlex]. \href{https://doi.org/10.1007/s10615-019-00743-x}{doi:10.1007/s10615-019-00743-x}.
\item Case Medical Research (2020). \textit{Repeat Dosing of Psilocybin in Migraine Headache}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04218539}{doi:10.31525/ct1-nct04218539}.
\item Marcus Allgulin (2019). \textit{Psilocybin and LSD in the Treatment of Depression and Anxiety}. Diva portal (Dalarna University Library). [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18843}{source link}.
\item Courtney Ledford (2019). \textit{Predicting the Efficacy of Psilocybin in Treating Mental Health and Addiction}. PDXScholar (Portland State University). [published; OpenAlex]. \href{https://pdxscholar.library.pdx.edu/altreu\_projects/5}{source link}.
\item Katariina Sarajärvi (2019). \textit{Psilocybin's effects on the brain and implications for depression treatment}. Epubl LTU. [published; OpenAlex]. \href{http://urn.kb.se/resolve?urn=urn:nbn:se:ltu:diva-79481}{source link}.
\item Ammar Jawad (2019). \textit{Drugs and the Music Industry: How the Neurological and Visual Effects of LSD and Psilocybin Impact Creativity and Songwriting Abilities}. VCU Scholars Compass (Virginia Commonwealth University). [published; OpenAlex]. \href{https://scholarscompass.vcu.edu/uresposters/356}{source link}.
\item Krista Worden (2019). \textit{The Efficacy of Psilocybin Compared to Selective Serotonin Reuptake Inhibitors in the Treatment of Adults with Major Depressive Disorder}. Unknown journal. [published; OpenAlex]. \href{https://scholarworks.arcadia.edu/showcase/2020/pa/60/}{source link}.
\item JEC Anthony, Adam Winstock, JA Ferris, DJ Nutt (2019). \textit{Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/2050324520942345}{doi:10.1177/2050324520942345}.
\item Natasha L. Mason, Patrick C. Dolder, Kim P. C. Kuypers (2019). \textit{Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts}. Drug Science Policy and Law. [published; OpenAlex]. \href{https://doi.org/10.1177/2050324519900068}{doi:10.1177/2050324519900068}.
\item Ho JT, Preller KH, Lenggenhager B (2019). \textit{Neuropharmacological modulation of the aberrant bodily self through psychedelics.}. Neuroscience and biobehavioral reviews. [published; PubMed]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.006}{doi:10.1016/j.neubiorev.2019.12.006}.
\item Krishna Kumar Varshney (2019). \textit{Structure Based Drug Design towards Exploring Potential Anti-Psychotic and Anti-Depressant Activity of Possible Stiff Base of Psilocybin}. SSRN Electronic Journal. [published; OpenAlex]. \href{https://papers.ssrn.com/sol3/papers.cfm?abstract\_id=3528349}{source link}.
\item Rosalind Watts, Jason B. Luoma (2019). \textit{The use of the psychological flexibility model to support psychedelic assisted therapy}. Journal of Contextual Behavioral Science. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcbs.2019.12.004}{doi:10.1016/j.jcbs.2019.12.004}.
\item Corne R, Mongeau R. (2019). \textit{[Neurotrophic mechanisms of psychedelic therapy].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1051/jbio/2019015}{doi:10.1051/jbio/2019015}.
\item Dos Santos RG, Hallak JEC. (2019). \textit{Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2019.12.001}{doi:10.1016/j.neubiorev.2019.12.001}.
\item Mie Madsen, P.M. Fisher, D.S. Stenbæk, S. Kristiansen, D. Burmester, S. Lehel, Tomáš Páleníček, Claus Svarer, B. Ozenne, Gitte M. Knudsen (2019). \textit{P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personality}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.232}{doi:10.1016/j.euroneuro.2019.09.232}.
\item Dea Siggaard Stenbæk, M.K. Madsen, Brice Ozenne, Søren Kristiansen, Daniel Burmester, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher (2019). \textit{P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levels}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.702}{doi:10.1016/j.euroneuro.2019.09.702}.
\item Martin Andersson, Anette Kjellgren (2019). \textit{Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube}. Harm Reduction Journal. [published; OpenAlex]. \href{https://doi.org/10.1186/s12954-019-0333-3}{doi:10.1186/s12954-019-0333-3}.
\item Sally Meikle, Paul Liknaitzky, Susan L. Rossell, Margaret Ross, Nigel Strauss, Neil Thomas, Greg Murray, M.L. Williams, David Castle (2019). \textit{Psilocybin-assisted therapy for depression: How do we advance the field?}. Australian \& New Zealand Journal of Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1177/0004867419888575}{doi:10.1177/0004867419888575}.
\item Felix Blei, Sebastian Dörner, Janis Fricke, Florian Baldeweg, Felix Trottmann, Anna J. Komor, Florian Meyer, Christian Hertweck, Dirk Hoffmeister (2019). \textit{Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in “Magic” Mushrooms}. Chemistry - A European Journal. [published; OpenAlex]. \href{https://doi.org/10.1002/chem.201904363}{doi:10.1002/chem.201904363}.
\item Case Medical Research (2019). \textit{Psilocybin-assisted Psychotherapy for Opioid Use Disorder}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04161066}{doi:10.31525/ct1-nct04161066}.
\item Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL. (2019). \textit{DARK Classics in Chemical Neuroscience: NBOMes.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.9b00528}{doi:10.1021/acschemneuro.9b00528}.
\item Jordan Sloshower, Jeffrey Guss, Robert Krause, Ryan Wallace, Monnica T. Williams, Sara Reed, Matthew D. Skinta (2019). \textit{Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame}. Journal of Contextual Behavioral Science. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jcbs.2019.11.002}{doi:10.1016/j.jcbs.2019.11.002}.
\item Chris Letheby (2019). \textit{The Varieties of Psychedelic Epistemology}. UWA Profiles and Research Repository (University of Western Australia). [published; OpenAlex]. \href{https://admin.research-repository.uwa.edu.au/en/publications/12436068-2f0c-4c50-8bb8-de189a427289}{source link}.
\item Case Medical Research (2019). \textit{Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients}. Case Medical Research. [published; OpenAlex]. \href{https://doi.org/10.31525/ct1-nct04141501}{doi:10.31525/ct1-nct04141501}.
\item Lukasz Smigielski, Michael Kometer, Milan Scheidegger, Rainer Krähenmann, Theo Huber, Franz X. Vollenweider (2019). \textit{Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat}. Scientific Reports. [published; OpenAlex]. \href{https://doi.org/10.1038/s41598-019-50612-3}{doi:10.1038/s41598-019-50612-3}.
\item Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz (2019). \textit{Psilocybin for depression: Considerations for clinical trial design}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.026}{doi:10.1556/2054.2019.026}.
\item Hannes Kettner, Natasha L. Mason, Kim P. C. Kuypers (2019). \textit{Motives for Classical and Novel Psychoactive Substances Use in Psychedelic Polydrug Users}. Contemporary Drug Problems. [published; OpenAlex]. \href{https://doi.org/10.1177/0091450919863899}{doi:10.1177/0091450919863899}.
\item Grandjean J, Buehlmann D, Buerge M, Sigrist H, Seifritz E, Vollenweider FX, Pryce CR, Rudin M. (2019). \textit{Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/751255}{doi:10.1101/751255}.
\item King's College London (2019). \textit{A Randomised, Balanced, Double-blind Two-way Crossover Design Study to Evaluate the Effects of SRC Kinase Inhibitor, Saracatinib, on Brain Activity Associated With Visual Processing in Patients With Parkinson's Disease Psychosis.}. ClinicalTrials.gov. [clinical trial; ClinicalTrials.gov]. \href{https://clinicaltrials.gov/study/NCT03661125}{source link}.
\item Kuypers KP, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D. (2019). \textit{Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881119857204}{doi:10.1177/0269881119857204}.
\item Thomas Anderson, Rotem Petranker, Adam Christopher, Daniel Rosenbaum, Cory R. Weissman, Lê-Anh Dinh-Williams, Katrina Hui, Emma Hapke (2019). \textit{Psychedelic microdosing benefits and challenges: an empirical codebook}. Harm Reduction Journal. [published; OpenAlex]. \href{https://doi.org/10.1186/s12954-019-0308-4}{doi:10.1186/s12954-019-0308-4}.
\item David Nutt (2019). \textit{Psychedelic drugs-a new era in psychiatry?}. Dialogues in Clinical Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.31887/dcns.2019.21.2/dnutt}{doi:10.31887/dcns.2019.21.2/dnutt}.
\item Richard Simoneaux (2019). \textit{The Potential of Psilocybin Administration in Terminal Cancer Patients}. Oncology Times. [published; OpenAlex]. \href{https://doi.org/10.1097/01.cot.0000574916.46844.cf}{doi:10.1097/01.cot.0000574916.46844.cf}.
\item Carla Pallavicini, Martina G. Vilas, Mirta F. Villarreal, Federico Zamberlán, Suresh Muthukumaraswamy, David Nutt, Robin Carhart-Harris, Enzo Tagliazucchi (2019). \textit{Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2019.06.053}{doi:10.1016/j.neuroimage.2019.06.053}.
\item Doreen M. Lewis (2019). \textit{Faces of HPPD: Hallucinogen Persisting Perception Disorder Patient Survey Results and a Descriptive Analysis of Patient Demographics, Medical Background, Drug Use History, Symptoms, and Treatments}. Addictive Disorders \& Their Treatment. [published; OpenAlex]. \href{https://doi.org/10.1097/adt.0000000000000178}{doi:10.1097/adt.0000000000000178}.
\item Michael Winkelman (2019). \textit{Introduction: Evidence for entheogen use in prehistory and world religions}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2019.024}{doi:10.1556/2054.2019.024}.
\item Madsen MK, Fisher PM, Burmester D, Dyssegaard A, Stenbæk DS, Kristiansen S, Johansen SS, Lehel S, Linnet K, Svarer C, Erritzoe D, Ozenne B, Knudsen GM. (2019). \textit{Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/s41386-019-0360-5}{doi:10.1038/s41386-019-0360-5}.
\item Louis-David Lord, Paul Expert, Selen Atasoy, Leor Roseman, Kristina M. Rapuano, Renaud Lambiotte, David Nutt, Gustavo Deco, Robin Carhart-Harris, Morten L. Kringelbach, Joana Cabral (2019). \textit{Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2019.05.060}{doi:10.1016/j.neuroimage.2019.05.060}.
\item Oskar Hougaard Jefsen, Kristoffer Højgaard, Sofie Laage Christiansen, Betina Elfving, David Nutt, Gregers Wegener, Heidi Kaastrup Müller (2019). \textit{Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat}. Acta Neuropsychiatrica. [published; OpenAlex]. \href{https://doi.org/10.1017/neu.2019.15}{doi:10.1017/neu.2019.15}.
\item Izumi Morita, Hiroyuki Oyama, Rie Tanaka, Ruri Kikura-Hanajiri, Norihiro Kobayashi (2019). \textit{Generation of monoclonal antibodies for on-site analysis of psilocin and psilocybin in hallucinogenic mushrooms}. Clinica Chimica Acta. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cca.2019.03.139}{doi:10.1016/j.cca.2019.03.139}.
\item Witkin JM, Martin AE, Golani LK, Xu NZ, Smith JL. (2019). \textit{Rapid-acting antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.apha.2019.03.002}{doi:10.1016/bs.apha.2019.03.002}.
\item Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini, Laura Orsolini, Amira Guirguis, John Corkery, Stefania Bonaccorso, A Ricciardi, Norbert Scherbaum, Alessandro Vento (2019). \textit{New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues}. Current Addiction Reports. [published; OpenAlex]. \href{https://doi.org/10.1007/s40429-019-00249-z}{doi:10.1007/s40429-019-00249-z}.
\item Roland R. Griffiths, Ethan Hurwitz, Alan K. Davis, Matthew W. Johnson, Robert L. Jesse (2019). \textit{Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0214377}{doi:10.1371/journal.pone.0214377}.
\item McKenna Silva (2019). \textit{Attitudes Toward Medical Psychedelics}. Dominican Scholar (Dominican University of California). [published; OpenAlex]. \href{https://scholar.dominican.edu/scw/SCW2019/conference-presentations-exhibits-and-performances/83}{source link}.
\item Lukasz Smigielski, Milan Scheidegger, Michael Kometer, Franz X. Vollenweider (2019). \textit{Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects}. NeuroImage. [published; OpenAlex]. \href{https://doi.org/10.1016/j.neuroimage.2019.04.009}{doi:10.1016/j.neuroimage.2019.04.009}.
\item Meghan Hibicke, Alexus N. Landry, Zoe K. Talman, Charles D. Nichols (2019). \textit{Psychedelics Improve the Mental Health of Rats}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.2019.33.1\_supplement.666.1}{doi:10.1096/fasebj.2019.33.1\_supplement.666.1}.
\item Richard Doblin, Merete Bruun Christiansen, Lisa Jerome, Brad Burge (2019). \textit{The Past and Future of Psychedelic Science: An Introduction to This Issue}. Journal of Psychoactive Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.2019.1606472}{doi:10.1080/02791072.2019.1606472}.
\item Ahmed Al-Imam, Faris Lami (2019). \textit{One Ultimate Journey? AKA the Huxley’s Method: Perspectives of (Ab)Users of Hallucinogens and Entheogens on Having Planned Pre-Mortem Psychedelic Trip}. Modern Applied Science. [published; OpenAlex]. \href{https://doi.org/10.5539/mas.v13n3p13}{doi:10.5539/mas.v13n3p13}.
\item M. Madsen, Patrick M. Fisher, Daniel Burmester, Agnete Dyssegaard, Dea Siggaard Stenbæk, Sara Kristiansen, Sys Stybe Johansen, Sczabolz Lehel, Kristían Línnet, Claus Svarer, David Erritzøe, Brice Ozenne, Gitte M. Knudsen (2019). \textit{Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels}. Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1038/s41386-019-0324-9}{doi:10.1038/s41386-019-0324-9}.
\item Stenbaek DS, Kristiansen S, Burmester D, Madsen MK, Frokjaer VG, Knudsen GM, Fisher PM. (2019). \textit{Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/hbm.24511}{doi:10.1002/hbm.24511}.
\item Farhana Sakloth, Elizabeth Leggett, Megan J. Moerke, E. Andrew Townsend, Matthew L. Banks, S. Stevens Negus (2019). \textit{Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.}. Experimental and Clinical Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1037/pha0000253}{doi:10.1037/pha0000253}.
\item William G. Crane (2018). \textit{Serotonergic Psychoactive Compounds as a Treatment for Addiction, Anxiety, and Depression: Their Efficacy and Legality}. Furman University Scholar Exchange (Furman University). [published; OpenAlex]. \href{https://scholarexchange.furman.edu/furmanengaged/2019/all/522}{source link}.
\item P. Dürler (2018). \textit{Psilocybin induces aberrant prediction error processing for tactile mismatch responses}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2018.11.477}{doi:10.1016/j.euroneuro.2018.11.477}.
\item Kelly M. Brinsko, Dean Golemis, Meggan B. King, Gary J. Laughlin, Sebastian B. Sparenga (2018). \textit{Microcrystal Tests for the Identification of Illicit Drugs: Phencyclidine, Pseudoephedrine, and Psilocin}. The Microscope. [published; OpenAlex]. \href{https://doi.org/10.59082/tnwk8166}{doi:10.59082/tnwk8166}.
\item Dinis-Oliveira RJ, Pereira CL, da Silva DD. (2018). \textit{Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1874467211666181010154139}{doi:10.2174/1874467211666181010154139}.
\item Gregory Scott, Robin Carhart-Harris (2018). \textit{Psychedelics as a treatment for disorders of consciousness}. Neuroscience of Consciousness. [published; OpenAlex]. \href{https://doi.org/10.1093/nc/niz003}{doi:10.1093/nc/niz003}.
\item M. Madsen, Daniel Burmester, Dea Siggaard Stenbæk, Søren Kristiansen, Agnete Dyssegaard, Szabolcs Lehel, Kristían Línnet, Sys Stybe Johansen, Claus Svarer, Brice Ozenne, David Erritzøe, Patrick M. Fisher, Gitte M. Knudsen (2018). \textit{Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2018.11.474}{doi:10.1016/j.euroneuro.2018.11.474}.
\item Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. (2018). \textit{Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pharmthera.2018.11.010}{doi:10.1016/j.pharmthera.2018.11.010}.
\item Wasko MJ, Witt-Enderby PA, Surratt CK. (2018). \textit{DARK Classics in Chemical Neuroscience: Ibogaine.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00294}{doi:10.1021/acschemneuro.8b00294}.
\item Elizabeth M. Nielson, Jeffrey Guss (2018). \textit{The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training}. Journal of Psychedelic Studies. [published; OpenAlex]. \href{https://doi.org/10.1556/2054.2018.009}{doi:10.1556/2054.2018.009}.
\item Jalal B. (2018). \textit{The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-018-5042-1}{doi:10.1007/s00213-018-5042-1}.
\item Nicole Fossos-Wong, Ha-Yoon Lee, Kathryn B. Vincent, Devon Alisa Abdallah, Krista S. Dashtestani, M. Dolores Cimini, Karen L. Sokolowski, Geetha Subramaniam, Irene M. Geisner (2018). \textit{1.13 Microdosing of Hallucinogens Among College Students: Frequency, Correlates, and Consequences}. Journal of the American Academy of Child \& Adolescent Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.jaac.2018.09.029}{doi:10.1016/j.jaac.2018.09.029}.
\item Müller F, Liechti ME, Lang UE, Borgwardt S. (2018). \textit{Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2018.08.004}{doi:10.1016/bs.pbr.2018.08.004}.
\item Robin Carhart-Harris (2018). \textit{Serotonin, psychedelics and psychiatry}. World Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1002/wps.20555}{doi:10.1002/wps.20555}.
\item Millière R, Carhart-Harris RL, Roseman L, Trautwein FM, Berkovich-Ohana A. (2018). \textit{Psychedelics, Meditation, and Self-Consciousness.}. Frontiers in Psychology. [published; Europe PMC]. \href{https://doi.org/10.3389/fpsyg.2018.01475}{doi:10.3389/fpsyg.2018.01475}.
\item Horsley RR, Páleníček T, Kolin J, Valeš K. (2018). \textit{Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/fbp.0000000000000394}{doi:10.1097/fbp.0000000000000394}.
\item De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G. (2018). \textit{d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/bs.pbr.2018.07.008}{doi:10.1016/bs.pbr.2018.07.008}.
\item Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC. (2018). \textit{Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/17512433.2018.1511424}{doi:10.1080/17512433.2018.1511424}.
\item Flanagan TW, Nichols CD. (2018). \textit{Psychedelics as anti-inflammatory agents.}. International Review of Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2018.1481827}{doi:10.1080/09540261.2018.1481827}.
\item Ross S. (2018). \textit{Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/09540261.2018.1482261}{doi:10.1080/09540261.2018.1482261}.
\item Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR. (2018). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-018-4981-x}{doi:10.1007/s00213-018-4981-x}.
\item Blei F, Baldeweg F, Fricke J, Hoffmeister D. (2018). \textit{Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase-Enhanced Reactions.}. Chemistry - A European Journal. [published; Europe PMC]. \href{https://doi.org/10.1002/chem.201801047}{doi:10.1002/chem.201801047}.
\item Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE. (2018). \textit{The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2018.05.012}{doi:10.1016/j.neuropharm.2018.05.012}.
\item Aixalà M, Dos Santos RG, Hallak JEC, Bouso JC. (2018). \textit{Psychedelics and Personality.}. ACS Chemical Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00237}{doi:10.1021/acschemneuro.8b00237}.
\item Vigerelli H, Sciani JM, Eula MAC, Sato LA, Antoniazzi MM, Jared C, Pimenta DC. (2018). \textit{Biological Effects and Biodistribution of Bufotenine on Mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1155/2018/1032638}{doi:10.1155/2018/1032638}.
\item Whelan A, Johnson MI. (2018). \textit{Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2217/pmt-2017-0068}{doi:10.2217/pmt-2017-0068}.
\item Grimm O, Kraehenmann R, Preller KH, Seifritz E, Vollenweider FX. (2018). \textit{Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.}. European Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2018.03.016}{doi:10.1016/j.euroneuro.2018.03.016}.
\item Michael C. McKenna, John R. Fedota, Albert Garcia-Romeu, Matthew R. Johnson, Roland R. Griffiths, Elliot A. Stein (2018). \textit{T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking Smokers}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.biopsych.2018.02.600}{doi:10.1016/j.biopsych.2018.02.600}.
\item Mascha M.J. Linszen, Hidde Kleijer, Iris E. Sommer (2018). \textit{Visual hallucinations and lifetime use of hallucinogen perception persisting disorder associated recreational drugs: results from a large online survey}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2017.12.114}{doi:10.1016/j.euroneuro.2017.12.114}.
\item Elaheh Mahmoudi, Mehrdad Faizi, Reza Hajiaghaee, Ali Razmi (2018). \textit{Alteration of Depressive-like Behaviors by Psilocybe cubensis Alkaloid Extract in Mice: the Role of Glutamate Pathway}. DOAJ (DOAJ: Directory of Open Access Journals). [published; OpenAlex]. \href{https://doi.org/10.22127/rjp.2018.58486}{doi:10.22127/rjp.2018.58486}.
\item Nichols DE. (2018). \textit{Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/acschemneuro.8b00043}{doi:10.1021/acschemneuro.8b00043}.
\item Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC. (2018). \textit{Horizontal gene cluster transfer increased hallucinogenic mushroom diversity.}. Evolution Letters. [published; Europe PMC]. \href{https://doi.org/10.1002/evl3.42}{doi:10.1002/evl3.42}.
\item Camila Sanz, Federico Zamberlán, Earth Erowid, Fire Erowid, Enzo Tagliazucchi (2018). \textit{The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports}. Frontiers in Neuroscience. [published; OpenAlex]. \href{https://doi.org/10.3389/fnins.2018.00007}{doi:10.3389/fnins.2018.00007}.
\item Bravermanová A, Viktorinová M, Tylš F, Novák T, Androvičová R, Korčák J, Horáček J, Balíková M, Griškova-Bulanova I, Danielová D, Vlček P, Mohr P, Brunovský M, Koudelka V, Páleníček T. (2018). \textit{Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4807-2}{doi:10.1007/s00213-017-4807-2}.
\item Kayla Wilwohl (2017). \textit{Are psychedelics effective in treating anxiety associated with a lifethreatening disease}. Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine). [published; OpenAlex]. \href{https://digitalcommons.pcom.edu/pa\_systematic\_reviews/308}{source link}.
\item Landon M. Klein (2017). \textit{If you give a mouse a mushroom: Behavioral effects of hallucinogens in mice}. eScholarship (California Digital Library). [published; OpenAlex]. \href{https://escholarship.org/uc/item/3bx3d6pf}{source link}.
\item Kometer M, Vollenweider FX. (2017). \textit{Serotonergic Hallucinogen-Induced Visual Perceptual Alterations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2016\_461}{doi:10.1007/7854\_2016\_461}.
\item Preller KH, Vollenweider FX (2017). \textit{Phenomenology, Structure, and Dynamic of Psychedelic States.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_459}{doi:10.1007/7854\_2016\_459}.
\item Halberstadt AL, Geyer MA (2017). \textit{Effect of Hallucinogens on Unconditioned Behavior.}. Current topics in behavioral neurosciences. [published; PubMed]. \href{https://doi.org/10.1007/7854\_2016\_466}{doi:10.1007/7854\_2016\_466}.
\item Bogenschutz MP, Ross S. (2017). \textit{Therapeutic Applications of Classic Hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2016\_464}{doi:10.1007/7854\_2016\_464}.
\item Martin DA, Nichols CD. (2017). \textit{The Effects of Hallucinogens on Gene Expression.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_479}{doi:10.1007/7854\_2017\_479}.
\item López-Giménez JF, González-Maeso J. (2017). \textit{Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/7854\_2017\_478}{doi:10.1007/7854\_2017\_478}.
\item Canal CE. (2017). \textit{Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/164\_2018\_107}{doi:10.1007/164\_2018\_107}.
\item Witkin JM, Knutson DE, Rodriguez GJ, Shi S. (2017). \textit{Rapid-Acting Antidepressants.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1381612824666180730104707}{doi:10.2174/1381612824666180730104707}.
\item Joanna Stefaniuk (2017). \textit{„Terapia szokowa”, czyli agoniści receptor 5-HT2A w leczeniu depresji i lęku}. CeON Repository (Centre for Evaluation in Education and Science). [published; OpenAlex]. \href{https://depot.ceon.pl/handle/123456789/13483}{source link}.
\item Kraehenmann R, Pokorny D, Aicher H, Preller KH, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX. (2017). \textit{LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.}. Frontiers in Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.3389/fphar.2017.00814}{doi:10.3389/fphar.2017.00814}.
\item Carbonaro TM, Johnson MW, Hurwitz E, Griffiths RR. (2017). \textit{Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-017-4769-4}{doi:10.1007/s00213-017-4769-4}.
\item Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ. (2017). \textit{Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.}. Scientific Reports. [published; Europe PMC]. \href{https://doi.org/10.1038/s41598-017-13282-7}{doi:10.1038/s41598-017-13282-7}.
\item Di Giovanni G, De Deurwaerdère P. (2017). \textit{TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2017.10.004}{doi:10.1016/j.neuropharm.2017.10.004}.
\item Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T. (2017). \textit{Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pnpbp.2017.09.012}{doi:10.1016/j.pnpbp.2017.09.012}.
\item Ahmed Al-Imam (2017). \textit{Google Trends Analyses and Case Report: A Persistently Dilated Pupil in Psychedelics’ User}. Global Journal of Health Science. [published; OpenAlex]. \href{https://doi.org/10.5539/gjhs.v9n11p168}{doi:10.5539/gjhs.v9n11p168}.
\item Pokorny T, Preller KH, Kometer M, Dziobek I, Vollenweider FX. (2017). \textit{Effect of Psilocybin on Empathy and Moral Decision-Making.}. The International Journal of Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyx047}{doi:10.1093/ijnp/pyx047}.
\item Reynolds HT, Vijayakumar V, Gluck-Thaler E, Korotkin HB, Matheny PB, Slot JC. (2017). \textit{Horizontal gene cluster transfer increased hallucinogenic mushroom diversity}. bioRxiv. [preprint; bioRxiv]. \href{https://doi.org/10.1101/176347}{doi:10.1101/176347}.
\item Lewis CR, Preller KH, Kraehenmann R, Michels L, Staempfli P, Vollenweider FX. (2017). \textit{Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.}. NeuroImage. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuroimage.2017.07.020}{doi:10.1016/j.neuroimage.2017.07.020}.
\item Majić T, Jungaberle H, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J. (2017). \textit{[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-0043-103085}{doi:10.1055/s-0043-103085}.
\item Janis Phelps (2017). \textit{Developing Guidelines and Competencies for the Training of Psychedelic Therapists}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167817711304}{doi:10.1177/0022167817711304}.
\item Anne Walley (2017). \textit{The Effects of LSD and Psilocin on Anxiety-Related Behaviours in Zebrafish}. Student Research Proceedings. [published; OpenAlex]. \href{https://journals.macewan.ca/studentresearch/article/view/1171}{source link}.
\item Thomas K, Malcolm B, Lastra D. (2017). \textit{Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2017.1320734}{doi:10.1080/02791072.2017.1320734}.
\item Jonathan Nash (2017). \textit{The Development and Regulation of Psychedelic Medicines}. Northumbria Research Link (Northumbria University). [published; OpenAlex]. \href{http://nrl.northumbria.ac.uk/id/eprint/31696/1/SLSA.pptx}{source link}.
\item Thomas W. Flanagan, Melaine N. Sebastian, Charles D. Nichols (2017). \textit{Anti-inflammatory effects of serotonin 5-HT2A receptor activation in ovalbumin-induced allergic asthma models}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.31.1\_supplement.820.4}{doi:10.1096/fasebj.31.1\_supplement.820.4}.
\item Dos Santos RG, Bouso JC, Hallak JEC. (2017). \textit{Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125316689030}{doi:10.1177/2045125316689030}.
\item Huestis MA, Tyndale RF. (2017). \textit{Designer Drugs 2.0.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.575}{doi:10.1002/cpt.575}.
\item Dinis-Oliveira RJ. (2017). \textit{Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/03602532.2016.1278228}{doi:10.1080/03602532.2016.1278228}.
\item Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S. (2017). \textit{The fibrinolytic system: A new target for treatment of depression with psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.mehy.2017.01.013}{doi:10.1016/j.mehy.2017.01.013}.
\item Keli A. Herr (2016). \textit{Sex Differences in Serotonergic and Dopaminergic Mediation of LSD Discrimination in Rats}. ScholarWorks - WMU (Western Michigan University). [published; OpenAlex]. \href{https://scholarworks.wmich.edu/dissertations/3170}{source link}.
\item Albert Garcia-Romeu (2016). \textit{Psychedelics as change agents in addiction and mood disorders.}. Unknown journal. [published; OpenAlex]. \href{https://www.drugsandalcohol.ie/29118/}{source link}.
\item Daniel J, Haberman M. (2016). \textit{Clinical potential of psilocybin as a treatment for mental health conditions.}. Mental Health Clinician. [published; Europe PMC]. \href{https://doi.org/10.9740/mhc.2017.01.024}{doi:10.9740/mhc.2017.01.024}.
\item Nichols DE, Johnson MW, Nichols CD. (2016). \textit{Psychedelics as Medicines: An Emerging New Paradigm.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/cpt.557}{doi:10.1002/cpt.557}.
\item Celia J. A. Morgan, Amy McAndrew, Tobias Stevens, David Nutt, Will Lawn (2016). \textit{Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use}. Current Opinion in Behavioral Sciences. [published; OpenAlex]. \href{https://doi.org/10.1016/j.cobeha.2016.10.009}{doi:10.1016/j.cobeha.2016.10.009}.
\item Dos Santos RG, Osório FL, Crippa JAS, Hallak JEC. (2016). \textit{Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neubiorev.2016.10.026}{doi:10.1016/j.neubiorev.2016.10.026}.
\item Mahapatra A, Gupta R. (2016). \textit{Role of psilocybin in the treatment of depression.}. Therapeutic Advances in Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/2045125316676092}{doi:10.1177/2045125316676092}.
\item Michael P. Bogenschutz, Alyssa A. Forcehimes (2016). \textit{Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167816673493}{doi:10.1177/0022167816673493}.
\item Filip Tylš, Čestmír Vejmola, Michaela Viktorinová, L. Kadeřábek, Tomáš Páleníček (2016). \textit{Psilocybin-induced psychosis in humans and in rats − translational quantitative EEG study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(16)31133-6}{doi:10.1016/s0924-977x(16)31133-6}.
\item O. Grimm, Rainer Krähenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider (2016). \textit{Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination task}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(16)31070-7}{doi:10.1016/s0924-977x(16)31070-7}.
\item Karolina Dydak, Mariola Śliwińska-Mossoń, Halina Milnerowicz (2016). \textit{Psilocybin as an alternative medicine for patients suffering from depression}. Psychiatria i Psychologia Kliniczna. [published; OpenAlex]. \href{https://doi.org/10.15557/pipk.2016.0023}{doi:10.15557/pipk.2016.0023}.
\item William A. Richards (2016). \textit{Psychedelic Psychotherapy: Insights From 25 Years of Research}. Journal of Humanistic Psychology. [published; OpenAlex]. \href{https://doi.org/10.1177/0022167816670996}{doi:10.1177/0022167816670996}.
\item de Veen BT, Schellekens AF, Verheij MM, Homberg JR. (2016). \textit{Psilocybin for treating substance use disorders?}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/14737175.2016.1220834}{doi:10.1080/14737175.2016.1220834}.
\item Johnson MW, Garcia-Romeu A, Griffiths RR. (2016). \textit{Long-term follow-up of psilocybin-facilitated smoking cessation.}. The American Journal of Drug and Alcohol Abuse. [published; Europe PMC]. \href{https://doi.org/10.3109/00952990.2016.1170135}{doi:10.3109/00952990.2016.1170135}.
\item Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Lomnicka I, Waguespack M, Johnson MW, Griffiths RR, Riba J. (2016). \textit{Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.}. The International Journal of Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1093/ijnp/pyw016}{doi:10.1093/ijnp/pyw016}.
\item Howland RH. (2016). \textit{Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.}. Journal of Psychosocial Nursing and Mental Health Services. [published; Europe PMC]. \href{https://doi.org/10.3928/02793695-20160616-09}{doi:10.3928/02793695-20160616-09}.
\item Bartolucci Silvia, Mari Michele, Di Gregorio Giovanni, Piersanti Giovanni (2016). \textit{ChemInform Abstract: Observations Concerning the Synthesis of Tryptamine Homologues and Branched Tryptamine Derivatives via the Borrowing Hydrogen Process: Synthesis of Psilocin, Bufotenin, and Serotonin.}. ChemInform. [published; Crossref]. \href{https://doi.org/10.1002/chin.201633131}{doi:10.1002/chin.201633131}.
\item Tylš F, Páleníček T, Kadeřábek L, Lipski M, Kubešová A, Horáček J. (2016). \textit{Sex differences and serotonergic mechanisms in the behavioural effects of psilocin.}. Behavioural Pharmacology. [published; Europe PMC]. \href{https://doi.org/10.1097/fbp.0000000000000198}{doi:10.1097/fbp.0000000000000198}.
\item Filip Tylš, Michaela Viktorinová, Dominika Prokopcova, Jakub Korčák, Renata Androvičová, Martin Brunovský, Jiřı́ Horáček (2016). \textit{PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG}. The International Journal of Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1093/ijnp/pyw041.506}{doi:10.1093/ijnp/pyw041.506}.
\item Rickli A, Moning OD, Hoener MC, Liechti ME. (2016). \textit{Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2016.05.001}{doi:10.1016/j.euroneuro.2016.05.001}.
\item Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ. (2016). \textit{Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.}. The Lancet Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/s2215-0366(16)30065-7}{doi:10.1016/s2215-0366(16)30065-7}.
\item Bartolucci Silvia, Mari Michele, Di Gregorio Giovanni, Piersanti Giovanni (2016). \textit{Observations concerning the synthesis of tryptamine homologues and branched tryptamine derivatives via the borrowing hydrogen process: synthesis of psilocin, bufotenin, and serotonin}. Tetrahedron. [published; Crossref]. \href{https://doi.org/10.1016/j.tet.2016.03.007}{doi:10.1016/j.tet.2016.03.007}.
\item Preller KH, Pokorny T, Hock A, Kraehenmann R, Stämpfli P, Seifritz E, Scheidegger M, Vollenweider FX. (2016). \textit{Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.}. Proceedings of the National Academy of Sciences. [published; Europe PMC]. \href{https://doi.org/10.1073/pnas.1524187113}{doi:10.1073/pnas.1524187113}.
\item Nichols DE. (2016). \textit{Psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1124/pr.115.011478}{doi:10.1124/pr.115.011478}.
\item Laura Orsolini, Alessandro Valchera, Duccio Papanti, R. Vecchiotti, Domenico De Berardis (2016). \textit{The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/j.eurpsy.2016.01.1060}{doi:10.1016/j.eurpsy.2016.01.1060}.
\item Suzuki K. (2016). \textit{[Three cases of acute serotonin syndrome due to psilocybin mushroom poisoning].}. PubMed. [published; Europe PMC]. \href{https://europepmc.org/article/MED/27255023}{source link}.
\item Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX. (2016). \textit{Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.}. European Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2016.01.005}{doi:10.1016/j.euroneuro.2016.01.005}.
\item Joseph Havens (2015). \textit{MEMO ON THE RELIGIOUS IMPLICATIONS OF THE CONSCIOUSNESS-CHANGING DRUGS (LSD, Mescalin, Psilocybin)}. Unknown journal. [published; OpenAlex]. \href{https://www.jstor.org/stable/1384511}{source link}.
\item Dimitria Electra Gatzia, Berit Brogaard (2015). \textit{Psilocybin, LSD, Mescaline and drug-induced synesthesia}. PhilPapers (PhilPapers Foundation). [published; OpenAlex]. \href{https://philarchive.org/rec/BROPLM}{source link}.
\item Albert Garcia-Romeu, Tehseen Noorani, Roland R. Griffiths, Matthew W. Johnson (2015). \textit{Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accounts}. Drug and Alcohol Dependence. [published; OpenAlex]. \href{https://doi.org/10.1016/j.drugalcdep.2015.07.1130}{doi:10.1016/j.drugalcdep.2015.07.1130}.
\item Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, Milan Scheidegger, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider (2015). \textit{P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(15)30364-3}{doi:10.1016/s0924-977x(15)30364-3}.
\item Kraehenmann R, Schmidt A, Friston K, Preller KH, Seifritz E, Vollenweider FX. (2015). \textit{The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.}. NeuroImage Clinical. [published; Europe PMC]. \href{https://doi.org/10.1016/j.nicl.2015.08.009}{doi:10.1016/j.nicl.2015.08.009}.
\item Kometer M, Pokorny T, Seifritz E, Volleinweider FX. (2015). \textit{Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-015-4026-7}{doi:10.1007/s00213-015-4026-7}.
\item Spain A, Howarth C, Khrapitchev AA, Sharp T, Sibson NR, Martin C. (2015). \textit{Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.}. Neuropharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2015.07.018}{doi:10.1016/j.neuropharm.2015.07.018}.
\item Wiltshire PE, Hawksworth DL, Edwards KJ. (2015). \textit{Light microscopy can reveal the consumption of a mixture of psychotropic plant and fungal material in suspicious death.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jflm.2015.05.010}{doi:10.1016/j.jflm.2015.05.010}.
\item Araújo AM, Carvalho F, Bastos Mde L, Guedes de Pinho P, Carvalho M. (2015). \textit{The hallucinogenic world of tryptamines: an updated review.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00204-015-1513-x}{doi:10.1007/s00204-015-1513-x}.
\item Zhuk O, Jasicka-Misiak I, Poliwoda A, Kazakova A, Godovan VV, Halama M, Wieczorek PP. (2015). \textit{Research on acute toxicity and the behavioral effects of methanolic extract from psilocybin mushrooms and psilocin in mice.}. Toxins. [published; Europe PMC]. \href{https://doi.org/10.3390/toxins7041018}{doi:10.3390/toxins7041018}.
\item D.J. Nutt (2015). \textit{5HT2a Receptors - a New Target for Depression?}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(15)30027-4}{doi:10.1016/s0924-9338(15)30027-4}.
\item Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider (2015). \textit{The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(15)30017-1}{doi:10.1016/s0924-9338(15)30017-1}.
\item Majić T, Schmidt TT, Gallinat J (2015). \textit{Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?}. Journal of psychopharmacology (Oxford, England). [published; PubMed]. \href{https://doi.org/10.1177/0269881114568040}{doi:10.1177/0269881114568040}.
\item Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ. (2015). \textit{Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881114565144}{doi:10.1177/0269881114565144}.
\item Ben Sessa (2014). \textit{Turn on and tune in to evidence-based psychedelic research}. The Lancet Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s2215-0366(14)00120-5}{doi:10.1016/s2215-0366(14)00120-5}.
\item Tittarelli R, Mannocchi G, Pantano F, Romolo FS. (2014). \textit{Recreational use, analysis and toxicity of tryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/1570159x13666141210222409}{doi:10.2174/1570159x13666141210222409}.
\item Wilcox JA. (2014). \textit{Psilocybin and Obsessive Compulsive Disorder.}. Journal of Psychoactive Drugs. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2014.963754}{doi:10.1080/02791072.2014.963754}.
\item Sakashita Y, Abe K, Katagiri N, Kambe T, Saitoh T, Utsunomiya I, Horiguchi Y, Taguchi K. (2014). \textit{Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats.}. Biological and Pharmaceutical Bulletin. [published; Europe PMC]. \href{https://doi.org/10.1248/bpb.b14-00315}{doi:10.1248/bpb.b14-00315}.
\item Unknown authors (2014). \textit{Hallucinogens induce a specific barcode of phosphorylation on the serotonin2A receptor that underlies a weaker receptor desensitization and internalization}. Receptors \& Clinical Investigation. [published; OpenAlex]. \href{https://doi.org/10.14800/rci.230}{doi:10.14800/rci.230}.
\item Rainer Kraehenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider (2014). \textit{P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(14)70316-5}{doi:10.1016/s0924-977x(14)70316-5}.
\item Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR. (2014). \textit{Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881114548296}{doi:10.1177/0269881114548296}.
\item Ron Cole-Turner (2014). \textit{ENTHEOGENS, MYSTICISM, AND NEUROSCIENCE}. Zygon®. [published; OpenAlex]. \href{https://doi.org/10.1111/zygo.12110}{doi:10.1111/zygo.12110}.
\item Baumeister D, Barnes G, Giaroli G, Tracy D (2014). \textit{Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.}. Therapeutic advances in psychopharmacology. [published; PubMed]. \href{https://doi.org/10.1177/2045125314527985}{doi:10.1177/2045125314527985}.
\item Halberstadt AL. (2014). \textit{Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bbr.2014.07.016}{doi:10.1016/j.bbr.2014.07.016}.
\item Rambousek L, Palenicek T, Vales K, Stuchlik A. (2014). \textit{The effect of psilocin on memory acquisition, retrieval, and consolidation in the rat.}. Frontiers in Behavioral Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.3389/fnbeh.2014.00180}{doi:10.3389/fnbeh.2014.00180}.
\item Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX. (2014). \textit{Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.}. Biological Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2014.04.010}{doi:10.1016/j.biopsych.2014.04.010}.
\item Karaki S, Becamel C, Murat S, Mannoury la Cour C, Millan MJ, Prézeau L, Bockaert J, Marin P, Vandermoere F. (2014). \textit{Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.}. Molecular \& Cellular Proteomics. [published; Europe PMC]. \href{https://doi.org/10.1074/mcp.m113.036558}{doi:10.1074/mcp.m113.036558}.
\item Tyls F., Palenicek T., Novakova P., Kaderabek L., Fujakova M., Kubesova A., Horacek J. (2014). \textit{P.4.022 The impact of serotonin system modulation on behavior and quantitative EEG in an animal model of psychosis induced by psilocin}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/s0924-977x(14)70111-7}{doi:10.1016/s0924-977x(14)70111-7}.
\item Tomáš Páleníček, Filip Tylš, M. Fujáková, Anna Kubešová, Pavlína Nováková, L. Kadeřábek, Martin Brunovský, Jiřı́ Horáček (2013). \textit{EPA-0137 - EEG power spectra and connectivity changes in animal serotonergic and glutamatergic models of psychosis - implications for treatment}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(14)77609-6}{doi:10.1016/s0924-9338(14)77609-6}.
\item Javier González-Maeso (2013). \textit{EPA-1211 - Role of 5-HT2a and mglu2 as a gpcr heterocomplex in antipsychotic action}. European Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-9338(14)78457-3}{doi:10.1016/s0924-9338(14)78457-3}.
\item Charlesice Hawkins (2013). \textit{Literature review: Considerations for Psychedelic Research}. UC Merced Undergraduate Research Journal. [published; OpenAlex]. \href{https://doi.org/10.5070/m451020759}{doi:10.5070/m451020759}.
\item Brogaard B. (2013). \textit{Serotonergic hyperactivity as a potential factor in developmental, acquired and drug-induced synesthesia.}. Frontiers in Human Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.3389/fnhum.2013.00657}{doi:10.3389/fnhum.2013.00657}.
\item Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ. (2013). \textit{Broadband cortical desynchronization underlies the human psychedelic state.}. Journal of Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.2063-13.2013}{doi:10.1523/jneurosci.2063-13.2013}.
\item Halberstadt AL, Geyer MA. (2013). \textit{Serotonergic hallucinogens as translational models relevant to schizophrenia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1017/s1461145713000722}{doi:10.1017/s1461145713000722}.
\item Robin Carhart-Harris (2013). \textit{PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS}. Journal of Neurology Neurosurgery \& Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1136/jnnp-2013-306103.17}{doi:10.1136/jnnp-2013-306103.17}.
\item Bernasconi F, Schmidt A, Pokorny T, Kometer M, Seifritz E, Vollenweider FX. (2013). \textit{Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.}. Cerebral Cortex. [published; Europe PMC]. \href{https://doi.org/10.1093/cercor/bht178}{doi:10.1093/cercor/bht178}.
\item Catlow BJ, Song S, Paredes DA, Kirstein CL, Sanchez-Ramos J. (2013). \textit{Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.}. Experimental Brain Research. [published; Europe PMC]. \href{https://doi.org/10.1007/s00221-013-3579-0}{doi:10.1007/s00221-013-3579-0}.
\item Kometer M, Schmidt A, Jäncke L, Vollenweider FX. (2013). \textit{Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.}. Journal of Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.3007-12.2013}{doi:10.1523/jneurosci.3007-12.2013}.
\item Helander A, Beck O, Hägerkvist R, Hultén P. (2013). \textit{Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.3109/00365513.2013.793817}{doi:10.3109/00365513.2013.793817}.
\item Moreno JL, Holloway T, Rayannavar V, Sealfon SC, González-Maeso J. (2013). \textit{Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neulet.2012.12.053}{doi:10.1016/j.neulet.2012.12.053}.
\item Kometer, Michael, Schmidt, André, Jäncke, Lutz, Vollenweider, Franz X (2012). \textit{Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations}. Open MIND. [published; OpenAlex]. \href{https://openalex.org/W6929930661}{source link}.
\item Hanks JB, González-Maeso J. (2012). \textit{Animal models of serotonergic psychedelics.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/cn300138m}{doi:10.1021/cn300138m}.
\item Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F. (2012). \textit{The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-012-2811-0}{doi:10.1007/s00213-012-2811-0}.
\item Jacomien Aleman, Mirjam Crul, Peter H. J. van der Voort, Eric J. F. Franssen (2012). \textit{Anticholinergic toxicity after the ingestion of serotonergic 'magic mushrooms'}. Pure Amsterdam UMC. [published; OpenAlex]. \href{https://pure.amsterdamumc.nl/en/publications/9641390d-ba9e-4cf0-a1d5-445ec0f4717b}{source link}.
\item Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX. (2012). \textit{Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.}. Biological Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2012.04.005}{doi:10.1016/j.biopsych.2012.04.005}.
\item Evan J. Kyzar, Christopher Collins, Jeremy Green, Siddharth Gaikwad, Andrew Roth, Louis Monnig, Mohamed El-Ounsi, Nicholas Capezio, Andrew J. Freeman, Ari Davis, Allan V. Kalueff (2012). \textit{Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiology}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.26.1\_supplement.1043.3}{doi:10.1096/fasebj.26.1\_supplement.1043.3}.
\item LI Yu-bai (2011). \textit{Flavone Glycoside Antagonizes Psilocybin-Induced Toxicity by Reducing Oxidative Stress in Rats Model}. Zhongguo Yike Daxue xuebao. [published; OpenAlex]. \href{https://en.cnki.com.cn/Article\_en/CJFDTOTAL-ZGYK201201019.htm}{source link}.
\item David Luke, Devin B. Terhune, Ross Friday (2011). \textit{Psychedelic synaesthesia: Evidence for a serotonergic role in synaesthesia}. Seeing and Perceiving. [published; OpenAlex]. \href{https://doi.org/10.1163/187847612x646956}{doi:10.1163/187847612x646956}.
\item Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE, Seifritz E, Vollenweider FX. (2011). \textit{Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/npp.2011.261}{doi:10.1038/npp.2011.261}.
\item Quednow BB, Kometer M, Geyer MA, Vollenweider FX. (2011). \textit{Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.}. Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1038/npp.2011.228}{doi:10.1038/npp.2011.228}.
\item Moreno JL, Kurita M, Holloway T, López J, Cadagan R, Martínez-Sobrido L, García-Sastre A, González-Maeso J. (2011). \textit{Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.}. Journal of Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1523/jneurosci.4230-10.2011}{doi:10.1523/jneurosci.4230-10.2011}.
\item Moreno JL, Holloway T, Albizu L, Sealfon SC, González-Maeso J. (2011). \textit{Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neulet.2011.01.046}{doi:10.1016/j.neulet.2011.01.046}.
\item Halberstadt AL, Geyer MA. (2011). \textit{Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuropharm.2011.01.017}{doi:10.1016/j.neuropharm.2011.01.017}.
\item Halberstadt AL, Koedood L, Powell SB, Geyer MA. (2010). \textit{Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.}. Journal of Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881110388326}{doi:10.1177/0269881110388326}.
\item Kometer M, Cahn BR, Andel D, Carter OL, Vollenweider FX. (2010). \textit{The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.}. Biological Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.1016/j.biopsych.2010.10.002}{doi:10.1016/j.biopsych.2010.10.002}.
\item Matthew J. Baggott, Jennifer D. Siegrist, Gantt P. Galloway, Lynn C. Robertson, Jeremy Coyle, John Mendelson (2010). \textit{Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans}. PLoS ONE. [published; OpenAlex]. \href{https://doi.org/10.1371/journal.pone.0014074}{doi:10.1371/journal.pone.0014074}.
\item Sumnall HR, Measham F, Brandt SD, Cole JC. (2010). \textit{Salvia divinorum use and phenomenology: results from an online survey.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1177/0269881110385596}{doi:10.1177/0269881110385596}.
\item Thiago Berti Kirsten, Maria Martha Bernardi (2010). \textit{Acute toxicity of Psilocybe cubensis (Ear.) Sing., Strophariaceae, aqueous extract in mice}. Revista Brasileira de Farmacognosia. [published; OpenAlex]. \href{https://doi.org/10.1590/s0102-695x2010000300017}{doi:10.1590/s0102-695x2010000300017}.
\item Jan RK, Lin JC, Lee H, Sheridan JL, Kydd RR, Kirk IJ, Russell BR. (2010). \textit{Determining the subjective effects of TFMPP in human males.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-010-1911-y}{doi:10.1007/s00213-010-1911-y}.
\item Matthias Karst, John H. Halpern, Michael Bernateck, Torsten Passie (2010). \textit{The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series}. Cephalalgia. [published; OpenAlex]. \href{https://doi.org/10.1177/0333102410363490}{doi:10.1177/0333102410363490}.
\item O. Carter, John D. Pettigrew, Felix Hasler, Guy Wallis, Franz X. Vollenweider (2010). \textit{Psilocybin slows binocular rivalry switching through serotonin modulation}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/6.6.43}{doi:10.1167/6.6.43}.
\item Olivia Carter, David C. Burr, John D. Pettigrew, Franz X. Vollenweider (2010). \textit{Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptors}. Journal of Vision. [published; OpenAlex]. \href{https://doi.org/10.1167/5.8.683}{doi:10.1167/5.8.683}.
\item Butelman ER, Rus S, Prisinzano TE, Kreek MJ. (2010). \textit{The discriminative effects of the kappa-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-009-1771-5}{doi:10.1007/s00213-009-1771-5}.
\item Matthew J. Baggott (2009). \textit{Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention}. eScholarship (California Digital Library). [published; OpenAlex]. \href{https://escholarship.org/uc/item/7409s4th}{source link}.
\item Kovacic P, Somanathan R. (2009). \textit{Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.}. Oxidative Medicine and Cellular Longevity. [published; Europe PMC]. \href{https://doi.org/10.4161/oxim.2.4.9380}{doi:10.4161/oxim.2.4.9380}.
\item González-Maeso J, Sealfon SC. (2008). \textit{Agonist-trafficking and hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/092986709787581851}{doi:10.2174/092986709787581851}.
\item Adams JD. (2008). \textit{Chemical interactions with pyramidal neurons in layer 5 of the cerebral cortex: control of pain and anxiety.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.2174/092986709789057626}{doi:10.2174/092986709789057626}.
\item Hasler F, Kuznetsova OF, Krasikova RN, Cservenyak T, Quednow BB, Vollenweider FX, Ametamey SM, Westera G. (2008). \textit{GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.apradiso.2008.12.007}{doi:10.1016/j.apradiso.2008.12.007}.
\item J.C. Winter (2008). \textit{Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-008-1356-8}{doi:10.1007/s00213-008-1356-8}.
\item Geyer MA, Vollenweider FX. (2008). \textit{Serotonin research: contributions to understanding psychoses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.tips.2008.06.006}{doi:10.1016/j.tips.2008.06.006}.
\item F.X. Vollenweider, Daniel Hell, Michael Kometer (2008). \textit{Effects of the hallucinogenic 5-HT2A agonist psilocybin on object completion in humans}. International Journal of Psychophysiology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.ijpsycho.2008.05.397}{doi:10.1016/j.ijpsycho.2008.05.397}.
\item Danuta Marona-Lewicka, Benjamin R. Chemel, David E. Nichols (2008). \textit{Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI}. Psychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1007/s00213-008-1238-0}{doi:10.1007/s00213-008-1238-0}.
\item Wojciech Kostowski, W Rewerski, T Piechocki (2008). \textit{II. The Effects of Some Hallucinogens on Aggressiveness of Mice and Rats}. Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1159/000136297}{doi:10.1159/000136297}.
\item Heekeren K, Daumann J, Daumann J, Neukirch A, Stock C, Kawohl W, Norra C, Waberski TD, Gouzoulis-Mayfrank E. (2008). \textit{Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-008-1129-4}{doi:10.1007/s00213-008-1129-4}.
\item Nef HM, Möllmann H, Hilpert P, Krause N, Troidl C, Weber M, Rolf A, Dill T, Hamm C, Elsässer A. (2008). \textit{Apical regional wall motion abnormalities reminiscent to Tako-Tsubo cardiomyopathy following consumption of psychoactive fungi.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.ijcard.2007.12.064}{doi:10.1016/j.ijcard.2007.12.064}.
\item Bray JK, Goddard WA. (2008). \textit{The structure of human serotonin 2c G-protein-coupled receptor bound to agonists and antagonists.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.jmgm.2008.02.006}{doi:10.1016/j.jmgm.2008.02.006}.
\item González-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, López-Giménez JF, Zhou M, Okawa Y, Callado LF, Callado LF, Milligan G, Gingrich JA, Filizola M, Meana JJ, Sealfon SC. (2008). \textit{Identification of a serotonin/glutamate receptor complex implicated in psychosis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/nature06612}{doi:10.1038/nature06612}.
\item Briony J. Catlow (2007). \textit{Involvement of 5-HT2A Receptor in the Regulation of Hippocampal-Dependent Learning and Neurogenesis}. Digital Commons - University of South Florida (University of South Florida). [published; OpenAlex]. \href{https://digitalcommons.usf.edu/etd/166}{source link}.
\item Carter OL, Hasler F, Pettigrew JD, Wallis GM, Liu GB, Vollenweider FX. (2007). \textit{Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.}. Psychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-007-0930-9}{doi:10.1007/s00213-007-0930-9}.
\item Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC. (2007). \textit{Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2007.09.007}{doi:10.1016/j.pbb.2007.09.007}.
\item Winter JC. (2007). \textit{Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2007.07.007}{doi:10.1016/j.pbb.2007.07.007}.
\item Winter JC, Rice KC, Amorosi DJ, Rabin RA. (2007). \textit{Psilocybin-induced stimulus control in the rat.}. Pharmacology Biochemistry and Behavior. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2007.06.003}{doi:10.1016/j.pbb.2007.06.003}.
\item Marona-Lewicka D, Nichols DE. (2007). \textit{Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.pbb.2007.06.001}{doi:10.1016/j.pbb.2007.06.001}.
\item Vollenweider FX, Csomor PA, Knappe B, Geyer MA, Quednow BB. (2007). \textit{The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.}. Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1038/sj.npp.1301324}{doi:10.1038/sj.npp.1301324}.
\item González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA. (2007). \textit{Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/j.neuron.2007.01.008}{doi:10.1016/j.neuron.2007.01.008}.
\item Veniero Gambaro, Lucia Dell’Acqua, P.F. Croci, CM Pecoraro (2006). \textit{HPLC/DAD analysis of psilocin and psilocybin in psilocybe cubensis}. Unknown journal. [published; OpenAlex]. \href{https://air.unimi.it/handle/2434/146135}{source link}.
\item Majdanik S, Borowiak K, Brzezńska M, Machoy-Mokrzyńska A. (2006). \textit{[Concentration of selected microelements in blood serum of rats exposed to the action of psilocin and phenylethylamine].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/20143700}{source link}.
\item Moreno FA, Wiegand CB, Taitano EK, Delgado PL. (2006). \textit{Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.}. The Journal of Clinical Psychiatry. [published; Europe PMC]. \href{https://doi.org/10.4088/jcp.v67n1110}{doi:10.4088/jcp.v67n1110}.
\item Kelly Morris (2006). \textit{Hallucinogen research inspires “neurotheology”}. The Lancet Neurology. [published; OpenAlex]. \href{https://doi.org/10.1016/s1474-4422(06)70541-5}{doi:10.1016/s1474-4422(06)70541-5}.
\item David L. Eldridge, Karin Hillenbrand (2006). \textit{Hallucinogens}. Pediatrics in Review. [published; OpenAlex]. \href{https://doi.org/10.1542/pir.27.8.314}{doi:10.1542/pir.27.8.314}.
\item Wittmann M, Carter O, Hasler F, Cahn BR, Grimberg U, Spring P, Hell D, Flohr H, Vollenweider FX. (2006). \textit{Effects of psilocybin on time perception and temporal control of behaviour in humans.}. Queensland's institutional digital repository (The University of Queensland). [published; Europe PMC]. \href{https://doi.org/10.1177/0269881106065859}{source link}.
\item Jensen N, Gartz J, Laatsch H. (2006). \textit{Aeruginascin, a trimethylammonium analogue of psilocybin from the hallucinogenic mushroom Inocybe aeruginascens.}. Planta Medica. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2006-931576}{doi:10.1055/s-2006-931576}.
\item M. Braden, James J. Chambers, David E. Nichols (2006). \textit{Effects of the N343A mutation in TM6 of the human serotonin 5-HT2A Receptor}. The FASEB Journal. [published; OpenAlex]. \href{https://doi.org/10.1096/fasebj.20.4.a247-c}{doi:10.1096/fasebj.20.4.a247-c}.
\item Krzysztof Borowiak, Anna Machoy-Mokrzyńska, Sławomir Majdanik, Piotr Waloszczyk, Małgorzata Piasecka, Tomasz Janus, E. Jasionowicz-Piatek, Mirosław Parafiniuk (2005). \textit{Psilocin multiple intake resulted and in cardiotoxic effects}. Acta Toxicologica. [published; OpenAlex]. \href{http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-f39ab4e7-0a77-47a4-b535-5656f3d5df88}{source link}.
\item Howard Sard, Govindaraj Kumaran, Cynthia Morency, Bryan L. Roth, Beth Ann Toth, Ping He, Louis Shuster (2005). \textit{SAR of Psilocybin Analogues: Discovery of a Selective 5-HT2C Agonist.}. ChemInform. [published; OpenAlex]. \href{https://doi.org/10.1002/chin.200602219}{doi:10.1002/chin.200602219}.
\item Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M, Kovar KA. (2005). \textit{Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.}. Pharmacopsychiatry. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2005-916185}{doi:10.1055/s-2005-916185}.
\item Carter OL, Burr DC, Pettigrew JD, Wallis GM, Hasler F, Vollenweider FX. (2005). \textit{Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.}. Journal of Cognitive Neuroscience. [published; Europe PMC]. \href{https://doi.org/10.1162/089892905774597191}{doi:10.1162/089892905774597191}.
\item Sard H, Kumaran G, Morency C, Roth BL, Toth BA, He P, Shuster L. (2005). \textit{SAR of psilocybin analogs: discovery of a selective 5-HT2C agonist.}. Bioorganic \& Medicinal Chemistry Letters. [published; Europe PMC]. \href{https://doi.org/10.1016/j.bmcl.2005.06.104}{doi:10.1016/j.bmcl.2005.06.104}.
\item Euphrosyne Gouzoulis-Mayfrank, Anna Neukirch, Karsten Heekeren (2005). \textit{Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-2005-918695}{doi:10.1055/s-2005-918695}.
\item Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D, Vollenweider FX. (2005). \textit{Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/sj.npp.1300621}{doi:10.1038/sj.npp.1300621}.
\item Unknown authors (2004). \textit{P.3.027 Mismatch negativity generation in the human serotonergic and antiglutamatergic model of psychosis}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(05)80963-0}{doi:10.1016/s0924-977x(05)80963-0}.
\item Albers C, Köhler H, Lehr M, Brinkmann B, Beike J. (2004). \textit{Development of a psilocin immunoassay for serum and blood samples.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00414-004-0469-9}{doi:10.1007/s00414-004-0469-9}.
\item Carter OL, Pettigrew JD, Burr DC, Alais D, Hasler F, Vollenweider FX. (2004). \textit{Psilocybin impairs high-level but not low-level motion perception.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00001756-200408260-00023}{doi:10.1097/00001756-200408260-00023}.
\item O. Carter, David Alais, David C. Burr, Felix Hasler, G. Liu, Guy Wallis, Franz X. Vollenweider, John D. Pettigrew (2003). \textit{The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection Thresholds}. Queensland's institutional digital repository (The University of Queensland). [published; OpenAlex]. \href{https://openalex.org/W111026355}{source link}.
\item Leon Gussow (2003). \textit{Designer Hallucinogens}. Emergency Medicine News. [published; OpenAlex]. \href{https://doi.org/10.1097/00132981-200312000-00015}{doi:10.1097/00132981-200312000-00015}.
\item Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX. (2003). \textit{Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-003-1640-6}{doi:10.1007/s00213-003-1640-6}.
\item Felix Hasler, Ulrike Grimberg, Martin Benz, F.X. Vollenweider (2003). \textit{P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosis}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(03)92355-8}{doi:10.1016/s0924-977x(03)92355-8}.
\item Anna Machoy-Mokrzyńska, Krzysztof Safranow, Krzysztof Borowiak, Sławomir Majdanik, Violetta Dziedziejko, Monika Białecka, Dariusz Chlubek (2002). \textit{The influence of psilocin and phenylethylamine on the energy metabolism in the rat heart}. Acta Toxicologica. [published; OpenAlex]. \href{http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-8e3dbd92-615e-497e-af12-c98c681b8b63}{source link}.
\item Krzysztof Borowiak, Anna Machoy-Mokrzyńska, Leszek Domański, Sławomir Majdanik, Edward Dutkiewicz, K Safranow, Tomasz Janus, V Mikolajek (2002). \textit{Electrocardiographic examination of heart function in rats exposed to hallucinogens from Psilocybe mushrooms}. Acta Toxicologica. [published; OpenAlex]. \href{http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-d607ea49-70b5-4739-b280-7088af5d6e30}{source link}.
\item O. Carter, Shaun P. Collin, Felix Hasler, George Liu, Franz X. Vollenweider, John D. Pettigrew (2002). \textit{A double-blind, placebo controlled study of the effect of the hallucinogenic 5-HT1A\&2A agonist psilocybin on binocular rivalry rate and rhythmicity}. Social Neuroscience. [published; OpenAlex]. \href{https://espace.library.uq.edu.au/view/UQ:161618}{source link}.
\item Umbricht D, Vollenweider FX, Schmid L, Grübel C, Skrabo A, Huber T, Koller R. (2002). \textit{Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/sj.npp.1300005}{doi:10.1038/sj.npp.1300005}.
\item Riba J, Rodríguez-Fornells A, Barbanoj MJ. (2002). \textit{Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/s00213-002-1237-5}{doi:10.1007/s00213-002-1237-5}.
\item Passie T, Seifert J, Schneider U, Emrich HM. (2002). \textit{The pharmacology of psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/1355621021000005937}{doi:10.1080/1355621021000005937}.
\item Rabin RA, Regina M, Doat M, Winter JC. (2002). \textit{5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0091-3057(01)00720-1}{doi:10.1016/s0091-3057(01)00720-1}.
\item Umbricht D, Koller R, Vollenweider FX, Schmid L. (2002). \textit{Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0006-3223(01)01242-2}{doi:10.1016/s0006-3223(01)01242-2}.
\item Fukuda K. (2002). \textit{Possible mechanisms of panic attack and schizophrenia via APUD system.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1054/mehy.2001.1473}{doi:10.1054/mehy.2001.1473}.
\item Vollenweider FX. (2001). \textit{Brain mechanisms of hallucinogens and entactogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.31887/dcns.2001.3.4/fxvollenweider}{doi:10.31887/dcns.2001.3.4/fxvollenweider}.
\item Vollenweider FX, Geyer MA. (2001). \textit{A systems model of altered consciousness: integrating natural and drug-induced psychoses.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0361-9230(01)00646-3}{doi:10.1016/s0361-9230(01)00646-3}.
\item Erik Hoffmann, Jan M. Keppel Hesselink, M. da Silveira Barbosa (2000). \textit{Effects of a Psychedelic, Tropical Tea, Ayahuasca, on the Electroencephalographic (EEG) Activity of the Human Brain during a Shamanistic Ritual}. Unknown journal. [published; OpenAlex]. \href{http://www.newbrainnewworld.com/?download=EEG-ayahuasca\%20study.pdf}{source link}.
\item Moldavan MG, Grodzinskaya AA, Solomko EF, Lomberh ML, Wasser SP, Storozhuk VM. (2000). \textit{The effect of Psilocybe cubensis extract on hippocampal neurons in vitro.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/11962085}{source link}.
\item Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D, Cumbay MG, Watts VJ, Barker EL, Nichols DE. (2000). \textit{Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/jm000339w}{doi:10.1021/jm000339w}.
\item Barrett SP, Archambault J, Engelberg MJ, Pihl RO. (2000). \textit{Hallucinogenic drugs attenuate the subjective response to alcohol in humans.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/1099-1077(200010)15:7<559::aid-hup230>3.0.co;2-j}{doi:10.1002/1099-1077(200010)15:7<559::aid-hup230>3.0.co;2-j}.
\item McBride MC. (2000). \textit{Bufotenine: toward an understanding of possible psychoactive mechanisms.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.2000.10400456}{doi:10.1080/02791072.2000.10400456}.
\item Daniel Umbricht, F.X. Vollenweider, L. Schmid, R. Koller (2000). \textit{177. NMDA and 5-HT2A receptor dysfunction in working memory deficits in schizophrenia}. Biological Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0006-3223(00)00439-x}{doi:10.1016/s0006-3223(00)00439-x}.
\item M. G. Moldavan, Elvira F. Solomko, Anna A. Grodzínskaya, V. М. Storozhuk, Margarita Lomberg (1999). \textit{Neurotropic Effect of Extracts from the Hallucinogenic Mushroom Psilocybe cubensis (Earle) Sing. (Agaricomycetideae). In Vitro Studies}. International journal of medicinal mushrooms. [published; OpenAlex]. \href{https://doi.org/10.1615/intjmedmushr.v2.i4.130}{doi:10.1615/intjmedmushr.v2.i4.130}.
\item Gerasimov M, Marona-Lewicka D, Kurrasch-Orbaugh DM, Qandil AM, Nichols DE. (1999). \textit{Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/jm990325u}{doi:10.1021/jm990325u}.
\item Vollenweider FX, Vontobel P, Hell D, Leenders KL. (1999). \textit{5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0893-133x(98)00108-0}{doi:10.1016/s0893-133x(98)00108-0}.
\item Franco Tagliaro (1998). \textit{Recommended Methods for the Detection and Assay of Lysergide (LSD), Phencyclidine (PCP), Psilocybin and Methaqualone in biological Specimens (multiauthored manual)}. Unknown journal. [published; OpenAlex]. \href{https://iris.univr.it/handle/11562/302309}{source link}.
\item Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D. (1998). \textit{Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00001756-199812010-00024}{doi:10.1097/00001756-199812010-00024}.
\item Euphrosyne Gouzoulis-Mayfrank, Karsten Heekeren, B. Thelen, Hiltrud Lindenblatt, K.-A. Kovar, H. Sass, M.A. Geyer (1998). \textit{529 The hallucinogen psilocybin increases prepulse inhibition of the startle reflex in healthy humans}. International Journal of Psychophysiology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0167-8760(98)90528-1}{doi:10.1016/s0167-8760(98)90528-1}.
\item Vollenweider FX. (1998). \textit{Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-2007-979353}{doi:10.1055/s-2007-979353}.
\item Ametamey S., Vollenweider F. X., Patt J., Bourquin D., Hasler F., Beer H.-F., Schubiger P. A. (1998). \textit{11C-radiolabeling of hallucinogenic psilocin, a potential radioligand for studying the role of serotonin receptors in psychotic symptom formation}. Journal of Labelled Compounds and Radiopharmaceuticals. [published; Crossref]. \href{https://doi.org/10.1002/(sici)1099-1344(199807)41:7<585::aid-jlcr115>3.0.co;2-u}{doi:10.1002/(sici)1099-1344(199807)41:7<585::aid-jlcr115>3.0.co;2-u}.
\item Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, Angst J. (1997). \textit{Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0893-133x(96)00246-1}{doi:10.1016/s0893-133x(96)00246-1}.
\item Almaula N, Ebersole BJ, Ballesteros JA, Weinstein H, Sealfon SC. (1996). \textit{Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0026-895x(25)09149-7}{doi:10.1016/s0026-895x(25)09149-7}.
\item Hanes KR. (1996). \textit{Serotonin, psilocybin, and body dysmorphic disorder: a case report.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1097/00004714-199604000-00011}{doi:10.1097/00004714-199604000-00011}.
\item Hery F, Hamon M. (1993). \textit{[Neuroleptics and serotonin].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/7905821}{source link}.
\item Strassman RJ. (1992). \textit{Human hallucinogen interactions with drugs affecting serotonergic neurotransmission.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1388647}{source link}.
\item T. Stijve (1991). \textit{Psilocin, psilocybin, serotonin and urea in Panaeolus cyanescens from various origin}. The Digital Academic Repository of Naturalis Biodiversity Center (Naturalis Biodiversity Center). [published; OpenAlex]. \href{http://www.repository.naturalis.nl/record/532101}{source link}.
\item Buckholtz NS, Zhou DF, Freedman DX, Potter WZ. (1990). \textit{Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1969270}{source link}.
\item Eivindvik K, Rasmussen KE, Sund RB. (1988). \textit{Handling of psilocybin and psilocin by everted sacs of rat jejunum and colon.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/2610906}{source link}.
\item Appel JB, Callahan PM. (1988). \textit{Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0014-2999(89)90041-1}{doi:10.1016/0014-2999(89)90041-1}.
\item Leonard HL, Rapoport JL. (1987). \textit{Relief of obsessive-compulsive symptoms by LSD and psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/ajp.144.9.1239b}{doi:10.1176/ajp.144.9.1239b}.
\item Martin WR, Sloan JW. (1986). \textit{Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(86)90369-2}{doi:10.1016/0091-3057(86)90369-2}.
\item Jochen Gartz (1985). \textit{Psilocybin in Mycelkulturen von Inocybe aeruginascens}. Biochemie und Physiologie der Pflanzen. [published; OpenAlex]. \href{https://doi.org/10.1016/s0015-3796(86)80042-7}{doi:10.1016/s0015-3796(86)80042-7}.
\item Richard Evans Schultes (1984). \textit{The genus psilocybe}. Journal of Ethnopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/0378-8741(84)90031-x}{doi:10.1016/0378-8741(84)90031-x}.
\item Trulson ME, Preussler DW, Trulson VM. (1983). \textit{Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)21616-0}{doi:10.1016/s0022-3565(25)21616-0}.
\item McCall RB. (1981). \textit{Neurophysiological effects of hallucinogens on serotonergic neuronal systems.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0149-7634(82)90033-1}{doi:10.1016/0149-7634(82)90033-1}.
\item Trulson ME, Heym J, Jacobs BL. (1981). \textit{Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-8993(81)90507-2}{doi:10.1016/0006-8993(81)90507-2}.
\item Laubscher A, Pletscher A, Noll H. (1981). \textit{Interaction of D-LSD with blood platelets of rabbits: shape change and specific binding.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)32431-6}{doi:10.1016/s0022-3565(25)32431-6}.
\item Migliaccio GP, Shieh TL, Byrn SR, Hathaway BA, Nichols DE. (1981). \textit{Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR spectroscopy.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1021/jm00134a016}{doi:10.1021/jm00134a016}.
\item Järbe TU. (1980). \textit{LDS-25 as a discriminative stimulus for response selection by pigeons.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0091-3057(80)90279-8}{doi:10.1016/0091-3057(80)90279-8}.
\item McCall RB, Aghajanian GK. (1980). \textit{Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0024-3205(80)90654-2}{doi:10.1016/0024-3205(80)90654-2}.
\item Chilton WS, Bigwood J, Jensen RE. (1978). \textit{Psilocin, bufotenine and serotonin: historical and biosynthetic observations.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1080/02791072.1979.10472093}{doi:10.1080/02791072.1979.10472093}.
\item Whitaker PM, Seeman P. (1978). \textit{High-affinity 3H-serotonin binding to caudate: inhibition by hallucinogens and serotoninergic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00428022}{doi:10.1007/bf00428022}.
\item Meltzer HY, Fessler RG, Simonovic M, Fang VS. (1978). \textit{Stimulation of rat prolactin secretion by indolealkylamine hallucinogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00432847}{doi:10.1007/bf00432847}.
\item Green JP, Weinstein H, Maayani S. (1977). \textit{Defining the histamine H2-receptor in brain: the interaction with LSD.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/30911}{source link}.
\item Repke DB, Leslie DT, Guzmán G. (1977). \textit{Baeocystin in psilocybe, conocybe and panaeolus.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/600026}{source link}.
\item Jacobs BL, Trulson ME, Stern WC. (1977). \textit{Behavioral effects of LSD in the cat: proposal of an animal behavior model for studying the actions of hallucinogenic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-8993(77)90423-1}{doi:10.1016/0006-8993(77)90423-1}.
\item Trulson ME, Stark AD, Jacobs BL. (1977). \textit{Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0014-2999(77)90097-8}{doi:10.1016/0014-2999(77)90097-8}.
\item James Edward Guest (1976). \textit{Electroencephalographic and behavioral effects of 4-phosphoryloxy N, N-dimethyltryptamine (psilocybin) on the New Zealand albino rabbit}. UA Campus Repository (The University of Arizona). [published; OpenAlex]. \href{http://hdl.handle.net/10150/348103}{source link}.
\item Hungen KV, Roberts S, Hill DF. (1975). \textit{Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/0006-8993(75)90876-8}{doi:10.1016/0006-8993(75)90876-8}.
\item Fischer R, Goldman H. (1975). \textit{Therapeutic usefulness of hallucinogenic drugs as a function of their chemical structure.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1055/s-0028-1094457}{doi:10.1055/s-0028-1094457}.
\item Steven H. Pollock (1974). \textit{The Psilocybin Mushroom Pandemic}. Journal of Psychedelic Drugs. [published; OpenAlex]. \href{https://doi.org/10.1080/02791072.1975.10472640}{doi:10.1080/02791072.1975.10472640}.
\item Aghajanian GK, Hailgler HJ. (1974). \textit{Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1063421}{source link}.
\item Rech RH, Tilson HA, Marquis WJ. (1974). \textit{Adaptive changes in behavior after repeated administration of various psychoactive drugs.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/1163377}{source link}.
\item Fanciullacci M, Franchi G, Sicuteri F. (1974). \textit{Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headache.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01919685}{doi:10.1007/bf01919685}.
\item Hans Peter Weber, Trevor J. Petcher (1974). \textit{ChemInform Abstract: CRYSTAL STRUCTURES OF THE TEONANACATL HALLUCINOGENS PART1, PSILOCYBIN C12H17N2O4O}. Chemischer Informationsdienst. [published; OpenAlex]. \href{https://doi.org/10.1002/chin.197435062}{doi:10.1002/chin.197435062}.
\item Aboul-Enein HY. (1974). \textit{Psilocybin: a pharmacological profile.}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/4853936}{source link}.
\item Stolk JM, Barchas JD, Goldstein M, Boggan W, Freedman DX. (1974). \textit{A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)29806-8}{doi:10.1016/s0022-3565(25)29806-8}.
\item Haefely W. (1973). \textit{The effects of 5-hydroxytryptamine and some related compounds on the cat superior cervical ganglion in situ.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00503495}{doi:10.1007/bf00503495}.
\item Dyer DC, Gant DW. (1973). \textit{Vasoconstriction produced by hallucinogens on isolated human and sheep umbilical vasculature.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)29420-4}{doi:10.1016/s0022-3565(25)29420-4}.
\item Robert Walker, G.N. Woodruff (1972). \textit{The effect of bufotenine, melatonin, psilocybin, and related compounds on the 5-hydroxytryptamine excitatory receptors of Helix aspersa neurons}. Comparative and General Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/0010-4035(72)90039-0}{doi:10.1016/0010-4035(72)90039-0}.
\item Brown JK, Shapazian L, Griffin GD. (1971). \textit{A rapid screening procedure for some "street drugs" by thin-layer chromatography.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0021-9673(00)92956-x}{doi:10.1016/s0021-9673(00)92956-x}.
\item Schechter MD, Rosecrans JA. (1971). \textit{Lysergic acid diethylamide (LSD) as a discriminative cue: drugs with similar stimulus properties.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00422707}{doi:10.1007/bf00422707}.
\item Andén NE, Corrodi H, Fuxe K. (1971). \textit{Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)29027-9}{doi:10.1016/s0022-3565(25)29027-9}.
\item K. Genest, Lorna J. Lowry (1970). \textit{Microcrystalloptic tests for lysergic acid diethylamide and other hallucinogens}. Journal of Pharmacy and Pharmacology. [published; OpenAlex]. \href{https://doi.org/10.1111/j.2042-7158.1970.tb08449.x}{doi:10.1111/j.2042-7158.1970.tb08449.x}.
\item 五郎 中村 (1970). \textit{PsilocybinおよびLSDの精神身体症状におよぼす影響-1-LSDに就て}. 新潟医学会雑誌. [published; OpenAlex]. \href{http://ci.nii.ac.jp/naid/40018192360}{source link}.
\item Richard Hill, Roland A. Fischer (1970). \textit{Psilocybin-Induced Transformations of Visual Space}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1094281}{doi:10.1055/s-0028-1094281}.
\item J. PICKER, R. W. RICKARDS (1970). \textit{The occurrence of the psychotomimetic agent psilocybin in an Australian agaric, Psilocybe subaeruginosa}. Australian Journal of Chemistry. [published; OpenAlex]. \href{https://doi.org/10.1071/ch9700853}{doi:10.1071/ch9700853}.
\item Martin WR, Eades CG. (1969). \textit{The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00402084}{doi:10.1007/bf00402084}.
\item Peter Gwynne, Roland Fischer, Richard Hill (1969). \textit{Hypnotic Induction of the Interference of Psilocybin with Optically Induced Spatial Distortion}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1094250}{doi:10.1055/s-0028-1094250}.
\item Edward T. Uyeno (1969). \textit{Alteration of a learned response of the squirrel monkey by hallucinogens}. International Journal of Neuropharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/0028-3908(69)90045-8}{doi:10.1016/0028-3908(69)90045-8}.
\item Hill RM, Fischer R, Warshay D. (1969). \textit{Effects of excitatory and tranquilizing drugs on visual perception. Spatial distortion thresholds.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf01899105}{doi:10.1007/bf01899105}.
\item R Fischer, Diana Warshay (1968). \textit{Psilocybin-induced Autonomic, Perceptual, and Behavioral Change}. Pharmacopsychiatry. [published; OpenAlex]. \href{https://doi.org/10.1055/s-0028-1094227}{doi:10.1055/s-0028-1094227}.
\item C Schneider (1968). \textit{Behavioural Effects of some Morphine Antagonists and Hallucinogens in the Rat}. Nature. [published; OpenAlex]. \href{https://doi.org/10.1038/220586a0}{doi:10.1038/220586a0}.
\item Appel JB, Freedman DX. (1968). \textit{Tolerance and cross-tolerance among psychotomimetic drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00401404}{doi:10.1007/bf00401404}.
\item Malcolm B. Bowers (1967). \textit{Dynamics of Psychedelic Drug Abuse}. Archives of General Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1001/archpsyc.1967.01730230044006}{doi:10.1001/archpsyc.1967.01730230044006}.
\item Gilmour LP, O'Brien RD. (1966). \textit{Psilocybin: reaction with a fraction of rat brain.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.155.3759.207}{doi:10.1126/science.155.3759.207}.
\item Corne SJ, Pickering RW. (1966). \textit{A possible correlation between drug-induced hallucinations in man and a behavioural response in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00401509}{doi:10.1007/bf00401509}.
\item Richard R. Heim, K. Genest, Donald W. Hughes, G. Belec (1966). \textit{Botanical and Chemical Characterisation of a Forensic Mushroom Specimen of the Genus Psilocybe}. Journal of the Forensic Science Society. [published; OpenAlex]. \href{https://doi.org/10.1016/s0015-7368(66)70336-3}{doi:10.1016/s0015-7368(66)70336-3}.
\item Collins RL, Ordy JM, Samorajski T. (1966). \textit{Psilocin: effects on behaviour and brain serotonin in mice.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1038/209785a0}{doi:10.1038/209785a0}.
\item Uyeno ET. (1966). \textit{Inhibition of isolation-induced attack behavior of mice by drugs.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1002/jps.2600550221}{doi:10.1002/jps.2600550221}.
\item Sjoberg BM, Hollister LE. (1965). \textit{The effects of psychotomimetic drugs on primary suggestibility.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1007/bf00407857}{doi:10.1007/bf00407857}.
\item John C. Pollard, Leonard Uhr, Elizabeth Stein (1964). \textit{Drugs and phantasy: the effects of LSD, psilocybin, and sernyl on college students}. Medical Entomology and Zoology. [published; OpenAlex]. \href{http://ci.nii.ac.jp/ncid/BA15610290}{source link}.
\item LUDWIG AM, LEVINE J. (1964). \textit{PATTERNS OF HALLUCINOGENIC DRUG ABUSE.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1001/jama.1965.03080020020006}{doi:10.1001/jama.1965.03080020020006}.
\item TOLAN EJ, LINGL FA. (1964). \textit{"MODEL PSYCHOSIS" PRODUCED BY INHALATION OF GASOLINE FUMES.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1176/ajp.120.8.757}{doi:10.1176/ajp.120.8.757}.
\item Joseph Havens (1963). \textit{A Working Paper: Memo on the Religious Implications of the Consciousness-Changing Drugs (LSD, Mescalin, Psilocybin)}. Journal for the Scientific Study of Religion. [published; OpenAlex]. \href{https://doi.org/10.2307/1384511}{doi:10.2307/1384511}.
\item WOOLLEY DW, CAMPBELL NK. (1962). \textit{Serotonin-like and antiserotonin properties of psilocybin and psilocin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1126/science.136.3518.777}{doi:10.1126/science.136.3518.777}.
\item VITEK V, VOJTECHOVSKY M, GROF S. (1961). \textit{[Serotonin metabolism in experimental psilocybin psychosis].}. Unknown journal. [published; Europe PMC]. \href{https://europepmc.org/article/MED/13926289}{source link}.
\item F. Silva, R.G. Heath, Thomas Rafferty, Robert A. Johnson, William R. Robinson (1960). \textit{Comparative effects of the administration of taraxein, d-LSD, mescaline, and psilocybin to human volunteers}. Comprehensive Psychiatry. [published; OpenAlex]. \href{https://doi.org/10.1016/s0010-440x(60)80060-0}{doi:10.1016/s0010-440x(60)80060-0}.
\item GESSNER PK, KHAIRALLAH PA, McISAAC WM, PAGE IH. (1960). \textit{The relationship between the metabolic fate and pharmacological actions of serotonin, bufotenine and psilocybin.}. Unknown journal. [published; Europe PMC]. \href{https://doi.org/10.1016/s0022-3565(25)25873-6}{doi:10.1016/s0022-3565(25)25873-6}.
\item S MALITZ, H ESECOVER, B WILKENS, P HOCH (1960). \textit{Some observations on psilocybin, a new hallucinogen, in volunteer subjects}. Corrosion Science. [published; OpenAlex]. \href{https://doi.org/10.1016/s0010-938x(60)80004-2}{doi:10.1016/s0010-938x(60)80004-2}.
\item Harold A. Abramson, Anabela P. Rolo, B. Sklarofsky, J. Stache (1959). \textit{Production of Cross-Tolerance to Psychosis-Producing Doses of Lysergic Acid Diethylamide and Psilocybin}. The Journal of Psychology. [published; OpenAlex]. \href{https://doi.org/10.1080/00223980.1960.9916396}{doi:10.1080/00223980.1960.9916396}.
\end{enumerate}
\end{document}
